Staphylococcus aureus: the paths and crosstalks that lead to heme by Videira, Marco A.M
  
Marco André Moras Videira 
 
Dissertation presented to obtain the Ph.D degree in 
Biochemistry 
Instituto de Tecnologia Química e Biológica António Xavier| Universidade 
Nova de Lisboa 
 
Supervisor: Dr. Lígia M. Saraiva 
Co-supervisor: Dr. Susana A. L. Lobo 
 
 
Oeiras, May 2018
Staphylococcus aureus: the 
paths and crosstalks that 
lead to heme 
ii 
From left to right: Maria Arménia carrondo, Susana Lobo, Lígia Saraiva, 
Carlos Salgueiro, Marco Videira, Maria Salomé Gomes, Mariana Pinho, 
Arsénio Fialho. 
14th of May 2018 
 
 
 
 
 
 
 
Third Edition, May 2018 
 
Molecular Mechanisms of Pathogen Resistance Laboratory  
Instituto de Tecnologia Química e Biológica  
Universidade Nova de Lisboa  
2780-157 Portugal
iii 
Acknowledgments 
 
I would like to express my gratitude to the people that contributed to 
this work and made this thesis possible: 
To my supervisor, Dr. Lígia Saraiva, for inviting me to apply for a PhD 
student grant and accepting me as member of her group. For her mentoring, 
constant support, motivation, advices and ideas. For her availability and for 
pointing the way when it was necessary. Thank you for the suggestions, 
critics and careful revision of this thesis. I also want to thank you for your 
friendship and making me a better person. Thank you very much. 
To my co-supervisor, Susana Lobo, for her friendship, guidance and 
helpful brainstorms. For teaching me since the first day I arrived at the lab. 
And not less important for the many rides home when I was not coming to 
the lab by car! Thank you. 
To my PhD Thesis Committee, Prof. Miguel Teixeira and Dr. Ana 
Melo, for accepting being part of the committee. For the availability for the 
meetings and for the discussions. A special thanks to Ana Melo for receiving 
me in her lab in my degree in biochemistry, showing me how to take my first 
steps in scientific research and for introducing me to Dr. Lígia Saraiva. 
I want to thank Fábio Fernandes and Ana countinho, from Instituto 
Superior Técnico, for their collaboration in FLIM-FRET and fluorescent 
anisotropy experiments. 
To Martin Warren and Dave Palmer for the collaboration in HPLC-MS 
experiments, for suggestions and experimental ideas and for the revision of 
the manuscripts. 
To João Carita and Isabel Pacheco for their technical support. 
iv 
I want to thank all the present and former members of our lab, 
Molecular Mechanisms of Pathogen Resistance, specially Lígia Nobre, 
Margarida Parente, João Monteiro, Liliana Silva, Sandra Carvalho, Joana 
Marques, Cátia Família and Patrícia Ferreira for your friendship, helpful 
discussions, for the laughs and for keeping the good environment in the lab 
throughout these years.  
I also want to thank to ITQB for the facilities and for making fell a 
home. 
To Fundação para a Ciência e Tecnologia (FCT) for the financial 
support and for awarding me a PhD grant (SFRH/BD/95912/2013). 
 
À minha família pelo carinho e apoio constante ao longo destes anos. 
Principalmente aos meus pais porque me possibilitaram o meu 
desenvolvimento científico e pessoal.  
Quero agradecer à Camila, minha mulher, pela ajuda preciosa que 
me deu! Pelo apoio e carinho constante mesmo nos momentos mais difíceis. 
Pelas discussões e paciência ao longo destes anos. Obrigado por me 
fazeres feliz! 
 
 
 
 
 
 
 
 
This thesis is dedicated to my parents and my wife 
v 
Thesis Publications 
 
 
This dissertation is based on the following original publications, listed by 
chronological order:  
Lobo SAL, Scott A, Videira MAM, Winpenny D, Gardner M, Palmer MJ, 
Schroeder S, Lawrence AD, Parkinson T, Warren MJ, Saraiva LM (2015) 
Staphylococcus aureus haem biosynthesis: characterisation of the enzymes 
involved in final steps of the pathway. Mol Microbiol 97(3):472–487. 
Videira MAM, Lobo SAL, Silva LSO, Palmer DJ, Warren MJ, Prieto M, 
Coutinho A, Sousa FL, Fernandes F, and Saraiva LM (2018) Staphylococcus 
aureus haem biosynthesis and acquisition pathways are linked through 
haem monooxygenase IsdG. Submitted 
 
Manuscript in preparation, based on results presented in Chapter 6:  
Videira MAM, Família C, Lobo SAL and Saraiva LM (2018) Characterization 
of siroheme synthesis in Staphylococcus aureus. 
 
Publications not included in this thesis: 
Lobo SAL, Videira, MAM, Pacheco, I, Wass MN., Warren, MJ., Teixeira M, 
Matias PM & Saraiva, LM. (2017). Desulfovibrio vulgaris CbiKP 
cobaltochelatase: evolution of a haem binding protein orchestrated by the 
incorporation of two histidine residues. Environ microbiol, 19 (1), 106-118. 
 
vii 
Abstract 
 
S. aureus is one of the leading causes of nosocomial infections and 
nowadays a major public health concern due to the increase in antibiotic 
resistant strains. During host invasion, S. aureus is exposed to different 
oxygen concentrations depending on the site of infection. When oxygen is 
available, S. aureus uses heme-dependent terminal oxidases for aerobic 
respiration. However, some locals of infection are oxygen-limited and in this 
case S. aureus has to use other substrates such as nitrate or nitrite as 
terminal electron acceptors of an anaerobic respiration chain, in which 
siroheme-containing enzymes are active. Also during infection, S. aureus 
uses the heme uptake system to scavenge heme from host hemoglobin and 
utilize it as iron source. In S. aureus, although the heme uptake system have 
been intensively studied, the knowledge on the biosynthesis of heme and 
siroheme remains incomplete. To better understand the metabolism that 
guarantees S. aureus survival during the infectious processes, this thesis 
elucidates the way S. aureus synthesizes these two tetrapyrroles. Herein, we 
Tetrapyrroles are biological molecules widespread through all living 
organisms and necessary for fundamental cellular processes. Within the 
wide range of known tetrapyrroles, heme and siroheme are prosthetic groups 
in proteins responsible for important functions such as gas transport and 
storage, electron transport, cellular signaling, cellular detoxification as well 
as for reduction of sulfite and nitrite. Both molecules are synthesized from a 
last common tetrapyrrole precursor, namely uroporphyrinogen III, forming 
heme via four enzymatic steps know as the classical heme biosynthesis 
pathway and generating siroheme via an independent route. In some 
organisms such as sulfate and nitrate reducing bacteria, heme is alternatively 
synthesized through the siroheme-dependent pathway. 
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provide new insights into the heme metabolism of S. aureus through the 
comprehensive study of three topics: (i) the characterization of the heme 
biosynthesis pathway of S. aureus and its possible utilization as an 
antimicrobial target; (ii) clarification on how S. aureus is able to fine-tune the 
heme that is either synthesized de novo or acquired from the host; and (iii) 
characterization of the siroheme biosynthesis pathway of S. aureus. 
The analysis of S. aureus genome revealed the presence of genes 
encoding putative enzymes involved in the late steps of heme biosynthesis 
pathway, namely HemE, HemN, HemY and HemH. The role of these 
enzymes in the heme biosynthesis pathway of S. aureus was addressed by 
overexpression, purification and characterization of the enzymes. The results 
have shown that in S. aureus, the coproporphyrinogen III produced by 
uroporphyrinogen III decarboxylase HemE is converted to coproporphyrin III 
by coproporphyrinogen III oxidase HemY, which is then used by 
coproporphyrin ferrochelatase HemH for iron insertion into the macrocycle, 
leading to the formation of iron-coproporphyrin III. A S. aureus strain deleted 
in hemH was constructed and shown to accumulate coproporphyrin III. It was 
demonstrated that HemY oxidizes coproporphyrinogen III with a specific 
activity of 24.6 nmol.min-1mg-1 and HemH inserts iron into coproporphyrin III 
with an activity of 815 nmol.min-1mg-1. It was shown that the last step of this 
pathway is the decarboxylation of iron-coproporphyrin III by the iron-
coproporphyrin decarboxylase HemQ. This pathway represents a new 
transitional route between to previously described pathways, the classical 
and the siroheme-dependent pathways.     
 On the search for inhibitors of the pathway, HemY was shown to be 
impaired by derivatives of diphenyl-ether herbicides making this enzyme a 
promising candidate for drug discovery, which could be important for tackling 
the problem of antibiotic resistance.  
The second part of the work addressed the link between the systems 
for heme uptake and heme biosynthesis of S. aureus. Both routes are known 
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to supply heme to S. aureus, and thus a regulation mechanism was 
hypothesized to occur to ensure heme homeostasis, so that the toxicity 
associated with elevated concentration of heme is avoided. To pursue this 
hypothesis, the late steps of S. aureus heme biosynthesis pathway were 
reconstituted in an E. coli strain unable to synthesize heme and also devoid 
of S. aureus heme oxygenases IsdG and IsdI. The results have shown that 
IsdG, but not IsdI, impairs the growth of the complemented E. coli strain by 
hampering heme synthesis. IsdG was shown to inhibit the ferrochelatase 
activity of HemH in a concentration dependent manner. It was shown by 
fluorescence anisotropy and also FLIM-FRET that IsdG interacts in vitro and 
in vivo with S. aureus HemH. It was also shown through RT-qPCR and flow 
cytometry that the cellular content of IsdG is higher in the presence of heme, 
which suggests that heme increases the content of IsdG promoting 
interaction with the ferrochelatase enzyme of the heme biosynthesis pathway 
which results in inhibition of the endogenous produced heme. Furthermore, 
an in silico analysis have revealed that one third of the genomes encoding 
heme biosynthesis pathway also contains a gene for an IsdG-type heme 
oxygenase. This analysis also revealed that IsdG homologues are normally 
encoded in genomes also containing HemH and/or HemQ. Altogether, this 
part of the work has demonstrated that bacteria are able to regulate heme 
homeostasis by linking the heme biosynthesis pathway and the heme uptake 
system through HemH and IsdG. 
Upon infection of the host, S. aureus utilizes the siroheme-containing 
protein nitrite reductase to reduce nitrite, either using it as part of the 
respiratory chain to accept electrons when exposed to low oxygen 
environments or for the detoxification of nitrite produced by neighboring and 
host enzymes. Analysis of S. aureus genome showed that it contains three 
genes that may be involved in siroheme synthesis, which two were annotated 
as cysG in accordance to the siroheme synthase of E. coli. One cysG is 
located on the nirBD operon and the other cysG is separately localized in a 
x 
cluster downstream cysJ. The two gene products were overexpressed, the 
proteins purified, and in vitro and in vivo assays were performed to analyze 
their role in S. aureus. Enzymatic assays have shown that the protein 
encoded by the cysG gene downstream nirBD acts as uroporphyrinogen III 
methyltransferase (SirA), generating precorrin-2, and the protein encoded by 
the cysG gene downstream cysJ acts as a precorrin-2 dehydrogenase (SirC), 
which is able to produce sirohydrochlorin when incubated with precorrin-2 
and NAD+. Since one last step was missing and no apparent protein was 
present, a new search for a putative sirohydrochlorin ferrochelatase (SirB) 
was made. Blast analysis revealed the occurrence of a gene annotated as 
nirR which shares 25% sequence identity and 44% similarity to B. 
megaterium SirB. Following cloning and expression, the purified protein was 
shown to act as sirohydrochlorin ferrochelatase. Moreover, functional 
complementation experiments were performed, where S. aureus SirB in 
combination with SirA and SirC was able to complement an E. coli strain 
lacking cysG and thus unable to synthesize siroheme. Therefore, this protein 
constitutes the last step of the pathway that generates the final product 
siroheme. Altogether the siroheme pathway active in S. aureus was 
established for the first time. 
To conclude, the results presented in this thesis contribute to a better 
understanding of the S. aureus physiology and metabolism, by elucidating 
the way in which the life dependent tetrapyrroles heme and siroheme are 
formed. Not less important, it was shown how S. aureus maintains the 
adequate levels of heme avoiding the excess of intracellular free toxic heme 
that would challenge the pathogen survival. 
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Resumo 
 
Os Tetrapirróis são moléculas biológicas presentes em todos os 
organismos vivos e necessários para processos celulares fundamentais. 
Entre os tetrapirróis mais conhecidos, o hemo e o sirohemo são grupos 
prostéticos de proteínas com funções importantes, tais como o transporte e 
armazenamento de gases, o transporte de eletrões, a sinalização celular, a 
desintoxicação celular e também a redução de sulfito e nitrito. As duas 
moléculas são sintetizadas a partir de um percursor final comum, o 
uroporfirinogénio III, onde a formação de hemo ocorre através de quatro 
reações enzimáticas pela via clássica de biossíntese de hemo e produzindo 
sirohemo através de uma via independente. Em alguns organismos como 
bactérias redutoras de sulfato e nitrato, a síntese do hemo ocorre através de 
uma via dependente de sirohemo. 
S. aureus é uma das principais causas de infeções nosocomiais e 
atualmente, é considerado um grave problema de saúde pública devido ao 
aumento de estirpes resistentes aos antibióticos. Durante a infeção no 
hospedeiro, S. aureus está exposto a mudanças na concentração de 
oxigénio nos diferentes locais de infeção. Quando existe oxigénio disponível, 
S. aureus utiliza oxidases terminais dependentes de hemo para a respiração 
aeróbia. Contudo, alguns locais de infeção têm concentrações limitadas de 
oxigénio e neste caso S. aureus utiliza outros substratos, tais como o nitrato 
ou o nitrito, como aceitadores finais de eletrões numa cadeia respiratória 
anaeróbia, em que estão ativas enzimas que contêm sirohemo. Também 
durante a infeção, S. aureus recolhe hemo presente na hemoglobina do 
hospedeiro, através do sistema de aquisição do hemo, e utiliza-a como fonte 
de ferro. Embora o sistema de aquisição de hemo tenha sido intensamente 
estudado em S. aureus, o conhecimento acerca da síntese do hemo e 
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sirohemo é limitado. Para melhor compreender o metabolismo que permite 
a sobrevivência de S. aureus durante os processos de infeção, esta tese 
pretende elucidar as etapas essenciais para a síntese destes dois 
tetrapirróis em S. aureus. Nesta dissertação, apresentamos novas 
perspetivas sobre o metabolismo do hemo em S. aureus através do estudo 
abrangente de três tópicos: (i) a caracterização da via de biossíntese do 
hemo de S. aureus e a sua possível utilização como alvo antimicrobiano; (ii) 
a compreensão de como S. aureus equilibra o hemo que é sintetizado de 
novo ou adquirido através hospedeiro; e (iii) a caracterização da via de 
biossíntese de siroheme de S. aureus. 
Através da análise do genoma de S. aureus verificou-se a presença 
de genes que codificam enzimas que poderão estar envolvidas nos passos 
tardios da via de biossíntese do hemo, nomeadamente a HemE, HemN, 
HemY e HemH. Determinou-se o papel destas enzimas na via de 
biossíntese do hemo de S. aureus através da sua sobreexpressão, 
purificação e caracterização. Os resultados mostraram que em S. aureus, o 
coproporfirinógenio III produzido pela uroporfirinogénio III descarboxilase 
HemE é convertido em coproporfirina III pela coproporfirinógenio III oxidase 
HemY, sendo posteriormente utilizado pela HemH para inserção de ferro no 
macrociclo, levando à formação de ferro-coproporfirina III. Foi construída 
uma estirpe de S. aureus mutante no gene hemH e mostrou-se que esta 
acumula coproporfirina III. Foi demonstrado que a HemY oxida o 
coproporfirinógeno III com uma atividade específica de 24,6 nmol.min-1mg-1 
e a HemH insere ferro na coproporfirina III com uma atividade de 815 
nmol.min-1mg-1. Mostrou-se também que o último passo é a descarboxilação 
de ferro-coproporfirina III pela ferro-coproporfirina descarboxilase HemQ. 
Esta via representa um novo caminho transicional entre duas vias de 
biossíntese do hemo descritas anteriormente, a via clássica e a dependente 
de sirohemo. 
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Através da pesquisa por inibidores para esta via, demonstrou-se que 
a HemY é inibida por derivados de herbicidas de difenil-éter que tornam esta 
enzima um candidato promissor para descoberta de fármacos, o que pode 
ser importante para enfrentar o problema da resistência a antibióticos.  
Na segunda parte do trabalho, estudou-se a associação entre o 
sistema de aquisição de hemo e a via de biossíntese do hemo em S. aureus. 
As duas vias são conhecidas por fornecer hemo a S. aureus, e, portanto, 
colocou-se a hipótese de existir um mecanismo de regulação para garantir 
a homeostase do hemo, de modo a que a toxicidade associada às elevadas 
concentrações do hemo seja evitada. Para investigar esta hipótese, os 
últimos passos da via de biossíntese de hemo em S. aureus foi reconstituída 
numa estirpe de E. coli incapaz de sintetizar hemo, e em que também estão 
ausentes as oxigenases de hemo IsdG e IsdI de S. aureus. Os resultados 
mostraram que a IsdG, mas não a IsdI, prejudica o crescimento da estirpe 
de E. coli complementada, dificultando a síntese de hemo. Demonstrou-se 
que a IsdG inibe a atividade de ferroquelatase da HemH estando 
dependente da sua concentração. Mostrou-se por anisotropia de 
fluorescência e também por FLIM-FRET que a IsdG interage in vitro e in vivo 
com a HemH de S. aureus. Também se mostrou através de RT-qPCR e 
citometria de fluxo que o conteúdo celular de IsdG é maior na presença de 
hemo, o que sugere que o hemo aumenta o conteúdo de IsdG para 
promover a interação com a enzima ferroquelatase da via de biossíntese do 
hemo, resultando na inibição na produção endógena de hemo. Além disso, 
uma análise in silico revelou que um terço dos genomas que codificam a via 
de biossíntese do hemo também codificam uma oxigenase de hemo do tipo 
IsdG. Esta análise também revelou que homólogos da IsdG são 
normalmente codificados em genomas que também contêm HemH e / ou 
HemQ. Em conclusão, esta parte do trabalho demonstrou que as bactérias 
são capazes de regular a homeostase do hemo por ligação da via de 
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biossíntese do hemo e do sistema de aquisição de hemo através da HemH 
e da IsdG. 
Após a infeção do hospedeiro, S. aureus utiliza a proteína reductase 
de nitrito, que contêm sirohemo, para reduzir nitrito, utilizando-a como parte 
da cadeia respiratória para aceitar eletrões quando em ambientes com baixo 
oxigénio ou para destoxificação de nitrito produzido por enzimas próximas 
ou do hospedeiro. Através da análise do genoma verificou-se que S. aureus 
contém três genes que podem estar envolvidos na síntese de sirohemo, 
sendo que dois destes genes estão anotados como cysG conforme a síntase 
de sirohemo de E. coli. Um dos genes cysG está localizado no operão nirBD 
enquanto que o outro gene cysG está localizado separadamente a jusante 
do gene cysJ. Os produtos dos dois genes foram sobreexpressos, as 
proteínas foram purificadas e foram efetuados ensaios in vitro e in vivo para 
analisar o seu papel em S. aureus. Através de ensaios enzimáticos mostrou-
se que a proteína codificada pelo gene cysG a jusante do gene nirBD atua 
como uma uroporfirinogénio III metiltransferase (SirA), ao gerar precorrina-
2 e o gene cysG a jusante cysJ atua como uma precorrina-2 desidrogenase 
(SirC), que é capaz de produzir sirohidroclorina quando incubada com 
precorrina-2 e NAD+. Uma vez que faltava um passo para a produção de 
sirohemo e aparentemente nenhuma proteína foi encontrada, efetuou-se 
uma nova busca por uma proteína ferroquelatase de sirohydroclorina (SirB) 
hipotética. A análise Blast revelou a presença de um gene anotado como 
nirR que compartilha 25% de identidade e 44% de similaridade com a SirB 
de B. megaterium. Após a clonagem e expressão, mostrou-se que a proteína 
atua como uma ferroquelatase de sirohidroclorina. Além disso, foram feitas 
experiências de complementação funcional onde se demostrou que a SirB 
de S. aureus em combinação com a SirA e a SirC é capaz de complementar 
uma estirpe de E. coli sem cysG e, portanto, incapaz de sintetizar sirohemo. 
Portanto, esta proteína constituí o último passo da via que sintetiza o produto 
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final sirohemo. Em suma foi mostrado pela primeira vez uma via de síntese 
do sirohemo em S. aureus. 
Para concluir, os resultados apresentados nesta tese contribuem 
para uma melhor compreensão da fisiologia e do metabolismo de S. aureus, 
elucidando o caminho pelos quais os tetrapirrois, hemo e o sirohemo são 
formados. Não menos importante, mostrou-se como S. aureus mantém 
níveis de hemo adequados evitando o excesso de hemo intracelular livre 
que pode comprometer a sobrevivência do patogénico.  
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1.1 General Features 
Staphylococcus aureus is 
one of the most important and 
well-studied species of the genus 
staphylococci. It was first isolated 
by Alexander Ogston in 1882 (1) 
and named Staphylococcus due to 
its appearance, a bunch of grapes, 
in Greek. In general, these 
bacteria grow in pairs, tetrads, 
short chains or clusters that can 
be visualized under the 
microscope (Fig 1.1). Later, in 
1884, Rosenbach provided the 
first description of the S. aureus species (2, 3).  
S. aureus belong to the phylum Firmicutes and are Gram-positive 
round (cocci) bacteria, measuring around 1 µm diameter. These 
microorganisms are non-motile, non-spore-forming facultative anaerobes 
and coagulase and catalase positive (3). The production of coagulase 
enables S. aureus to clot blood plasma while the expression of catalase 
confers resistance to H2O2, which is detoxified to H2O and O2. Catalase and 
coagulase tests are often used in clinics: catalase test is used to distinguish 
staphylococci from streptococci and coagulase test is employed to 
differentiate S. aureus from other coagulase-negative staphylococci (3–5). 
S. aureus colonizes asymptomatically the anterior nares of 
approximately 30% of the human population (6, 7) and the throat (8). 
Although less frequent, also the skin, the perineum, the intestine, the axillae 
and vagina are sites of colonization (6, 9, 10). Human transmission of S. 
Figure 1.1 Bright field microscope image of S. 
aureus. 
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aureus occurs by direct contact, contaminated surfaces and through the air 
(11, 12). Additionally, S. aureus also infects other mammals and birds (12). 
 
 
1.2 Pathogenesis, clinical relevance and antibiotic resistance 
S. aureus is a human commensal bacteria and the pathogenesis of 
infection is only initiated when the bacteria breaches the skin or tissue via a 
lesion (13). S. aureus contains several virulence factors that allow the 
microorganism to adhere and proliferate inside the host. Among the virulence 
factors identified so far, some examples of proteins required for innate 
immune evasion are, protein A, responsible for inhibiting phagocytosis 
through binding to the host IgG, fibronectin-binding proteins Fbp and 
clumping factor A ClfA, which are proteins involved in platelet activation and 
aggregation, and are responsible for protecting S. aureus against 
phagocytosis. Additionally, chemotaxis inhibitory protein of staphylococci, 
CHIPS, and extracellular adherence protein, Eap, inhibit the recruitment of 
neutrophils to the infection sites (14, 15, 16).  
S. aureus also possesses several hemolysins, such as the alpha, 
beta, and gamma-hemolysins which are able to mediate lysis of red blood 
and white blood cells (15). Erythrocyte lysis releases hemoglobin that is 
captured by the iron-regulated surface determinant (Isd) system of S. aureus, 
removing heme, which is degraded by heme oxygenases to supply nutrient 
iron, an essential element during the infection process (16, 17). Bacterial 
heme-uptake systems and the Isd family of S. aureus will be described in 
detail in Chapter 3 of this dissertation. 
S. aureus microorganism is currently a serious human threat and one 
of the main causes of nosocomial infections (14). Among the diseases 
caused by S. aureus are skin and soft tissue infections (folliculitis and 
impetigo), invasive diseases such as osteomyelitis, endocarditis, 
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bacteremia, pneumonia and toxin mediated diseases such as food poisoning 
and toxic shock syndrome (6, 10, 18). The occurrence of infections is 
strengthened by the ability of the bacteria to form biofilms, which allows S. 
aureus to adhere various surfaces and to resist antimicrobials.  
Several S. aureus strains show resistance to antibiotics. The first 
emergence of drug resistant S. aureus strains was detected only one year 
after the introduction of penicillin in 1940 (19–21) (Fig 1.2). These strains 
harbored plasmids encoding penicillinase, a β-lactamase with the ability to 
destroy the β-lactam ring of penicillin (22). To overcome the penicillin 
resistance of S. aureus strains, a novel antibiotic, methicillin, was introduced. 
However, like for penicillin, resistant strains were identified only a few years 
later (23). The increase of hospital-acquired Methicillin-Resistant 
Staphylococcus aureus (HA-MRSA) infections led to the introduction of 
vancomycin. However, the frequent use of this antibiotic caused the 
appearance of the first vancomycin-intermediate S. aureus (VISA) resistant 
strains in 1997 (24), followed by the emergence of latter vancomycin-
resistant S. aureus (VRSA) strains, that can cope with very high 
concentrations of vancomycin (25). Yet, vancomycin remains one of the first-
line antibiotics to treat severe MRSA infections. More recently, linezolid, 
ceftaroline, and daptomycin have been utilized for the treatment of serious 
MRSA infections, which are used in combination with vancomycin or other 
β-lactams (26). Therefore the high increase of antibiotic resistance has been 
observed in the last years, which makes the pathogen one of major concerns 
in public health worldwide with a remarkable economic burden (27, 28). 
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Figure 1.2 Timeline of the emergence of antibiotic resistance in S. aureus. MRSA, community-
associated methicillin-resistant S. aureus; VISA, vancomycin-intermediate S. aureus; VRSA, 
vancomycin-resistant S. aureus; CA-MRSA community-acquired methicillin-resistant S. 
aureus. Adapted from (22). 
 
Currently, the strains that exhibit resistance to the whole β-lactam 
class of antibiotics are generally designated Methicillin-Resistant 
Staphylococcus aureus (MRSA) strains. The last years have shown a 
worldwide spread of MRSA present not only in the health care facilities, the 
so-called HA-MRSA, but also in the community (designated as  the 
community-acquired MRSA (CA-MRSA)) (22). Although in general CA-
MRSA strains are more virulent, they show susceptibility to several 
antibiotics, which suggests that these strains may be descendants strains of 
the HA-MRSA (22, 29). Nevertheless, an increase of HA-MRSA strains in the 
community  have been reported (30).  
In the latest report of the European Antimicrobial Resistance 
Surveillance Network (EARS-Net 2016), 10 out of 30 countries have MRSA 
percentages above 25%, while Portugal has approximately 44% (31). 
Despite the high prevalence of MRSA in Portugal, this percentage has been 
decreasing in the last years (31).  
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Hence, it is essential to understand the mechanisms that promote S. 
aureus survival, to discover novel therapeutic targets. 
 
1.3 S. aureus metabolism 
As above mentioned, S. aureus is a facultative anaerobic organism, 
which means it usually relies on oxygen respiration. However, these 
microorganisms can use alternative electron acceptors or grow by 
fermentation (3). Since S. aureus has the ability to invade niches with 
different oxygen concentrations, it is crucial for this organism to fine-tune the 
energy metabolism with the O2 availability in these environments.  
The O2 dependent respiratory chain of S. aureus (Fig 1.3) comprises 
two nicotinamide adenine dinucleotide (NADH) dehydrogenases (NDH-2) 
type 2, (NdhC and NdhF) (32), menaquinones and a branched respiratory 
system harboring two or three types of oxygen reductases that are heme 
containing enzymes, namely, a bd-type menaquinol oxidase (CydAB), a 
heme-copper aa3/ba3-type menaquinol oxidase (QoxABCD), and a bo-type 
menaquinol oxidase (3). It also contains a F0F1-ATP synthase 
(AtpBEFHAGDC) but lacks the canonical complex I NADH: quinone 
oxidoreductase and a Na+-translocating NADH:quinone oxidoreductase (3, 
33). Instead, the respiratory chain of S. aureus has a MpsABC (membrane 
potential-generating system) linked to NDH-2  that is able to generate proton 
motive force similar to complex I (33). In this chain, electrons are transferred 
to menaquinones (MQ) generating reduced menaquinone, MQH2, which 
transfer the electrons to the terminal oxidases aa3 menaquinol oxidase 
(composed by cytochromes b-561 and a-602), bo-type menaquinol oxidase 
(composed by cytochromes b-555) or the cytochrome bd oxidase. 
Cytochrome b-552 is proposed to be linked to an aa3-type menaquinol 
oxidase while cytochrome b-557 is suggested to be connected to the bo-type 
menaquinol oxidase (3, 34, 35). Electrons flow to these cytochromes before 
10 
passing to the terminal menaquinol oxidases, where O2 is converted to H2O 
(34). Cytochromes aa3 and bo are believed to act as proton pumps (36, 37), 
while cytochromes aa3 and bd are suggested to support aerobic respiration 
(34, 38). 
 
Figure 1.3 Scheme of the respiratory chain of S. aureus. L-lactate (Lqo), succinate (Sdh) and 
malate (Mqo) dehydrogenases; Mps, membrane potential-generating system; suc, succinate; 
fum, fumarate; L-lac, L-lactate; pyr, pyruvate; mal, malate; oxac, oxaloacetate, MQ, 
menaquinone; MQH2, menaquinol; NADH, nicotinamide adenine dinucleotide reduced; NAD+, 
nicotinamide adenine dinucleotide oxidized; H+, proton; out, outside and in, inside. Adapted 
from (33). 
 
Due to the high number of heme containing enzymes, mutations in 
the biosynthesis of heme and menaquinones cofactors leads to impairment 
of the S. aureus growth, generating the so-called colony variants (SCV) that 
are persister cells (39). A detail description of the heme cofactors and their 
crucial role will be presented in Chapter 2. 
To grow under anaerobic conditions, S. aureus utilizes nitrate or 
nitrite as electron terminal acceptors (40, 41). The genome of S. aureus 
contains a nar operon that encodes a nitrate reductase (NarGHI) that 
promotes the reduction of nitrate to nitrite using electrons provided by NADH 
(42) (Fig 1.4). The nitrite produced by NarGHI is converted to ammonia by 
the dissimilatory nitrite reductase (NirBD), encoded by nirBD, that also uses 
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NADH as electron donor (Fig 1.4) (3, 42). The nir operon has two additional 
genes, nasF (also annotated as cysG), proposed to be involved in the 
synthesis of siroheme and, nirR, that encodes a hypothetical protein with a 
so far unknown function, but which is speculated to control the nir promoter 
activity or to be involved in the synthesis of siroheme (3, 42). A detailed 
description of the synthesis of siroheme will be provided in the next chapter, 
section 2.4. 
 
Figure 1.4 Genetic map of the genes involved in nitrite and nitrate reduction in S. aureus. 
Putative promoters are indicated as angled arrows. Adapted from (42).  
 
 S. aureus also contains an oxygen-responsive nitrogen regulation 
system (NreABC), encoded by the gene cluster nreABC (Fig. 1.4) and 
positively regulates the expression of the nitrate and nitrite genes in cells 
exposed to oxygen  (42, 43). In cells grown under anaerobic conditions in the 
presence of nitrate, deletion of this operon resulted in impairment of nitrate 
and nitrite reduction and consequently in a SCV growth phenotype (42). 
NreC also controls the expression of the nitrate transporter encoding gene 
narK (42).  Moreover, when growing anaerobically in the presence of nitrate, 
S. aureus NreC downregulates fermentative genes, such as acetaldehyde 
dehydrogenase (adhE), L-lactate dehydrogenase (lctE) and alcohol 
dehydrogenase I (adh1) (42). 
The importance of tetrapyrrole molecules, such as heme and 
siroheme and their associated proteins in the life-time of S. aureus, is patent 
in the processes mentioned above. Therefore, the de novo synthesis and 
acquisition pathways that provide these cofactors to S. aureus were studied 
under the scope of this dissertation and will be highlighted in the next 
chapters. 
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2.1 Importance of tetrapyrroles  
Tetrapyrroles are frequently called the pigments of life and include 
chlorophylls, coenzyme F430, bilins, cobalamin (vitamin B12), hemes and 
siroheme (1) (Fig 2.1).  
Tetrapyrroles are molecules involved in many essential biological 
processes, such as DNA replication, cellular detoxification, metabolism, cell 
communication, respiration, signal transduction, reduction of nitrite and 
sulfite, and photosynthesis (2). These compounds derive all from a same 
universal common tetrapyrrole precursor, namely uroporphyrinogen III 
(uro´gen III), that is synthesized from δ-aminolaevulinic acid (δ-ALA) 
(detailed below). The tetrapyrrole structure is formed by four pyrrole aromatic 
rings often linked by methine groups, in linear (e.g., bilins) or cyclic 
arrangements (e.g., porphyrins). In the latter, the nitrogen atoms of each 
pyrrole ring face the center of the macrocycle, which allows the chelation of 
specific metal ions. Examples of chelated metal ions are: Fe2+ in heme, 
siroheme and heme d1; Mg2+ in chlorophylls and bacteriochlorophylls; Ni2+ in 
coenzyme F430; and Co2+ in cobalamin (1, 3). 
Some porphyrins have clinical applications, such as for the treatment 
of tumors and infections. Porphyrins are light activated  at specific 
wavelengths, transferring electrons to O2 and generating reactive oxygen 
species (ROS) which are used to promote cell death (4). 
 
  
 
20 
 
 
 
 
 
 
Figure 2.1. Examples of known tetrapyrroles. The rings A, B, C and D and carbons 
are indicated in heme b according to the Fisher nomenclature. 
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2.2 Heme 
Heme is a hydrophobic molecule and the prosthetic group of 
numerous proteins involved in crucial life associated processes. One of the 
best  acknowledged function is the storage and transport diatomic gases in 
hemoglobin and myoglobin (5). Other important roles of heme are for 
example: i) electron conservation and transfer throughout the respiratory 
chain in heme containing cytochromes to promote the synthesis of cellular 
energy (6); ii) catalytic purposes namely in detoxification enzymes such as 
catalases and peroxidases that reduce H2O2 to H2O (7), and in cytochrome 
P450, that catalyzes the oxidation of organic substrates (8); iii) gas sensors, 
as observed for the CO-sensing CooA transcription factor (9), and as 
demonstrated for DosS and DosT sensory kinases of Mycobacterium 
tuberculosis (10); iv) regulation of transcription, translation, protein 
translocation and protein assembly through the interactions with Heme 
Regulatory Motifs (HRMs), which are short motifs constituted of cysteine-
proline sequences (11).  
The iron coordinated to the porphyrin moiety allows heme to function 
as an electron donor or acceptor due to the change between Fe2+ and Fe3+ 
redox states. Iron is coordinated by the nitrogen atoms of each pyrrole ring 
and can be further coordinated by up to two axial ligands to yield a five or 
six-coordinated heme, respectively (1). The axial ligands are usually 
histidine, cysteine or methionine from the polypeptide chain. Five-
coordinated hemes are generally present in proteins with catalytic, gas 
sensor and transporter functions as it allows the coordination of a substrate 
molecule, while six-coordinated hemes are usually present in electron 
transfer proteins (1, 12). Several types of heme are found in organisms 
(Hemes a, b, c, d and o) (Fig 2.1), being the more common one heme b, 
which is also the precursor of all other types of hemes. Heme b is 
characterized by the presence of vinyl groups attached to rings A and B, 
22 
propionic acid groups in rings C and D, and four methyl groups distributed 
one per ring. Heme a and o are very similar between them, as heme o is an 
intermediary compound of the heme a synthesis from heme b (1). In heme a 
and heme o, the vinyl group of ring A is substituted by an isoprenoid side 
chain; however, in position 8 heme a contains a formyl group, while a methyl 
group is present in heme o (Fig 2.1). In heme c, the vinyl groups of rings A 
and B are substituted by thioether bridges that covalently bound to the 
apoprotein through cysteines (Fig 2.1). The more significant modifications 
are present in heme d, where two additional hydroxyl groups are observed 
in ring C (Fig 2.1), and the hydroxyl and  propionate side groups in carbon 6 
can form a lactone (1, 13). These types of hemes are usually present in 
bacterial respiratory proteins (1). Other less common forms of heme are 
heme l, heme m and heme s. Heme l is found in mammalian 
lactoperoxidases, heme m in mammalian neutrophil enzyme 
myeloperoxidase while heme s is present in marine worm hemoglobins (1).  
Although heme has a high biological importance, the intracellular 
heme content has to be tightly regulated as high levels of free heme are 
highly reactive and toxic to the cells, for instance causing the formation of 
ROS, which damage DNA, lipids and proteins (14). Due to its hydrophobic 
properties, heme has the ability to intercalate into lipid membranes promoting 
the oxidation of membrane components that leads to cell lysis and death (5, 
15). Additionally, heme mediates degradation of proteins to small peptide 
fragments and is also a strong pro-inflammatory agent (5, 15). 
Heme toxicity is well studied in mammalian cells and is estimated that 
the physiological concentration of free heme ranges from 0.03 to 1 µM (16) 
and concentrations above 10 µM (16), produce ROS. In mammals the 
possible causes for accumulation of intracellular free heme are, the increase 
of heme synthesis, the accumulation of extracellular heme, deficient heme 
oxygenase activity, impaired heme incorporation in apo-proteins and 
enhanced hemeprotein degradation (5). Mammals avoid heme toxicity by 
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degradation of the free heme via heme oxygenase or by means of other 
proteins such as reduced glutathione and NADPH–cytochrome P-450 
reductase (15). Additionally, heme content is controlled by heme binding 
proteins such as hemopexin, albumin, haptoglobin, and heme-binding 
protein (HBP23), all of which form non-toxic heme complexes (15). In 
mammals, other mechanisms for regulation of intracellular heme content 
consists in the regulation of heme synthesis and in extracellular heme 
trafficking (5).  
In bacteria, the effects of heme toxicity are generally more 
pronounced in Gram-positive than in Gram-negative bacteria (17, 18). The 
growth of S. aureus is slightly inhibited at concentrations above 5 µM of 
hemin (19). Staphylococcus epidermidis seems to tolerate higher 
concentrations of hemin as concentrations above 10 µM are necessary for 
reduced growth (20). Pseudomonas aeruginosa and E. coli can cope with 
150 µM of hemin without growth impairment (17). Nevertheless, the number 
of studies on mechanisms of heme toxicity to bacteria are limited. In S. 
aureus and E. coli, heme was shown to cause DNA damage (21). Also for S. 
aureus, hemin was reported to induce ion fluxes in a light-independent mode, 
hence causing oxidative damage (22). Additionally, free iron released during 
heme degradation promotes bacterial cell damage through the production of 
hydroxyl free radicals (Fenton chemistry) (18). It was recently demonstrated 
for S. aureus that, when heme is in excess, heme molecules accumulate in 
bacterial membranes, that by interaction with oxygen and membrane 
menaquinones generate superoxide radicals (23).  
Bacteria have also evolved mechanisms to prevent heme toxicity that 
comprise heme efflux pumps, heme sequestration proteins and heme 
degrading proteins. Numerous Gram-positive bacteria encode a heme-
regulated transporter system (HrtAB), an efflux pump that was shown in S. 
aureus to act in combination with the heme sensor system HssRS. High 
levels of heme are recognized by HssRS that activates the HrtAB heme 
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export activity (19, 24). Orthologues of this efflux system were found in Gram-
positive bacteria such as Bacillus anthracis, Lactococcus lactis, 
Corynebacterium diphtheriae and Streptococcus agalactiae (25–28). 
Alternatively to the heme efflux systems mentioned above, Gram-negative 
bacteria rely on heme sequestration proteins to face heme toxicity. Examples 
of these proteins are Yersinia enterocolitica HemS (29), Pseudomonas 
aeruginosa PhuS (30), Escherichia coli O157:H7 ChuS (31), Yersenia pestis 
HmuS (32) and Shigella dysenteriae ShuS (33). Interestingly, some of these 
proteins are also considered part of the heme uptake systems operating in 
Gram-negatives. 
 
2.2.1 Heme biosynthesis 
In bacteria, heme is either synthesized endogenously or captured 
from the environment by heme uptake systems. Almost every living organism 
is capable of synthetizing heme; however, bacteria such as those of the 
genera Dehalococcoides and Thermotoga are not able to produce heme. 
Furthermore, Enterococcus faecalis, lactic acid bacteria, Bartonella 
hensaela, Haemophilus influenzaea and some Streptococcus species 
although possessing hemeproteins apparently do not contain heme 
biosynthesis related genes (14, 34).  
For organisms that produce endogenously heme and/or other 
tetrapyrroles, its synthesis starts with the formation of the universal 
tetrapyrrole precursor δ-aminolevulinic acid (δ-ALA) (Fig 2.2) (1, 3, 34–36).  
So far, two distinct pathways are known for the synthesis of δ-ALA: i) the 
Shemin or C4 pathway, where succinyl-coenzyme A and glycine are 
condensed to δ-ALA with the action of Ala synthase encoded by hemA (3, 
34, 37). This route is present in metazoans, fungi and alphaproteobacteria; 
ii) the C5-pathway, that although discovered latter it is likely to be the more 
ancient route, and which uses charged glutamyl-tRNA for the production of 
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δ-ALA in a two-step reaction (3, 34, 37). Glutamyl-tRNA is converted into 
glutamate-1-semialdehyde by glutamyl-tRNA reductase (HemA or GtrR) 
which is then converted into δ-ALA by glutamate-1-semialdehyde-2,1-
aminomutase encoded by the hemL gene (3, 34, 37). The C5-pathway 
occurs in most bacteria, plants and archaea. The only organisms known to 
have the two pathways for the synthesis of δ-ALA are Euglena gracilis and 
Chromobacterium violaceum (34).  
Figure 2.2 Scheme of the steps of the biosynthesis of heme b via the classical pathway, also 
known as the protoporphyrin-dependent pathway. The rings A, B, C and D and carbons are 
indicated in uro´gen III according to Fisher nomenclature. Adapted from (3). 
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Following the generation of δ-ALA, the porphobilinogen synthase 
enzyme (HemB) promotes the condensation of two molecules of δ-ALA to 
produce porphobilinogen (PBG) (3, 34).  
The next enzymatic step involves the deamination and assembly of 
four porphobilinogen molecules to yield hydroxymethylbilane, which is 
performed by hydroxymethylbilane (HMB) synthase (HemC). This enzyme 
deaminates PBG and promotes the assembly of the four deaminated 
porphobilinogen molecules into a linear complex (HMB) (3, 34). HMB 
spontaneously cyclizes to generate uroporphyrinogen I, a non-physiological  
compound (37). Therefore, HMB is converted into uro´gen III by cyclization 
and inversion of the acetate and propionate groups of the D pyrrole ring in 
the presence of uroporphyrinogen III synthase (HemD) (Fig 2.2) (3, 34).  
As mentioned in section 2.1, uro´gen III is the last common precursor 
of all known tetrapyrroles and until this step, all enzymatic reactions from δ-
ALA to uro´gen III are highly conserved in organisms that synthesize these 
pigments. In the classical pathway, following the generation of uro´gen III 
four extra enzymatic reactions are necessary to catalyze its conversion to 
the final product heme b (Fig 2.2).  
For many years, the classical pathway was considered as conserved 
in all heme producing organisms. However, a second type of route, named 
alternative heme biosynthetic pathway was revealed and broke that dogma 
(38). This new route proceeds via the methylation of uro´gen III through the 
generation of siroheme. The pathway has been proposed to precede the 
classical pathway since it utilizes intermediates, such as siroheme, that are 
more ancient than heme, and because the reactions take place under 
anaerobic conditions (34). The alternative heme biosynthetic pathway is 
widespread in archaea, denitrifying and sulphate-reducing bacteria (34, 38). 
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More recently a third route for the synthesis of heme has been 
reported to be present mostly in Firmicutes and Actinobacteria (39). This 
pathway, termed transitional pathway, branches from uro´gen III and 
contains coproporphyrin III as a new intermediate (39). This novel heme 
biosynthetic pathway was shown in this thesis to be active in S. aureus as 
described in chapter 4 of the results section.  
Very recently, in 2017 (34), these pathways were renamed as 
protoporphyrin-dependent (PPD), siroheme-dependent (SHD) pathway and 
coproporphyrin-dependent (CPD) pathway, respectively, as well as the 
enzymes involved. However, in this dissertation the enzyme names will be 
referred according to the classical nomenclature since this still remains the 
one that is most used.  
 
Protoporphyrin-dependent (PPD) pathway 
The synthesis of heme b through the PPD route (previously known as 
classical heme pathway (Fig 2.2) converts uro´gen III to coprophyrinogen III 
(copro´gen III) by the decarboxylation of the acetic acid side chains of each 
pyrrole ring, generating methyl groups, in a reaction that is catalyzed by 
uro´gen III decarboxylase enzyme (HemE) (3, 34). Bacterial HemE enzymes 
are homodimers with subunits of 40 kDa and with no apparent associated 
cofactor (34).  
In the next step, the propionate groups of rings A and B of copro´gen 
III are oxidatively decarboxylated to vinyl groups, yielding 
protoporphyrinogen IX (proto´gen IX) in a step catalyzed by 
coproporphyrinogen III decarboxylase. Depending on the oxygen 
dependence, two family of enzymes catalyze the reaction: the oxygen-
dependent HemF (copro´gen III decarboxylase) and the oxygen-independent 
HemN (copro´gen III dehydrogenase). HemF is typically a homodimer that 
requires O2 as a terminal electron acceptor, with the concomitant formation 
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of CO2 and H2O2 (40, 41). HemN is a monomeric protein which harbors a 
[4Fe-4S] cluster and a S-adenosyl-L-methionine (SAM) molecule (42).  
In the penultimate step of the pathway, proto´gen IX is oxidized to 
protoporphyrin IX in a reaction that involves six electrons. As in the previous 
step, the reaction may be performed by an oxygen-dependent or an oxygen-
independent enzyme. The oxygen-dependent proto´gen IX oxidase, HemY, 
is a homodimer protein containing flavin adenine dinucleotide (FAD) that, like 
HemF, utilizes O2 as terminal electron acceptor. The oxidation of proto´gen 
IX by HemY uses FAD and involves three O2 molecules generating three 
H2O2 molecules (34). The oxygen-independent HemG was first reported in 
E. coli and is a 21 kDa protein (35). Contrarily to HemY, HemG feeds 
electrons to the respiratory chain, anticipating the use of several electron 
acceptors (43). HemG is mostly present in γ-proteobacteria while HemY 
occurs in eukaryotes and prokaryotes (34, 44). In 2010, a new proto´gen 
oxidase was identified in α-proteobacteria and δ-proteobacteria and named 
HemJ, but its full characterization remains to be done (44, 45).  
The final step of heme biosynthesis consists in the insertion of iron 
into protoporphyrin IX to form protoheme, which is commonly designated as 
heme b (Fig 2.2). This reaction is catalyzed by protoporphyrin ferrochelatase 
(HemH), a well characterized enzyme that was reported to be a membrane-
bound protein in eukaryotes and several prokaryotes, but that is a soluble 
monomer in Gram-positive bacteria, such as B. subtilis (46–48). 
Furthermore, protoporphyrin ferrochelatases may contain an iron-sulfur 
cluster bound to C-terminal region of the protein, which occurs mainly in 
eukaryotes, but has also been reported for some bacteria, such as, 
Mycobacterium tuberculosis, Bdellovibrio bacteriovorus, Caulobacter 
crescentus and Myxococcus xanthus (47, 49). Apart from protoporphyrin, 
ferrochelatases may use a wide range of substrates such as, mesoporphyrin, 
deuteroporphyrin and protoporphyrin, and promote the insertion of other 
cations like Co2+, Zn2+ and Mn2+ (34, 35, 46). Interestingly, in murine and 
 29 
C
h
ap
te
r 
2
 
yeast ferrochelatases, the chelation of metal ions other than iron such as 
Cu2+, Zn2+, Co2+ and Ni2+ promotes substrate inhibition (50). 
 
Siroheme-dependent (SHD) pathway 
For the formation of heme through the SHD pathway (previously 
known as alternative heme biosynthetic pathway), uro´gen III is first 
converted to siroheme via precorrin-2 and sirohydrochlorin in three 
consecutive reactions involving the siroheme synthase CysG (Figure 2.3) (1, 
51). Siroheme is then converted to 12,18-didecarboxysiroheme by the 
decarboxylation of the acetic acid side chains in rings C and D to methyl 
groups, in a step involving the alternative heme biosynthesis proteins AhbA 
and AhbB (38, 52, 53) (Fig 2.3). Both proteins form a heterodimeric complex 
with a mass of 40 kDa named siroheme decarboxylase complex (52). The 
next step involves the elimination of the acetic acid residues of rings A and 
B, generating Fe-coproporphyrin III, also known as coproheme, which is 
catalyzed by AhbC in a SAM-dependent reaction (38, 53) (Fig 2.3). In the 
last step, the two propionate side chains of rings A and B of Fe-
coproporphyrin III are oxidative decarboxylated into vinyl groups forming the 
final product, heme b. This reaction is promoted by AhbD (38, 54) (Fig 2.3) 
and is also SAM-dependent. In D. vulgaris, AhbD was shown to be a 
monomeric cytoplasmic protein that harbors two iron-sulfur clusters (54). 
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2.2.2 Regulation of heme biosynthesis 
In several biosynthetic pathways, substrates and products may have 
an active role in the regulatory process. In heme biosynthesis the best known 
regulatory process involves the control of the first step by its final end 
product, heme. In Salmonella species and E. coli, heme binds to HemA 
promoting its degradation by proteases, which impairs the heme 
biosynthesis (55) and excess of cellular heme levels is avoided. In 
Corynebacterium diphtheriae, high concentrations of heme leads to 
repression of the hemA promoter by the Corynebacterium heme response 
system (ChrA-ChrS) and the heme response regulator (HrrA-HrrS). These 
two-component regulatory systems also activate the transcription of the 
hmuO gene, which encodes a heme oxygenase enzyme (56, 57). 
Furthermore, when heme levels are elevated, HrrA represses the 
transcription of hemE and hemH (57).  
In Acidithiobacillus ferrooxidans, addition of δ-ALA substrate to cells 
increases heme levels, decreasing the Glu-tRNA synthetase activity and the 
levels of Glu-tRNA reductase (58).  
Figure 2.3 Steps required for the synthesis of heme b via the siroheme-dependent pathway. Adapted 
from (38). 
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Iron is a limiting nutrient for the heme biosynthesis pathway as it is 
required by ferrochelatases for insertion into porphyrins. Therefore, it also 
plays a regulatory role. So far, the best studied system is the iron response 
regulator (Irr), which is present in Alphaproteobacteria (59). Irr is a repressor 
of the hemA and hemB genes. Under iron replete conditions, ferrochelatase 
binds Irr while producing heme. Consequently, the heme produced by 
ferrochelatase binds Irr, promoting its degradation. On the other hand, when 
iron concentrations are low, Irr does not bind to ferrochelatase remaining 
active to repress hemA and hemB, which impairs the formation of toxic 
porphyrin intermediates (60, 61).  
As previous mentioned, some of the heme biosynthetic enzymes 
utilize O2 as substrate, namely copro´gen III decarboxylase (HemF) and 
proto´gen IX oxidase (HemY). However, in other organisms these steps are 
done by oxygen-independent enzymes such as copro´gen III dehydrogenase 
(HemN) and proto´gen IX dehydrogenase (HemG).  
In Rhodobacter sphaeroides or Rhodobacter capsulatus, the oxygen-
sensing regulator FnrL (fumarate nitrate reductase regulator) binds to the  
hemA promoters and induces the synthesis δ-ALA under anaerobic 
conditions (62, 63). Also, in response to O2 tensions, the photosynthetic 
response regulator (PrrA) binds to the hemA promoter activating its 
transcription under aerobic and anaerobic growth conditions (64).  
In P. aeruginosa hemA, hemN and hemF are regulated by the oxygen 
sensor protein Anr and the redox regulator Dnr (65, 66). While both Anr and 
Dnr are required for the anaerobic induction of hemF and HemN, only Anr is 
necessary for the aerobic expression of hemN (65).  
Under low oxygen conditions, the two-component regulatory system 
FixLJ of Bradyrhizobium japonicum controls positively the hemA, hemB, 
hemN genes by activating the  FixK2 regulator (67, 68).  
In B. subtilis, the  hemHYE operon was found to be induced in a fnr 
mutant strain grown under anaerobic growth conditions (69). Also, oxidation 
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of the peroxide response regulator PerR by H2O2 is responsible for the de-
repression of hemAXCBL, which increases heme biosynthesis (70).  
In E. coli, H2O2 activates the peroxide-sensing transcriptional 
activator, OxyR, which induces the expression of hemH and hemF (71).  
 
2.3 Siroheme biosynthesis 
Siroheme is an iron containing tetrapyrrole used as cofactor in sulfite 
and nitrite reductases in plants, fungi and prokaryotes (1, 51). It works with 
a [4Fe-4S] cluster in sulfite and nitrite reductases to perform the six-electron 
reduction of sulfite or nitrite to sulfide and ammonia, respectively (51). 
Siroheme is an isobacteriochlorin with the same chemical groups of its 
precursor uro´gen III but with two additional methyl groups attached to 
carbons 1 and 3 of rings A and B, respectively (Fig 2.4). It is synthesized 
from uro´gen III in three enzymatic steps. The first enzymatic step consists 
in the bis-methylation of uro´gen III to yield precorrin-2, followed by oxidation 
to sirohydrochlorin. In the final step there is the insertion of ferrous iron into 
sirohydrochlorin to generate siroheme (Fig 2.4).  
 
 
Figure 2.4 Steps involved in the siroheme biosynthesis. Adapted from (72). 
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Until now, few genes were identified as involved in the synthesis of 
siroheme and, depending on the organism, the products of one, two or three 
genes are required to complete the three enzymatic reactions for the 
synthesis of siroheme from uro´gen III (Fig 2.4).  
In E. coli, only one gene, cysG, was described to be involved in the 
three steps required for this synthesis (73, 74), as its mutation generates 
cells with no nitrite reductase activity (75). The cysG gene encodes a 457-
amino acid protein that was named siroheme synthase (CysG) (74). E. coli 
CysG has a C-terminal part (CysGA) that provides the protein a SAM-
dependent uroporphyrinogen III methyltransferase (SUMT) activity, i.e., 
promotes the SAM-dependent methylation of carbons 1 and 3 of 
uroporphyrinogen III into precorrin-2 (76). The N-terminal part of E. coli CysG 
(CysGB) catalyzes the NAD+-dependent dehydrogenation of precorrin-2 into 
sirohydrochlorin and insertion of iron to yield siroheme (73). Similarly, 
Salmonella enterica also encodes a multifunctional homodimeric protein 
CysG with two structurally independent modules (77). The C-terminal part 
has a similar topology to SUMT, and the N-terminal part contains a NAD+-
binding Rossman fold and a phosphoserine, which acts as a regulatory 
residue between the synthesis of siroheme and cobalamin (77). 
In yeast, two genes are required for the synthesis of siroheme, MET1 
and MET8 (78). Met1p, the product of MET1 is a 526-amino acid protein 
whose C-terminal region shares a high degree amino acid sequence  
similarity with the C-terminus of E. coli CysG  and other SUMT proteins, 
displaying SUMT activity (78, 79). MET8 encodes a protein with 274 residues 
(Met8p) that shares amino acid sequence similarity with the N-terminal 
region of E. coli CysG and exhibits NAD+-dependent precorrin-2 
dehydrogenase and sirohydrochlorin chelatase activities (78–80).  
In Bacillus megaterium, three different enzymes named SirA, SirB 
and SirC, are required to synthesize siroheme, and the correspondent genes 
are organized in a operon (81, 82). SirA shares high amino acid sequence 
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similarity to the C-terminal part of E. coli CysG, and has SUMT activity (82). 
SirB shows amino acid similarity with B. megaterium CbiX, a 
cobaltochelatase involved in the synthesis of cobalamin (81). SirB was 
shown to have sirohydrochlorin ferrochelatase activity both in in vitro and in 
vivo experiments (81, 82). SirC carries precorrin-2 dehydrogenase activity 
and the protein shares amino acid sequence similarity with the E. coli CysGB 
and S. cerevisiae Met8p (82, 72).  
The sulfate reducer D. vulgaris also encodes a functional SirC that 
shares sequence identity with E. coli CysGB and has NAD+-dependent 
precorrin-2 dehydrogenase activity (83). Additionally, in D. vulgaris the 
SUMT activity is performed by CobA/HemD, a bi-functional enzyme that has 
uro´gen III synthase activity (83). This bacterium encodes two chelatases, 
CbiKC and CbiKP that have sirohydrochlorin ferro and cobalto-chelatase 
activities (84).  
Furthermore, it was shown recently, in a scientific publication in which 
I am the first co-author, that D. vulgaris CbiKP is a periplasmic protein that 
can bind two additional heme groups within the tetramer, through His103 in   
Δ28CbiKP (85). Also, two residues were identified as essential for the 
sirohydrochlorin ferrochelatase activity, namely His154 and His216 in 
Δ28CbiKP (85). The periplasmic localization and the ability to bind more heme 
groups indicate that D. vulgaris CbiKP may function as a heme transporter 
(85). 
In plants, siroheme is synthesized in plastids. The three consecutive 
steps for its synthesis in Arabidopsis thaliana are carried out by an uro´gen 
III methyltransferase (UPM1p) and a sirohydrochlorin ferrochelatase (SirB) 
(86). However, no precorrin-2 dehydrogenase has been described so far 
(87). UPM1p is synthesized in the cytosol and contains an N-terminal transit 
peptide that is cleaved after plastid translocation (88). SirB is located in the 
plastid, and the mature form of the enzyme contains 150 amino acid. 
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Interestingly, A. thaliana SirB contains an iron-sulfur cluster which is not 
required for sirohydrochlorin ferrochelatase activity (86, 87). 
The siroheme synthesis of S. aureus will be presented in the results 
section (Chapter 6). 
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3.1 Heme uptake systems 
Iron is an essential nutrient for almost all organisms, including 
bacteria, that in general, require iron for growth and virulence (1, 2). 
However, bacteria do not easily access the iron host as: i) Under 
physiological conditions, iron is in an insoluble form; ii) free iron is toxic to 
cells and therefore its amount in host cells is low; iii) iron is sequestered to 
limit iron acquisition by pathogenic bacteria as a defense mechanism, a 
phenomenon called nutritional immunity or iron withholding defense system 
(1, 3–5). Therefore, iron in the host is bound to proteins such as lactoferrin, 
transferrin and ferritin. In particular, the most abundant source of iron is found 
in hemeproteins (e.g. hemoglobin and myoglobin) (4–6). To access heme, 
the majority of bacterial pathogens produce hemolysins that lyse 
erythrocytes and release heme from hemoglobin. Heme is then captured by 
bacterial heme uptake systems and utililized as iron source or directly 
incorporated into heme containing enzymes where it acts as a cofactor, 
processes that are important for bacterial pathogenesis (3, 7, 8). 
 Several heme uptake systems are active in Gram-positive and Gram-
negative bacteria and they all share a similar strategy for the import and 
degradation of heme. First, a set of surface receptor proteins recognize and 
bind heme and/or heme-containing proteins. Free heme is then transferred 
to inner-membrane transporters and translocated into the cytoplasm where 
it is used as a whole or is degraded by heme oxygenases to release its iron 
which is used as nutrient. However, heme uptake systems differ between 
Gram-negative and Gram-positive bacteria due to the presence of the outer 
membrane in Gram-negative bacteria, that constitutes an additional barrier 
for the transport of heme to the intracellular compartment. 
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3.1.1 Gram-negative heme uptake systems 
The heme uptake systems of Gram-negative bacteria are well 
characterized and include two categories: those that bind heme or 
hemeproteins directly, and those that use extracellular secreted hemophores 
to bind hemeproteins (6). Both systems require the coupling of cytoplasmic 
membrane proton motive force and TonB–like proteins to transport heme 
across the outer membrane (3, 6).  
 
 Direct heme uptake systems 
 
The direct heme uptake systems can be found in several Gram-
negative bacteria such as the Hem system present in Yersinia enterocolitica 
(9, 10) and Serratia marcescens (11), the Chu system of E. coli (12), the 
Hmu system in Yersinia pestis (13) and Porphyromonas gingivalis (14), and 
the Shu system described in Shigella dysenteriae (15).  
One of the better characterized direct heme uptake system is that of 
Pseudomonas aeruginosa. Pseudomonas heme uptake (Phu) system (Fig 
3.1) is a non-hemophore heme uptake system that involves: i) an outer 
membrane receptor (PhuR), that is responsible for the binding of heme and 
heme-containing proteins; ii) a periplasmic heme transport protein (PhuT) 
that uses a TonB-dependent process to pass heme into the periplasm; iii) an 
inner membrane ABC transporter (PhuUVW) that transfers heme from the 
periplasmic space to the cytoplasm passing it to the cytoplasmic protein 
PhuS (2, 3); iv) a heme trafficking protein PhuS, that transfers heme to the 
P. aeruginosa heme oxygenase HemO, also called PigA (16) (Fig 3.1). The 
promotors of phuR and phuSTUVW were shown to be repressed by the ferric 
uptake regulator (Fur) under iron-replete conditions (17).  
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Figure 3.1 Heme uptake system of P. aeruginosa. Direct heme uptake system via the Phu 
system and hemophore-mediated heme uptake via Has. Orthologue systems are present in 
other Gram-negative bacteria. Adapted from (3). 
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Neisseria meningitidis also imports heme through a direct heme 
uptake system using the hemoglobin receptor HmbR and the hemoglobin-
haptoglobin utilization receptor HpuAB. The latter is a bipartite two-
component receptor system which can be considered a third heme uptake 
system of Gram-negative bacteria. HpuAB is constituted by the lipoprotein 
HpuA, and the TonB-dependent transport protein HpuB (2, 18, 19). HpuAB 
acquires heme from hemoglobin and hemoglobin-haptoglobin complexes, 
while HmbR can only extract heme from hemoglobin (19, 20). Once heme is 
translocated into the cytoplasm is degraded by HemO to give iron (21). A Fur 
box is located upstream the promoter regions of hmbR and hpuAB genes, 
indicating that genes are regulated by Fur (3, 18). 
Haemophilus influenza encodes a variety of heme uptake systems 
(22). The direct heme uptake by H. influenza involves the hemoglobin–
haptoglobin binding proteins HgpA, HgpB, and HgpC that incorporate heme 
from hemoglobin-haptoglobin complexes (23–25), of which HgpB was shown 
to be the most efficient one (22). Additionally, H. influenzae expresses heme 
binding lipoprotein HpbA which is considered to be a periplasmic heme 
transporter protein (26). Haemophilus influenza lacks all proteins involved in 
heme biosynthesis except HemH, and thus it requires external heme for 
aerobic growth (27). 
 
Hemophore-mediated heme uptake system 
 
In Gram-negative bacteria, two hemophore-mediated heme uptake 
systems were identified so far, namely the heme acquisition system Has and 
the heme–hemopexin utilization HxuCBA. The Has system was 
characterized in S. marcescens (28), P. aeruginosa (29) (Fig 3.1), 
Pseudomonas fluorescens (30), and Y. pestis (31). In this system, 
hemophores such as HasA pick up free heme or, instead, extract heme from 
hemoglobin transferring it to the TonB-dependent outer-membrane receptor, 
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HasR (2, 32). However, HasR can also take up free heme without the need 
of a hemophore binding protein (33). Indeed, HasR activates a signaling 
cascade between the sigma factor HasI and anti-sigma factor HasS 
controlling the expression of hasAR which is dependent on the abundance 
of extracellular heme (32, 34). In S. marcescens, heme is transported across 
the membrane through HasR in a HasB dependent manner (35). Contrarily, 
P. aeruginosa does not encode a HasB  homolog and thus utilizes a non-
specific TonB-like protein or cytoplasmic and periplasmic components of the 
Phu system (32) (Fig 3.1). 
A second hemophore-mediated heme uptake system was described 
in H. influenza, namely HxuCBA (36). Alternatively to the direct heme uptake 
system, H. influenza uses the HxuCBA system to acquire free heme and 
heme-hemopexin (36, 37). The hemophore HxuA is secreted by the HxuB 
and HxuC is the TonB-dependent transporter that imports heme to the 
periplasm (36).  Additionally, HxuC can also utilize heme from heme–albumin 
(37).  
 
3.1.2 Gram-positive heme uptake systems 
The absence of outer membrane in Gram-positive bacteria precludes 
the necessity to utilize TonB-dependent transporters for heme import. 
Instead, the heme acquisition system of Gram-positive bacteria is equipped 
with surface receptors proteins for the binding of heme or hemeproteins, in 
some bacteria secreted hemophores, and ABC transporters for the transport 
of heme across the cytoplasmic membrane. The best characterized heme 
uptake system of Gram-positive organisms is the Isd system of S. aureus 
(Fig 3.2). S. aureus secretes hemolysins that lyse red blood cells, releasing 
hemoglobin (38). The surface exposed proteins IsdA, IsdB and IsdH bind 
free heme, hemoglobin and hemoglobin complexes (such as haptoglobin-
hemoglobin), respectively (3). Upon removal of heme from hemoglobin by 
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IsdB and IsdA, the later transfers heme directly to the cell wall-anchored 
protein IsdC  (38, 39). IsdH, IsdA, IsdB and IsdC are covalently anchored to 
peptidoglycan by sortases, namely sortase A surface expose IsdA/B/H and 
sortase B specifically buries IsdC into the cell wall (40, 41). IsdA, IsdH, IsdB 
and IsdC bind heme and hemeproteins through conserved Near-Iron 
Transport (NEAT) domains, which are 125 amino acid residues in an eight-
stranded β-sandwich fold with a large hydrophobic heme-binding pocket 
(42). IsdC transfers heme to the membrane transporter IsdDEF which passes 
heme into the cytoplasm (38). After import, heme is incorporated into 
hemeproteins or degraded by IsdG or IsdI for the release of iron (43).  The 
operons encoding the S. aureus isd acquisition system are regulated by Fur, 
that in environments with high concentration of iron represses isdA, isdB, 
isdCDEFsrtBisdG, and isdI (38). S. aureus mutants lacking genes of the isd 
system are defective in pathogenesis, demonstrating the importance of  this 
system in  this organism (44–47). However, this remains a controversial 
issue as IsdABH was reported in a mouse septic arthritis model to not 
contribute for the virulence of S. aureus (48). 
In addition to the IsdDEF membrane transporter, S. aureus also 
utilizes the heme transport system (htsABC) for heme-iron acquisition across 
the membrane. This system encodes an ABC transporter permease, also 
regulated by Fur, and contributes to the  pathogenecity of S. aureus (49). 
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Figure 3.2 Isd heme uptake system of S. aureus. Similar systems are present in other Gram-
positive bacteria. Adapted from (3). 
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Bacillus anthracis also encodes an Isd system (50). Although the Isd 
system of B. anthracis is very similar to that of S. aureus, B. anthracis 
encodes two extra secreted hemophores, IsdX1 and IsdX2, which were the 
first hemophores identified in Gram-positive bacteria (51).  
 Other heme uptake systems are present in Gram-positive bacteria 
such as, the hemin uptake system HmuTUV, heme-transport associated 
HtaABC, ChtABC/CirA of Corynebacterium diphterae (52–54), Sia  in 
Streptococcus pyogenes (55), and  Isd of Listeria monocytogenes (56). 
 
3.2 Heme oxygenases 
Heme oxygenases (HO) are ubiquitous proteins that were firstly 
described in mammals for the protection of cells against the toxic effect of 
free heme (2). In bacteria, heme oxygenases are primarily responsible for 
the last step of the heme uptake system, which consists in the degradation 
of heme for the release of iron (2, 5, 57). However, some bacterial heme 
oxygenases were also shown to be implicated in relieving heme toxicity (58, 
59). The bacterial heme oxygenases can be sub-divided in two classes: 
canonical heme oxygenases and non-canonical heme oxygenases. 
Canonical heme oxygenases use three oxygen molecules for the conversion 
of heme to α-biliverdin with the concomitant release of carbon monoxide 
(CO) and iron (60) while non-canonical enzymes although use oxygen in the 
reaction, the protein binding cause ruffling distortions in the heme molecule 
leading to the formation of new products (61) (Fig 3.3). Although canonical 
heme oxygenases are monomeric proteins that adopt an α-helical structural, 
non-canonical heme oxygenases adopt a ferredoxin-like α/β-sandwich fold 
(62).  
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Figure 3.3 Heme degradation products of canonical and non-canonical heme oxygenases. 
Adapted from (62). 
 
The first canonical bacterial heme oxygenase was characterized in 
1998, in C. diphtheriae, namely HmuO (63). Canonical heme oxygenases 
are monomeric proteins that adopt an α-helical structural fold as shown for 
HmuO of C. diphtheriae (Fig 3.4). As mentioned in the last chapter, HmuO is 
activated by the ChrA-ChrS and the HrrA-HrrS two-component systems 
when high levels of heme are present (64) and similar to Fur, hmuO is also 
controlled by the diphtheria toxin repressor protein DtxR (63). 
58 
 
 
Figure 3.4 Structure of HmuO (PDB 1IW0) from C. diphtheriae and IsdI (PDB 3LGN) from S. 
aureus. HmuO has an overall α-helical structural fold, characteristic of the HO family of HOs. 
IsdI adopts a ferredoxin-like α/β-sandwich fold, which is present in the IsdG-type of HO. The 
proteins are represented in ribbon format with heme bound molecules in stick format. The 
representation was done in UCSF Chimera. 
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Other examples of bacterial pathogens encoding canonical heme 
oxygenases include N. meningitidis (59), Campylobacter jejuni (65) and P. 
aeruginosa (66, 67). The last encodes HemO, which is an uncommon 
canonical heme oxygenase since it produces unusual β-biliverdin and δ-
biliverdin isomers (66). Additionally, P. aeruginosa encodes another heme 
oxygenase, BphO, that produces the usual α-biliverdin (67).  
Non-canonical heme oxygenases were first identified in S. aureus 
(43). S. aureus encodes two heme oxygenases, IsdG and IsdI, that were 
shown in vitro to bind and degrade heme to a mixture of β-oxo-δ-bilirubin and 
δ-oxo-β-bilirubin, named staphylobilin (68). Interestingly, the cleavage of 
heme by these enzymes liberates formaldehyde instead of CO like in the 
canonical heme oxygenases (69) (Fig 3.3). The IruO reductase serves as 
electron donor for heme degradation in S. aureus (70). Moreover, the 
concentration of IsdG and IsdI enzymes are regulated by iron and heme (43, 
44). While both enzymes are expressed under iron-deplete conditions  
through a process regulated by Fur, only IsdG is targeted for degradation in 
the absence of heme (44). This process occurs through an amino acid motif 
that forms a flexible loop in the IsdG structure, which is absence from the 
sequence of IsdI (71). Unlike canonical heme oxyenases, IsdG and IsdI are 
homodimeric proteins with each monomer adopting a ferredoxin-like α/β-
sandwich (Fig 3.4).  
IsdG homologs are present in Gram-positive pathogens such as in B. 
anthracis (58) and S. lugdunensis (72). Another IsdG-like heme oxygenase, 
is the MhuD of Mycobacterium tuberculosis that converts heme into 
mycobilin and iron retaining the α-meso carbon as an aldehyde without 
releasing CO or formaldehyde (73) (Fig 3.3). Although L. monocytogenes Isd 
(74) and B. subtilis HmoB (75) are considered IsdG-like proteins, instead of 
homodimers, they are monomeric proteins that adopt a similar ferredoxin-
like structure (74, 76). B. subtilis also encodes another heme oxygenase, 
namely HmoA, which gene is repressed by Fur in contrast to HmoB, and 
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phylogenetic analysis have shown to cluster separately from HmoB and other 
IsdG-like proteins (75).  
An enzyme that does not fit in either canonical or non-canonical heme 
oxygenases is the ChuW of E. coli, a more recently discovered radical SAM 
enzyme that degrades heme to anaerobilin without using O2 (77). 
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4.1. Summary 
Heme is a life supporting molecule that is ubiquitous in all major 
kingdoms. In Staphylococcus aureus, the importance of heme is highlighted 
by the presence of systems both for the exogenous acquisition and 
endogenous synthesis of this prosthetic group. In this work, we show that in 
S. aureus the formation of heme involves the conversion of 
coproporphyrinogen III into coproporphyrin III by coproporphyrin synthase 
HemY, insertion of iron into coproporphyrin III via ferrochelatase HemH, and 
oxidative decarboxylation of Fe-coproporphyrin III into protoheme IX by Fe-
coproporphyrin oxidase/dehydrogenase HemQ. Together, this route 
represents a transitional pathway between the classic pathway and the more 
recently acknowledged alternative biosynthesis machinery. The role of the 
heme biosynthetic pathway in the survival of the bacterium was investigated 
by testing for inhibitors of HemY. Analogues of acifluorfen are shown to 
inhibit the flavin-containing HemY, highlighting that this as a suitable target 
for the development of drugs against S. aureus. Moreover, the presence of 
this transitional pathway for heme biosynthesis within many Gram-positive 
pathogenic bacteria suggests that this route has the potential not only for the 
design of antimicrobials but also for the selective discrimination between 
bacteria operating different routes to the biosynthesis of heme. 
 
4.2. Introduction 
Heme is a remarkably versatile prosthetic group that is found in all 
kingdoms of life. It is an iron-containing modified tetrapyrrole (porphyrin), 
which belongs to the same family of compounds as the chlorophylls, corrins 
(vitamin B12) and siroheme (1). Although some organisms, such as 
Caenorhabditis elegans, salvage heme from their environment (2) most 
organisms are able to synthesise the molecule de novo. Indeed, until 
74 
recently, it was largely accepted that heme is biosynthesized along a 
“classic” pathway, via four steps from the first common tetrapyrrole 
macrocyclic precursor uroporphyrinogen III (uro’gen III). These steps involve 
the selective decarboxylation of a number of the peripheral carboxylic acid 
side chains, macrocyclic ring oxidation and insertion of iron (Figure 4.1) (3). 
 
Figure 4.1 Transformation of uro’gen III into heme via the classic and alternative heme 
biosynthetic pathways. The classic pathway proceeds via copro’gen III, proto’gen IX and 
protoporphyrin IX (highlighted with the orange arrow) whereas the alternative pathway 
proceeds via siroheme, didecarboxysiroheme and Fe-coproporphyrin III (highlighted with the 
green arrow). 
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The heme biosynthetic pathway is initiated by the formation of 5-
aminolevulinic acid, the precursor of all naturally occurring tetrapyrroles, 
which is subsequently transformed into the first macrocyclic intermediate 
uro’gen III in three enzymatic steps that are catalyzed by HemB, C and D (3). 
Uro’gen III represents the first major branch point in the formation of modified 
tetrapyrroles from where the synthesis of molecules such as cobalamin and 
siroheme diverge from the synthesis of heme. For the classic heme pathway, 
all four acetic acid side chains of uro’gen III undergo decarboxylation, 
generating methyl groups, in a reaction catalyzed by the cofactor-free 
uro’gen decarboxylase (4). The product of this reaction, coproporphyrinogen 
III (copro’gen III), is transformed into protoporphyrinogen IX (proto´gen IX) 
by the oxidative decarboxylation of the two propionic acid side chains 
attached to rings A and B of the substrate by an enzyme called copro’gen 
oxidase (HemF) (5). Proto’gen IX is converted into protoporphyrin IX by the 
removal of six protons and six electrons in a reaction catalyzed by proto’gen 
oxidase (HemY), which requires FAD as cofactor (6, 7). Finally, protoheme 
IX is synthesized by the insertion of ferrous iron into the macrocyclic core of 
the maturing prosthetic group, a reaction catalyzed by protoporphyrin IX 
ferrochelatase (HemH) (8). 
Some of the steps described for the classic pathway, in particular 
those involving HemF and HemY, are oxygen-dependent and, therefore, are 
only operative under aerobic conditions (5–7). Anaerobic versions of these 
enzymes which are oxygen independent are also found and hence many 
bacteria, for instance, have HemN as an anaerobic substitute for HemF, 
which employs S-adenosyl-L-methionine (SAM) as a radical to mediate 
decarboxylation via dehydrogenation of the substrate (9). Similarly, many 
bacteria utilize non-homologous isofunctional equivalents for HemY, such as 
HemJ, that works under aerobiosis (10, 11) and HemG that possesses 
proto´gen oxidase activity in aerobic or anaerobic conditions (12, 13). Thus, 
the classic heme synthesis pathway is able to operate under different 
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oxygenated conditions yielding the same intermediates via the engagement 
of orthologous enzymes. 
Recently, we demonstrated that heme can be also made from 
siroheme (Figure 4.1), the prosthetic group of sulphite and nitrite reductases, 
through a pathway that is operative in sulphate reducing bacteria and 
archaea (14–16). In this “alternative heme biosynthesis” (Ahb) pathway, 
siroheme undergoes a bis-decarboxylation to give didecarboxysiroheme 
(DDSH) in a reaction mediated by siroheme decarboxylase (AhbA-B) (17). 
DDSH is subsequently converted into Fe-coproporphyrin III in a radical SAM 
mediated process via AhbC, which oversees the removal of the two acetic 
acid side chains attached to rings A and B of the substrate (14). The last step 
involves another radical SAM enzyme (AhbD) that is analogous to the HemN 
reaction in that it catalyses the oxidative decarboxylation of the two propionic 
acid side chains attached to C3 and C8 (Figure 4.1) via a dehydrogenation 
process that yields vinyl side chains, i.e. it converts Fe-coproporphyrin III to 
protoheme IX (18). 
In an attempt to characterize the heme biosynthetic pathway in the 
pathogen Staphylococcus aureus with a view to screening for potential 
antibiotics, we identified a number of issues that challenged the idea that S. 
aureus makes heme via the classic pathway. An analysis of the S. aureus 
genome revealed the presence of genes encoding orthologues of canonical 
enzymes such as HemE, HemN, HemY and HemH. However, our initial 
characterisation of HemY demonstrated that this enzyme oxidizes copro’gen 
III in preference to proto’gen IX and, similarly, HemH preferably uses 
coproporphyrin III over protoporphyrin IX for iron insertion, a set of results 
that are shown herein. Moreover, recently, insightful research from Dailey 
and colleagues has demonstrated that some bacteria operate a pathway that 
combines aspects of the classic and the alternative pathways (19). They 
reported that copro’gen is oxidized to coproporphyrin, into which iron is then 
inserted to give Fe-coproporphyrin prior to the final step involving the 
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synthesis of the vinyl side chains in a reaction catalyzed by the pentameric 
enzyme HemQ (19, 20). In this work, we demonstrate that this “transitional” 
pathway, intermediary between the classic and alternative pathways, 
operates in S. aureus and we provide a detailed characterization of the 
enzymes involved. We have also attempted to exploit the biochemical 
differences found within the S. aureus heme biosynthetic pathway by 
screening for inhibitors of the HemY enzyme.   
 
4.3. Materials and Methods 
Gene cloning and complementation assays  
Genes were amplified by means of PCR standard reactions using the 
oligonucleotides presented in Table S4.1 (Supplementary data). Plasmids 
used in this work are shown in Table 4.1. All recombinant plasmids were 
sequenced and the integrity of the inserted DNA sequences was confirmed. 
E. coli hemF gene was amplified using as template the pCalhemF plasmid 
(21) (kind gift from Prof. Dieter Jahn, Technical University Braunschweig, 
Germany), and subsequently subcloned into previously digested NdeI and 
ScaI pET-14b (Novagen). B. subtilis hemH was amplified from genomic DNA 
of B. subtilis strain 168 (kind gift from Dr. Adriano Henriques, ITQB, Portugal) 
and inserted into pET-23b. S. aureus hemE, hemY, hemQ and hemH genes 
were amplified from the S. aureus NCTC 8325 genomic DNA and cloned 
separately into pET-23b and pET-28a vectors (Novagen).  
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Table 4.1. Plasmids used in this study. 
Recombinant vector Restriction sites Organism Reference 
pET-14b-BmhemC - B. megaterium (22)  
pET-14b-DvhemC - D. vulgaris (23)  
pET-14b-DvhemDd - D. vulgaris (23)  
pET-14b-BmhemD - B. megaterium (22)  
pET-14b-HhemE 
HUROD 
(S19F mutant)  
- Human Gift from Dr. Sarah 
Woodcock 
pET-23b-SahemE NheI/HindIII S. aureus This study 
pET-14b-EchemF NdeI/ScaI E. coli This study 
pET-23b-SahemH NheI/HindIII S. aureus This study 
pET-23b-BshemH NheI/XhoI B. subtilis This study 
pET-28a-SahemY NdeI/HindIII S. aureus This study 
pET-23b-SahemQ NheI/HindIII S. aureus This study 
pET-23b-SahemHY - S. aureus This study 
pET-23b-SahemHQ - S. aureus This study 
pET-23b-SahemHQY 
pCALhemF 
- 
- 
S. aureus 
E. coli 
This study 
(21) 
 
For the complementation assays, the E. coli ferrochelatase mutant 
(ΔhemH) (kind gift from Prof. Mark O´Brian State University of New York at 
Buffalo, NY, USA) (24) was used together with plasmids pET-23b harbouring 
combinations of S. aureus hemY, hemQ and hemH genes that were 
prepared by the link and lock method, which allows the consecutive cloning 
of genes with the reuse of the same restriction enzyme sites (25). Plasmids 
pET-23b, pET-23b-SahemH, pET-23b-SahemQ, pET-23b-SahemHY, pET-
23b-SahemHQ and pET-23b-SahemHQY were transformed separately into 
chemically competent E. coli ΔhemH cells which were plated onto Luria 
Bertani (LB) agar containing ampicillin (100 μg.ml-1) and hemin (10 µg.ml-1), 
and incubated overnight, at 37 °C; the resultant colonies were streaked onto 
LB-antibiotic agar plates in the presence and absence of hemin to test for 
their viability.   
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Production and purification of recombinant proteins 
BL21STAR DE3 pLysS (Novagen) cells were transformed separately 
with each recombinant plasmid and grown in LB medium, at 37 °C, to an 
OD600 of 0.6. At this OD, 0.4 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was added and cells were grown for an extra 16–20 h, at 20 °C. For 
cells harbouring pET-23b-SahemH and pET-23b-BshemH, 8 mg.ml-1 of iron 
in the form of FeSO4 was added to the medium at the time of induction. Cells 
were harvested by centrifugation (11323 xg, 10 min) and pellets were 
resuspended in the appropriated lysis buffer. Cells expressing separately the 
Human HemE, E. coli HemF, B. megaterium HemC and HemD proteins were 
resuspended in 20 mM Tris-HCl pH 8, supplemented with 500 mM NaCl and 
5 mM imidazole. The buffer used for cells harbouring the S. aureus HemY 
protein consisted of 50 mM Tris-HCl pH 8 (buffer A) with 50 mM NaCl, 10 % 
glycerol, 5 mM imidazole and 1 % Triton X-100. In this later case, prior to cell 
breakage, the suspension was incubated with 0.02 % benzonase, at room 
temperature, for a sufficient time to observe a significant decline of the 
solution´s viscosity. 
Cell pellets were then lysed by sonication on ice-water slurry at 60 % 
amplitude, for 3 min and using 30 second bursts to allow for cooling. 
Insoluble material was removed by centrifugation at ~30000 xg, for 15 min, 
and at 4 °C. Each supernatant was loaded separately into a Ni2+ Sepharose 
column (GE Healthcare), and the column was washed with the respective 
lysis buffer (without Triton X-100, in the case of S. aureus HemY) to which 
was added 5 and 50 mM imidazole. Proteins were eluted by applying a 400 
mM imidazole containing lysis buffer and judged pure by SDS gel 
electrophoresis. Purified protein was buffer exchanged in a PD-10 column 
(GE Healthcare) loaded with buffer A with 150 mM NaCl, 20 % glycerol and 
5 mM DTT.  For the Human HemY, the buffer also contained 0.02 % Tween-
20. 
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The purification of proteins from the BL21STAR DE3 pLysS cells 
expressing S. aureus HemE, HemQ, HemH and B. subtilis HemH required 
slightly different conditions. In this case, the harvested cells were 
resuspended in buffer A and disrupted by passing three times through a 
French Press, at 900 Psi, followed by centrifugation at ~30000 xg, for 30 min. 
Each supernatant was loaded onto a 3 ml Ni2+ Sepharose column (GE 
Healthcare), previously equilibrated in buffer A plus 400 mM NaCl and 10 
mM imidazole. A step gradient of imidazole in buffer A was applied and the 
proteins were eluted at 250 mM imidazole, concentrated in an Amicon Stirred 
Ultrafiltration Cell using a 10 kDa membrane (Millipore), and submitted to 
buffer exchange by means of a PD10 column (GE Healthcare) that used 
buffer A as running buffer.  
In all cases, protein purity was evaluated by SDS-PAGE and the 
protein concentration was determined by the Pierce Bicinchoninc acid 
Protein Assay (Thermo Scientific) using Sigma protein standards. Protein 
molecular mass and quaternary structures were determined by passage 
through a Superdex 200 10/300GL column (GE, Healthcare), equilibrated 
with 50 mM sodium phosphate pH 7 buffer containing 150 mM NaCl and 
using protein standards from Sigma. 
 
Identification of HemY cofactors  
For protein ligand identification, samples were heat denatured in a 
heating block for 10 min and centrifuged at 12100 xg, for 5 min. The samples 
(50 µl) were injected into an ACE 5AQ column (dimensions 2.1 x 150 mm) 
connected to an Agilent 1100 HPLC with a flow rate of 1 ml.min-1. Using as 
aqueous phase 0.1 % trifluoroacetic acid (TFA) (A) and as organic phase 
acetonitrile (B), the following elution gradient was applied: 20 % B for 10 min, 
linear gradient up to 50 % B during 20 min, linear gradient up to 100 % B for 
10 min, 100 % B for 10 min and final re-equilibration to 20 % B, for 5 min. 
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Electrospray mass spectrometry (MS) was performed using in a Bruker 
microTOF-QII. 
 
Construction of S. aureus hemH and hemQ mutants 
S. aureus Newman hemH and hemQ non-polar mutants were 
constructed according to a method previously described (26). Briefly, the 
sequence upstream of the hemH (or hemQ) gene was amplified using two 
pairs of oligonucleotides HemHMutA/HemHMutB (HemQMutA/HemQMutB) 
and HemHMutC/HemHMutD (HemQMutC/HemQMutD) (Table S4.1, 
Supplementary data), which amplify DNA fragments located upstream 
(fragment A/B) and downstream (fragment C/D) of the hemH gene, 
respectively. Oligonucleotides HemHMutA (HemQMutA) and HemHMutD 
(HemQMutD) contained restriction sites for SacI and SalI, respectively and 
oligonucleotide HemHMutC (HemQMutC) contained a 5´ overhang 
sequence complementary to the 3´ of oligonucleotide HemHMutB 
(HemQMutB). Fragments A/B and C/D served as templates in a Splicing by 
Overlap Extension PCR reaction together with HemHMutA (HemQMutA) and 
HemHMutD (HemQMutD) oligonuleotides. The resultant A/D-PCR product 
was digested with SacI and SalI restriction enzymes, ligated to SacI-SalI 
linearized pIMAY vector, and transformed into E. coli DC10B (pIMAY and E. 
coli DC10B were a kind gift from the laboratory of T. J. Foster, Trinity College 
Dublin, Ireland). After confirming by sequencing the integrity of the final DNA 
fragment, the recombinant plasmid was electroporated into competent S. 
aureus Newman, and cells were plated onto trypic soy agar (TSA) 
supplemented with chloramphenicol 10 µg.ml-1, and grown overnight at 28 
°C. Single colonies were homogenized in 200 µl trypic soy broth (TSB), and 
the cell suspensions were diluted up to 10−3 fold. Each dilution was plated 
onto brain heart infusion agar (BHIA) supplemented with chloramphenicol 10 
µg.ml-1 (Cm10) and incubated overnight, at 37 °C, for the chromosomal 
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integration of pIMAY. Colony PCR analysis using oligonucleotides for the 
MCS site of pIMAY (Table S4.1, Supplementary data) allowed confirming the 
absence of extra plasmid DNA. Selected colonies were further checked by 
PCR for plasmid integration and localization using oligonucleotides 
HemHOutF/HemHMutA (HemQOutF/HemQMutA) and 
HemHOutF/HemHMutD (HemQOutF/HemQMutD). Plasmid excision from 
the genome was achieved by streaking overnight cultures onto TSA plus 10 
µg.ml-1 hemin (He10), and overnight incubation at 28 °C. Cells were then re-
platted onto TSA containing 1 µg.ml-1 anhydrotetracycline (ATc) and He10 
and incubated for 2 days, at 28 °C. Large colonies were patched onto TSA 
plus ATc and He10, and TSA plus Cm10 and He10, and incubated overnight, 
at 37 °C. For identification of the clones containing the hemH (or hemQ) 
mutation, Cm10 sensitive colonies were screened by PCR using 
oligonucleotides HemHOutF (HemQOutF) and HemHOutR (HemQOutR) 
(Table S4.1, Supplementary data).  
The absence of hemH or hemQ genes in S. aureus cells was also 
confirmed by gene expression analysis. Total RNA was extracted, using the 
High Pure RNA Isolation Kit (Roche), from S. aureus hemH and hemQ 
mutant cells previously grown in TSB medium containing He10, to an OD600 
of 1.5. RNA samples were purified from contaminant DNA by treatment with 
Ambion®TURBO DNA-free™ DNase kit (Life Technologies). cDNA was 
synthesized from the DNA-free RNA using the Transcriptor High Fidelity 
cDNA Synthesis Kit (Roche), and used as template in a PCR reaction done 
in the presence of oligonucleotides SaHemMutHF/SaHemMutHR, in the 
case of hemH mutant and SaHemMutQF/SaHemMutQR for the hemQ 
mutant (Table S4.1, Supplementary data).  
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Activity assays 
Porphobilinogen, coproporphyrin III, Fe-coproporphyrin III, hemin and 
protoporphyrin IX were purchased from Frontier Scientific. In these assays, 
freshly prepared enzymes were used. All experiments, except when 
otherwise indicated, were done under anaerobic conditions in Coy model A-
2463 and Belle Technology anaerobic chambers. Porphyrins were resolved 
by HPLC-MS on an Ace 5 AQ column attached to an Agilent 1100 series 
HPLC equipped with a diode array detector and coupled to a micrOTOF-Q II 
(Bruker) mass spectrometer, using the indicated solvents and gradients. 
Porphyrins were detected by their spectral absorbance at 390 and 400 nm. 
Unless otherwise indicated, reactions were done in buffer A loaded in 
magnetically stirred quartz cuvettes and recorded in a Shimadzu UV-1800 
spectrophotometer, at room temperature. Kinetic parameters were obtained 
by plotting the substrate concentration against rate, and using a non-linear 
regression to determine Vmax and KM by fitting the data to the Michaelis-
Menten equation in GraphPad Prism (GraphPad Software, La Jolla California 
USA).  For the determination of the kinetic parameters of S. aureus and B. 
subtilis HemH coproporphyrin III ferrochelatase data were fitted more 
accurately when using a substrate inhibition equation (Activity =
𝑉𝑚𝑎𝑥
1+
𝐾𝑚
[Fe]
+
[Fe]
𝐾𝑖
) in 
GraphPad Prism. 
HemE from S. aureus 
A linked protein assay was used to test the S. aureus HemE activity. 
To this end, HemC and HemDd from D. vulgaris were first expressed and 
purified according to a previously described procedure (23). Enzymatic 
reactions were done by mixing 20 µg S. aureus HemE, 70 µg D. vulgaris 
HemC, 620 µg D. vulgaris HemDd with 1.3 mg porphobilinogen in a 2.5 ml 
final volume of buffer A supplemented with 150 mM NaCl, 20 % glycerol and 
5 mM DTT. Control reactions were performed under the same conditions, but 
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omitting S. aureus HemE from the mixture. All reactions were incubated 
overnight, and the formation of uro´gen III and copro´gen III was evaluated 
by UV-visible spectroscopy and HPLC-MS analysis. Prior to the 
spectroscopic analysis, reactions were oxidized by addition of HCl to a final 
concentration of 0.1 M HCl. Samples for HPLC-MS analysis were first treated 
with 0.6 M HCl and centrifuged at 10500 xg, for 10 min, to remove the protein 
precipitates. Products separation was achieved by applying a binary 
gradient, at a flow rate of 0.2 ml.min-1, composed by 0.1 % TFA (solvent A) 
and acetonitrile (solvent B). The column was first equilibrated with 20 % 
solvent B and after sample injection the concentration of solvent B was 
increased up to 100 % during 50 min.  
 
HemY from S. aureus 
For the HemY activity assays, copro´gen III and proto´gen IX 
substrates were produced enzymatically as follows. Copro´gen III was made 
by mixing 50 μg HemC, 50 μg HemD (both from B. megaterium), 100 μg 
HemE (Human) and 200 μM porphobilinogen in a final volume of 200 μl buffer 
A supplemented with 50 mM NaCl, 20 % glycerol and 5 mM DTT. Proto´gen 
IX was generated in reactions that contained all of the above indicated 
proteins plus 50 μg HemF (E. coli) and 0.2 % Tween 20. Reaction mixtures 
were incubated, at 37 °C, for 50 min to allow the reaction to reach completion. 
The newly synthesised substrate was used immediately before depletion by 
auto-oxidation. An aliquot was retained and treated with 1 M HCl and 
production of the appropriate substrate was analyzed by quantitative HPLC-
MS. Samples (3 μl) were separated on a Waters Acquity UPLCT BEH C18 
1.7 µm column, in a Waters Acquity UPLC apparatus using a flow rate of 0.4 
ml.min-1. The aqueous phase consisted in 0.1 % formic acid (A) and the 
organic phase contained 0.1 % formic acid in methyl cyanide (B). The 
following gradient was applied: 2 % B for 1.7 min; a linear gradient up to 98 
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% of 0.1 % B during 7 min; 98 % B for 1.7 min, and re-equilibration to 2 % B 
for 3.5 min.  
HemY activity was measured aerobically in a Tecan Ultra or 
Fluorostar Optima plate reader (BMG Laboratories) using a 400 nm 
excitation filter and either a 615 nm or 620 nm emission filter. Reactions were 
done in black 96-well plates (Thermo-Matrix or Brand) with a final volume of 
100 µl reaction buffer A with 13 nM HemY, 0-3 µM copro´gen III or proto´gen 
IX, 150 mM NaCl, 20 % glycerol and 5 mM DTT. When using the proto´gen 
IX substrate, 0.2 % Tween 20 was added to the buffer. The fluorescence 
increase was monitored for 20 min, at 37 °C. The relative fluorescence units 
were converted into concentration by interpolation of a calibration curve 
obtained with coproporphyrin III and protoporphyrin IX standards. The initial 
rate was calculated from the linear region of the graph. Due to the high auto-
oxidation rate of the substrate, the background reaction was always 
subtracted from the rate of the enzyme reaction.  
 
HemH from S. aureus and B. subtilis  
The protoporphyrin IX stock solution was prepared by addition to the 
compound (1-3 mg) of 1-3 drops of 25 % NH4OH, 500 µl Triton X-100 and 
4.5 ml water, and its concentration was determined spectrophotometrically 
in 2.6 M HCl at 408 nm (ε= 297 mM-1cm-1). The coproporphyrin III stock 
solution was prepared as described for protoporphyrin IX, but with no Triton 
X-100 addition, and its concentration was determined spectrophotometrically 
in 0.1 M HCl by following the 548 nm absorbance band (ε= 16.8 mM-1cm-1).  
The S. aureus HemH protoporphyrin IX ferrochelatase specific 
activity was measured by following the decrease in absorbance of 
protoporphyrin IX, at 408 nm. Enzymatic reaction mixtures contained 240 µg 
S. aureus HemH, 10 µM protoporphyrin IX and 0-150 µM iron in the form of 
(NH4)2Fe(SO4)2 in 1 ml final volume of buffer A.  
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The coproporphyrin III ferrochelatase specific activity of S. aureus 
and B. subtilis HemH was measured by following the absorbance decrease 
at 392 nm and using an extinction coefficient of 115 mM-1cm-1, which was 
determined in this work. The reaction contained 0.5-10 µg S. aureus HemH 
or 0.5-32 µg B. subtilis HemH, 10 µM coproporphyrin III and 0-12 µM of iron 
in 1 ml final volume of buffer A. 
The ability of S. aureus HemH to insert iron into coproporphyrin III 
was also analyzed by HPLC. The reaction mixture contained S. aureus 
HemH (80 µg), coproporphyrin III (5 µM), iron (14 µM) in 0.5 ml buffer A, and 
the control reaction was prepared similarly but with no addition of the 
enzyme. After a 5 min incubation period, 0.6 M HCl was added to all reaction 
mixtures and all samples were centrifuged at 10500 xg, for 10 min. The 
tetrapyrrole products were separated by HPLC using 0.1 % TFA as solvent 
A and acetonitrile as solvent B, at a flow rate of 0.2 ml.min-1; the column was 
first equilibrated with 20 % solvent B, followed by a linear gradient up to 50 
% B (10 min), gradient up to 70 % B (10 min), gradient up to 100 % B (5 min) 
and washed with 100 % B for 5 min. 
 
HemQ from S. aureus  
Reaction mixtures containing S. aureus HemQ (0.5-1 mg), Fe-
coproporphyrin III (15 µM) and H2O2 (1-5 molar equivalents) were prepared 
in 0.5 ml buffer A, and incubated for 5-30 min, and stopped by the addition 
of 0.6 M HCl. The precipitated protein was removed by centrifugation at 
10500 xg, for 10 min. Samples were resolved by HPLC using 0.1 % TFA as 
solvent A and acetonitrile as solvent B, at a flow rate of 0.2 ml.min-1. The 
column was firstly equilibrated with 20 % solvent B and the following 
conditions were used: linear gradient up to 50 % B (10 min), gradient up to 
100 % B (17 min) and 100 % B for 8 min. Next, the masses of the several 
products were determined by HPLC-MS. 
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Inhibition assays of S. aureus HemY 
The inhibitors used in this work (Table S4.2, Supplementary data) 
were stored and serialised in 100 % DMSO, and the final concentration of 
DMSO in the assays was kept at 3 %. IC50 values, i.e. the concentration 
required for 50 % inhibition, were determined in reactions containing 6.5 nM 
HemY, 60 nM copro´gen III and by varying the concentration of the inhibitors 
between 1.5 pM and 3 mM. Controls samples were run in the absence of the 
inhibitor to measure the 100 % response (reaction without enzyme) and 0 % 
response (for reactions performed in the presence of enzyme and substrate). 
Enzyme activity was measured using a fluorescence plate reader 
assay under conditions similar to those described above for the S. aureus 
HemY activity assays. Fluorescence increase was monitored for 20 min and 
the initial rate calculated by linear regression; data were normalised using 
the 100 % and 0 % response control wells. IC50 values were calculated by 
fitting the data to a four parameter logistic equation in GraphPad Prism 
(GraphPad Software, La Jolla California USA) and Ki was estimated from the 
IC50 using the Cheng-Prusoff equation Ki=IC50/(1+[S]/KM) based on the 
assumption that all the inhibitors were competitive. 
 
S. aureus metabolite profile analysis 
Overnight cultures of S. aureus wild type and ΔhemH grown in TSB 
medium were inoculated 1:10 in fresh medium and cultured for another 8 h, 
at 37 °C. Cells were then diluted in 200 ml TSB, to an OD600 of 0.1, and left 
to grow overnight at the same temperature. Cells collected by centrifugation 
were resuspended in 2 ml of 20 mM potassium phosphate pH 7.6 (buffer B), 
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and washed twice with the same buffer. Aliquots of 0.5 ml of the cell 
suspensions were incubated with lysostaphin from Sigma (1 mg.ml-1, 100 µl) 
for 45 min, at 37 °C, after which the volume was adjusted with buffer B to a 
final volume of 1 ml. Cells were disrupted by passage into a French Press at 
900 Psi, and centrifuged at ~11000 xg, for 15 min. Protein content of the cell-
free lysates was quantified in a Nanodrop ND-2000C (Thermo Scientific). 
Cell-free lysates of S. aureus wild type and ΔhemH with the same protein 
concentration were prepared in buffer B (300 µl) and treated, at room 
temperature, with 0.6 M HCl, for 10 min. The precipitated proteins were 
removed by centrifugation at 10500 xg, for 10 min, and the extracted 
porphyrins were analyzed by HPLC-MS, using a binary gradient with 0.1 % 
TFA as solvent A and acetonitrile as solvent B, at a flow rate of 0.2 ml.min-1. 
The column was first equilibrated with 20 % solvent B and after sample 
injection the concentration of solvent B was increased to 100 %. The total 
duration of each run was 50 min. 
 
Homology-based modeling of HemY 
The homology model of S. aureus HemY was created using an 
internal software package MoViT (Pfizer Inc.). The B. subtilis HemY crystal 
structure that shares 47.5 % sequence identity with S. aureus HemY was 
used as a template (PDB: 3I6D) (27). FAD and acifluorfen were docked with 
PyMOL by simple superimposition of the B. subtilis crystal structure with the 
homology model and merging the ligand and homology model coordinates 
into a single file. To assess the potential binding interactions of the novel 
inhibitors, the acifluorfen molecule was edited in PyMOL using the Build 
command to generate structures resembling the inhibitors. 
 
4.4. Results 
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The S. aureus heme biosynthetic pathway was analyzed by studying 
the enzymes involved in the transformation of uro’gen III into protoheme IX, 
which was achieved by assaying their enzymatic activity and identifying the 
tetrapyrrole intermediates formed along the biosynthetic route. 
 
S. aureus uroporphyrinogen III decarboxylase HemE  
The ability of the recombinant S. aureus uro´gen III decarboxylase 
HemE to convert uro´gen III into copro´gen III was investigated. The 
substrate, uro’gen III, was synthesised from porphobilinogen using the heme 
synthesis enzymes HemC and HemDd from D. vulgaris (23). Addition of S. 
aureus HemE to the reaction mixture of HemC and HemDd led to the 
formation of copro´gen III, as shown by UV-visible spectroscopy and HPLC-
MS (Figure 4.2). Collectively, these results demonstrate that the S. aureus 
HemE is functional as uro´gen III decarboxylase.  
 
 
 
 
 
 
 
 
 
 
Figure 4.2.  Analysis of the reaction product of S. aureus HemE. A. UV-visible spectra of the 
uroporphyrin III standard (filled line) and the oxidized form of the reaction product of D. vulgaris 
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HemC and HemDd (dotted line) dissolved in 0.1 M HCl. B. UV-visible spectra of the 
coproporphyrin III standard (filled line) and oxidized reaction product of S. aureus HemE 
(dotted line), in 0.1 M HCl. C. HPLC-MS extracted-ion chromatogram (EIC) of the reaction of 
S. aureus HemE at the expected m/z for coproporphyrin III, the oxidized form of copro´gen III, 
with the corresponding mass spectrum showing an m/z of 655. 
 
S. aureus coproporphyrinogen III oxidase HemY 
The S. aureus hemY was cloned into pET-28a and transformed into 
E. coli for protein production. Cells expressing HemY exhibited a slight 
reddish colour whilst the supernatant had a pink coloration. This observation 
suggested that overproduction of S. aureus HemY leads to the accumulation 
of a porphyrin, some of which is excreted into the culture medium (7). After 
purification by immobilised metal affinity chromatography, the recombinant 
HemY was found to be yellow in colour, indicating the presence of a bound 
flavin. However, the UV-visible spectrum of the purified HemY failed to show 
the expected characteristics for a flavin, with maxima at 360 nm and 450 nm. 
Instead, a broad peak at 400 nm was observed, which may be due to the 
binding of porphyrin to HemY. Nevertheless, the presence of flavin could not 
be ruled out due to the broad peak at 400 nm that may mask the flavin 
spectrum. To investigate this possibility, HemY was denatured to allow the 
release of any bound material, and the supernatant was analyzed by HPLC-
MS (Figure 4.3). Two compounds were detected: the first eluted at 5 min and 
had an absorbance spectrum typical of a flavin with peaks at 360 nm and 
450 nm and m/z of 786, which corresponds to a FAD molecule (Figure 4.3A-
B). The second compound, eluted at 15 min, had an absorbance peak at 400 
nm and m/z of 653 (Figure 4.3C-D). This m/z value does not correspond to 
any known tetrapyrrole but it is only two units lower than the expected m/z of 
coproporphyrin III (655). It was concluded that the recombinant HemY is a 
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flavoprotein that also binds a tetrapyrrole molecule, and may therefore 
represent an enzyme-product complex. 
 
 
 
The enzymatic activity of HemY for proto´gen IX was measured with 
a fluorescence plate reader assay, as described in the Materials and 
Methods. Due to the high auto-oxidation rate of porphyrinogen, the 
background reaction rate was measured and subtracted from the rate of the 
enzyme catalyzed reaction. Unexpectedly, no activity could be detected 
above the background rate when proto´gen IX was used as a substrate in 
concentrations up to 5 μM, even in the presence of the detergent Tween-20. 
In contrast, when copro´gen III was supplied, a significant porphyrinogen 
oxidase activity was detected that was dependent on the enzyme 
concentration. Incubation of copro’gen III with HemY resulted only in the 
Figure 4.3.  Analysis of the ligands bound to HemY. Recombinant, purified S. aureus HemY 
was heat-denatured and the supernatant was run on HPLC-MS to identify bound 
chromophores. A. Absorption spectra for the eluate at 5 min. The maxima at 360 nm and 450 
nm are consistent with the presence of a flavin. B. The mass spectrum of the material identified 
in A. showing an m/z of 786, which corresponds to the molecular mass of FAD.C. Absorption 
spectra for the ligand eluting at 15 min. The absorption maximum at 400 nm suggests that the 
material is a porphyrin. D. The mass spectrum of the material identified in C showing an m/z 
of 653. The mass is close to the expected m/z of coproporphyrin (655). 
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formation of coproporphyrin III, as confirmed by mass spectrometry (m/z 
655), which negated the unlikely possibility that HemY may be able to convert 
coproporphyrin III into protoporphyrin IX. The kinetic parameters of HemY for 
coproporphyrin III synthase activity were as follows: maximal specific activity 
of 24.6 ± 0.7 nmol.min-1mg-1, kcat of 1.33 ± 0.04 min-1 and KM of 0.31 ± 0.01 
μM. Reactions performed in the presence of Tween-20 led to an approximate 
4-fold increase in KM, but did not alter the Vmax value. Thus, while S. aureus 
HemY can oxidise copro´gen III to coproporphyrin III it is unable to oxidise 
proto´gen IX to protoporphyrin IX.  
 
S. aureus coproporphyrin III ferrochelatase  
The recombinant S. aureus HemH specific activity for iron insertion 
into protoporphyrin IX was determined to be 10.1 ± 0.1 nmol.min-1mg-1. The 
dependence of the activity of HemH on iron concentration was obtained by 
non-linear regression to a Michaelis-Menten equation, which resulted in the 
determination of kcat as 15.3 ± 0.6 min-1 and a KM for iron of 52 ± 5 μM (Figure 
4.4A).  
As S. aureus HemY proved to oxidise copro´gen III, but not proto’gen 
IX, to the corresponding porphyrin, we therefore tested whether the S. aureus 
ferrochelatase, HemH, could use coproporphyrin III as substrate for metal 
chelation. The ability of S. aureus HemH to insert iron into coproporphyrin III 
was initially examined by incubating HemH with coproporphyrin III and iron, 
and analysing the products of the reaction by HPLC (Figure 4.5). While the 
control reaction, which contained all the components except HemH, gave 
only a single peak corresponding to the substrate, coproporphyrin III (Figure 
4.5B), and addition of HemH led to the complete conversion of 
coproporphyrin III into Fe-coproporphyrin III (Figure 4.5B). To obtain the 
kinetic parameters of HemH for the iron insertion into coproporphyrin III, the 
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consumption of coproporphyrin III was determined by following the decrease 
of the Soret band at 392 nm. Analysis of these data revealed that S. aureus 
HemH inserts iron into coproporphyrin III with a specific activity of 815 ± 30 
nmol.min-1mg-1, a kcat of 165 ± 54 min-1 and an apparent KM for iron of 0.6 ± 
0.1 μM. Since the activity of S. aureus HemH was inhibited by iron 
concentrations higher than 0.8 μM, the data was fitted with a substrate 
inhibition equation (see Materials and Methods) which allowed the 
determination of an apparent substrate binding inhibitory constant (Ki) of 0.8 
± 0.2 μM (Figure 4.4B). 
For comparison purposes, the ability of the Gram-positive bacterium 
B. subtilis HemH to insert iron into coproporphyrin III was evaluated. This 
enzyme also catalyses the metallation of coproporphyrin with a specific 
activity of 110 ± 7 nmol.min-1mg-1, an apparent KM of 0.15 ± 0.03 μM and a 
kcat of 78 ± 9 min−1. As with the S. aureus enzyme, the B. subtilis HemH kinetic 
data were fitted more accurately using a substrate inhibition equation with a 
Ki of 2.8 ± 0.5 μM (Figure 4.4C).  
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Figure 4.4. Activity profiles of S. aureus and B. subtilis HemH ferrochelatases for different 
porphyrin substrates and dependence on iron concentration. A. S. aureus HemH activity with 
protoporphyrin IX and iron (1 - 140 μM); data were fitted to the Michaelis-Menten equation, 
which provided a kcat of 15.3 ± 0.6 min-1 and a KM for iron of 52 ± 5 μM. B. S. aureus HemH 
activity profile with coproporphyrin III and iron (0.02 - 10 μM); data were fitted with a substrate 
inhibition equation and the following parameters were determined: kcat of 165 ± 54 min-1, KM 
of 0.6 ± 0.1 μM and a Ki of 0.8 ± 0.2 μM. C. B. subtilis HemH activity using coproporphyrin III 
and iron (0.02 - 12 μM); data were fitted with a substrate inhibition equation from which a kcat of 
78 ± 9 min−1, KM of 0.15 ± 0.03 μM and Ki of 2.8 ± 0.5 μM were calculated. 
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Figure 4.5. Conversion of coproporphyrin III into Fe-coproporphyrin III by S. aureus HemH. 
A. HPLC chromatogram of coproporphyrin III (Cp III) and Fe-coproporphyrin III (Fe-Cp III) 
standards, at 390 and 400 nm. B. HPLC chromatogram of the reaction product of S. aureus 
HemH using iron and coproporphyrin III as substrates (S. aureus HemH + Cp III + Fe), and of 
the control reaction done in the presence of all components except HemH (Cp III + Fe).  
 
S. aureus Fe-coproporphyrin III oxidase/dehydrogenase 
Taking into account the substrate preferences of S. aureus HemY and 
HemH, the ability of HemQ to convert Fe-coproporphyrin III, the product of 
S. aureus HemH, into protoheme IX was investigated. The S. aureus hemQ 
was cloned into pET23b and the recombinant protein was purified from 
suitably transformed E. coli cells by immobilised metal affinity 
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chromatography. In assays with Fe-coproporphyrin III, and in the absence of 
any electron acceptor, the recombinant S. aureus HemQ converted only a 
very minor proportion (around 1 %) of Fe-coproporphyrin III into protoheme 
IX (Figure 4.6A). However, a significant increase in protoheme IX synthesis 
activity was observed upon the addition of the strong oxidizer H2O2 (Figure 
4.6B-D). Reactions performed in the presence of one molar equivalent of 
H2O2 led to the formation of significant amounts of protoheme IX as well as 
the generation of the mono-vinyl intermediate (Figure 4.6B). The complete 
conversion of Fe-coproporphyrin III into protoheme IX by HemQ was 
achieved by the addition of 5 molar equivalents of H2O2 (Figure 4.6D). 
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Figure 4.6. Conversion of Fe-coproporphyrin III into protoheme IX by S. aureus HemQ. HPLC 
chromatograms of the reaction products of S. aureus HemQ recorded at 390 nm. The 
reactions were incubated for 5 minutes. The mass spectrum showed several m/z values: 708 
for the peak eluting at ~15 min consistent with Fe-coproporphyrin III (Fe-Cp III); 662 for the 
peak eluting at ~18 min corresponding to the mass of the mono-vinyl intermediate; and 616 
at ~21 min for protoheme IX. A.  Incubation of HemQ with Fe-Cp III. B.  Incubation of HemQ 
with Fe-Cp III in the presence of one molar equivalent of H2O2 leading to the appearance of 
the mono-vinyl intermediate and of the final product protoheme IX. C. Products of the reaction 
of HemQ achieved as in B but with the addition of 4 molar equivalents of H2O2, were a 
decrease in Fe-Cp III and increase of the mono-vinyl and protoheme IX peaks can be 
observed. D. Products of the reaction of HemQ achieved as in B, but with the addition of 5 
molar equivalents of H2O2. In this reaction, the full conversion of Fe-Cp III into protoheme IX 
was observed. 
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Previous reports indicated that S. aureus HemQ binds exogenous 
hemin (20, 28). In agreement, incubation of the E. coli supernatant containing 
overexpressed S. aureus HemQ with hemin, prior to purification of the protein 
on a nickel-column, yielded protein with 1 mol of protoheme IX/HemQ 
pentamer. This complex exhibited a typical protoheme IX-bound UV-visible 
spectrum (Figure S4.1, Supplementary data). To examine whether the bound 
prosthetic group modifies the protein activity, the hemin-loaded HemQ was 
incubated with Fe-coproporphyrin III in the presence and in the absence of 
H2O2, and the reaction products analyzed. Since under these conditions it is 
not possible to differentiate between protoheme IX formed during the 
reaction from that released from hemin-bound HemQ, the consumption of 
Fe-coproporphyrin III was monitored. The amount of Fe-coproporphyrin III 
remaining in the reaction mixture after incubation with HemQ or with hemin-
loaded HemQ was found to be similar (Figure S4.2, Supplementary data). 
These results indicate that the presence of a heme cofactor bound to the 
enzyme does not seem to modify the biochemical and enzymatic properties 
of HemQ, in agreement with what was previously observed for the 
Mycobacterium tuberculosis HemQ (19). 
 
S. aureus hemH mutant generate small colony variants  
We observed that S. aureus ΔhemH colonies grow poorly on tryptic soy agar 
(TSA) plates when compared to the wild type strain, forming the so-called 
small colony variants (SCVs) (29), and that the wild type phenotype was 
rescued by supplementation with exogenous hemin (Figure S4.3, 
Supplementary data). Tetrapyrrole intermediates of ΔhemH and parental 
strains were analyzed in cultures grown aerobically by means of HPLC-MS 
(Figure 4.7). In contrast to the wild type, ΔhemH accumulated coproporphyrin 
III (m/z = 655), which is consistent with a heme biosynthetic pathway of S. 
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aureus that proceeds via the coproporphyrin III and Fe-coproporphyrin III 
intermediates. 
Figure 4.7.  Porphyrin metabolite profile of S. aureus wild type and ΔhemH strains. HPLC-MS 
traces, recorded at 400 nm, of cell free extracts of S. aureus wild type (lower line) and ΔhemH 
(upper line), where the accumulation of coproporphyrin III (Cp III) in the ΔhemH mutant is 
observed. 
 
Complementation of the E. coli ΔhemH mutant strain with S. aureus 
heme synthesis enzymes 
The data above showed that the in vitro formation of heme in S. 
aureus from uro´gen III involves HemQ, HemY and HemH. To analyse the in 
vivo function of these gene products, complementation assays were 
performed in the background of the E. coli ΔhemH mutant using 
combinations of S. aureus hemH, hemY and hemQ genes (Table 4.1). The 
data demonstrated that the genetic deficiency of the E. coli ΔhemH mutant 
100 
is only overcome when the three genes are expressed simultaneously (Table 
4.2). Similar results were obtained for other Gram-positives bacteria (28). 
Together, these data are consistent with HemY, HemH and HemQ 
acting as a copro’gen III oxidase, coproporphyrin III ferrochelatase, and Fe-
coproporphyrin III oxidase/dehydrogenase, respectively, along a transitional 
route that is intermediary between the classic and alternative pathways. 
 
Table 4.2. Complementation of the E. coli ΔhemH with plasmids expressing S. aureus HemH, 
HemY and HemQ. E. coli ΔhemH cells harbouring the recombinant plasmids were streaked 
onto LB-antibiotic agar plates in the absence and presence of hemin (10 µg.ml-1) to test for 
their viability. (+) represents growth and (-) represents absence of growth.  
Recombinant plasmids LB agar plus hemin LB agar  
pET-23b + - 
pET-23b-SahemH + - 
pET-23b-SahemY + - 
pET-23b-SahemQ +  - 
pET-23b-SahemHQ +  - 
pET-23b-SahemHY +  - 
pET-23b-SahemHYQ +  + 
 
Inhibitor studies of S. aureus HemY 
S. aureus HemH contains no cofactor and the binding of protoheme 
IX to HemQ does not relate to the protein’s function. In contrast, HemY is a 
flavin containing enzyme whose function may be impaired by ligation to small 
molecules. Hence, in an attempt to find inhibitors of S. aureus flavin-
containing HemY, a search was made of Pfizer’s chemical library based on 
analogues of the commercially available diphenyl-ether herbicides. These 
herbicides are known to be potent inhibitors of proto’gen oxidases from a 
range of sources including human (30, 31), yeast (32) and bacterial species 
(33). Herein, the selection of the compounds was made by taking 
consideration of their structural similarity compared to the diphenyl-ether 
herbicides and the legal restrictions against their use in drug screening. In 
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total, 52 compounds were selected for screening, and their potency was 
evaluated by measuring the IC50 values at substrate concentrations below 
the KM, which allows the optimisation to sensitivity for competitive inhibitors 
such as diphenyl-ether herbicides (30, 32, 34, 35). For comparison purposes, 
screening also included acifluorfen, a known diphenyl-ether herbicide. For all 
compounds the Ki was calculated using the Cheng-Prusoff equation on the 
assumption that all the inhibitors were competitive. Tables 4.3 and S4.2 (in 
Supplementary data) show the structures and inhibition data for a selection 
of the compounds screened. Acifluorfen gave a Ki value of 77.1 µM revealing 
a weak inhibitory activity. Although, the majority of the Pfizer compounds 
gave little or no inhibition, nine compounds were more effective than 
acifluorfen. In particular, three compounds had Ki values <5 µM and the 
lowest Ki was observed for CP-027216 (Table 4.3). 
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Table 4.3. IC50 data for selected screening hits. Log IC50 values are the mean of two 
experiments. Ki values were calculated using the Cheng-Prusoff equation based on the 
assumption that the inhibitors are competitive. 
 
 
To determine the structure of S. aureus HemY and understand how 
the inhibitor and substrate interact with the protein, attempts were made to 
grow protein crystals for X-ray diffraction. However, this was unsuccessful 
despite a considerable effort. Therefore, a homology model was made using 
the B. subtilis HemY crystal structure (3I6D) as template (27) (Figure 4.8A), 
as it shares the highest sequence identity to S. aureus HemY among the 3D 
structures deposited in the PDB to date. In particular, all residues proposed 
to be involved in substrate binding and catalysis in the B. subtilis enzyme 
(27) are conserved in the homology model (Figure S4.4, Supplementary 
data).  
 
Compound 
Name 
Chemical Structure 
Mean Log 
IC50 (M) 
Calculated 
Ki (µM) 
Mean Hill 
Coefficient 
CP-027216 
 
-5.36±0.04 3.6 1.2 
MCP-77212 
(Oxyfluorfen) 
 
-5.31±0.02 4.1 1.1 
CP-143375 
 
-5.30±0.42 4.2 0.8 
Acifluorfen 
 
-4.03±0.07 77.1 0.7 
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Figure 4.8. S. aureus HemY homology modelling. A.  The homology model of S. aureus HemY 
was predicted using the MoViT molecular modelling tool (Pfizer, Inc.) (coloured in cyan). B. 
subtilis HemY crystal structure was used as template (3I6D) (coloured in light green). The 
FAD molecule is represented in yellow and the acifluorfen inhibitor in orange. The purple 
beads represent the “missing” residues from the crystal structure, which are not modelled. 
This picture was generated using YASARA View. The two structures were superimposed 
using MUSTANG align. The RMSD is 0.224 and the identity 47.5 %. B. Acifluorfen binding at 
the active site of S. aureus HemY model. Acifluorfen and FAD were positioned into the active 
site by alignment with the B. subtilis HemY structure (316D). Acifluorfen is held in place by a 
charge-dipole interaction between Lys63 and the chlorine, a hydrogen bond between the 
backbone oxygen of Ile149 and the carboxylic acid, hydrophobic interactions with Ile149 and 
pi stacking between the phenyl ring and FAD. 
104 
The herbicide acifluorfen and FAD cofactor were placed into the 
active site of the S. aureus homology model by structural alignment with the 
B. subtilis crystal structure which contains both ligands bound (3I6D) (Figure 
4.8B). The model predicts the aromatic-aromatic interaction between the 
nitrophenyl ring of acifluorfen and the isoalloxazine ring of FAD, the 
hydrophobic interaction with Ile149 (S. aureus numbering) and the hydrogen 
bond between the carboxy group, and the main chain oxygen on Ile149 and 
the dipole-charge interaction between chorine and Lys63.  
Structural comparison suggests that compounds with an oxyethyl 
group in the ortho position of the nitrophenyl ring and a meta chlorine in the 
trichlorophenyl ring (CP-027216) exhibited higher potency (Tables 4.3 and 
S4.2, Supplementary data). While for the first, the inhibitory effect may be 
due to the possible fitting of the oxyethyl group into a hydrophobic pocket of 
HemY, the second result suggests that the chlorine group strongly interacts 
with HemY.  
 
4.5. Discussion 
We have detailed and characterized the S. aureus enzymes involved 
in the transformation of uro’gen III into heme and shown that this organism 
operates a pathway that is distinct from both the “classical” and “alternative” 
routes. This route represents a transitional pathway that shares copro’gen III 
and Fe-coproporphyrin III intermediates of the classic and alternative 
pathways, respectively (Figure 4.9). During the course of our research Dailey 
et corworkers (19) highlighted that many Gram-positive bacteria appear to 
operate this transitional heme biosynthesis pathway although their 
experiments were carried out with enzymes from several organisms. This 
report represents the first demonstration that this pathway operates fully in 
S. aureus. The first step in the conversion of uro’gen III into heme involves 
the decarboxylation of the four acetic acid side chains of uro’gen III to give 
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copro’gen III in a reaction catalyzed by uro’gen III decarboxylase, HemE. The 
next step is catalyzed by HemY, an enzyme that co-purifies with FAD 
together with a tetrapyrrole that is likely to be coproporphyrin III. To avoid 
confusion, we suggest that HemY is termed coproporphyrin synthase, rather 
than copro’gen oxidase, since the latter is also an oxidative decarboxylase 
of the classic heme pathway. The kinetic parameters of the S. aureus 
coproporphyrin III synthase activity are similar to the previously reported for 
B. subtilis HemY (KM 0.56 μM, specific activity 7 nmol.min-1mg-1) (6) (Table 
S4.3, Supplementary data). The S. aureus HemH inserts iron into 
protoporphyrin IX with a kcat in the same order of magnitude as described for 
other bacterial ferrochelatases (36). However, considerably higher kcat values 
and lower KM values were found for iron insertion into coproporphyrin III, 
clearly indicating a much stronger preference for coproporphyrin III as the 
substrate. These results are similar to those obtained by us for B. subtilis 
HemH and recently reported by others (19). Altogether, these data help 
highlight the role of coproporphyrin III as an intermediate in the heme 
synthesis pathway of Gram-positive bacteria.   
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Figure 4.9. Diagrammatic representation of the relationship between the classic, transitional 
and alternative heme biosynthetic pathways. The classic pathway is highlighted in orange, the 
alternative pathway in green and the transitional pathway in blue. The transitional pathway 
shares copro’gen III as a substrate with the classic pathway and Fe-coproporphyrin III with 
the alternative pathway. The enzymes associated with each stage of the transformation are 
highlighted. HemY* and HemH* denote enzymes that use copro’gen and coproporphyrin as 
substrates, respectively.  
 
In this work, S. aureus, HemQ was shown to promote the sequential 
decarboxylation of the two propionates attached to the C3 and C8 of Fe-
coproporphyrin III to yield protoheme IX, the final product of the pathway. 
These results fully agree with those recently reported by Dailey and co-
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workers (19), although it remains to be determined whether the enzyme is 
an oxidase or a dehydrogenase.   
Interestingly, little primary sequence similarity is shared between 
HemQ and AhbD, which is a SAM-radical protoheme IX synthase enzyme 
that is active in the alternative heme pathway (18). The conversion of Fe-
coproporphyrin III into protoheme IX by the S. aureus HemQ, which involves 
the formation of a mono-vinyl intermediate, is fully achieved upon the addition 
of H2O2 that is most probably required as an electron acceptor (19). Although, 
it has been speculated that HemQ would contribute to lowering the 
intracellular content of reactive oxygen species (28), the hemQ mutant strain 
showed no increased in susceptibility to this type of stress (Figure S4.5, 
Supplementary data). Hence, it remains to be established whether H2O2 is 
the true physiological electron acceptor of HemQ.  
The S. aureus genome also encodes a HemN like protein, which we 
hypothesised that could convert coproporphyrin III into protoporphyrin IX 
since in other microorganisms it transforms copro´gen III into proto´gen IX. 
We overproduced S. aureus HemN but could find no activity for this protein 
in any of our assays. Hence, it is likely that HemN plays some other role, 
perhaps in heme trafficking as it has been suggested for HemN-like proteins 
in other organisms (19). Since many proteins annotated in bacterial genomes 
as “HemN” are not true radical SAM copro´gen III oxidases (19, 37), the 
possibility that the S. aureus hemN gene is unrelated to heme synthesis 
should be considered.  
As a unique coproporphyrin synthase in Gram-positive pathogens, 
HemY represents a candidate for inhibitor compounds, especially the 
derivatives of diphenyl-ether herbicides that have been previously proved to 
target protoporphyrin synthases in plants (38). Our results indicate that S. 
aureus HemY shares with B. subtilis HemY the resistance to acifluorfen, with 
a Ki for acifluorfen in the 30 - 200 μM range (7, 27, 39–41), whereas the 
Human PPOX exhibits a Ki for acifluorfen of 0.53 μM (42) (Table S4.4, 
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Supplementary data). Interestingly, from 52 analogues of diphenyl-ether 
herbicides, 9 are ~20 times more potent than acifluorfen including the 
commercial herbicide oxyfluorfen herein named MCP-77212. Of the tested 
compounds, CP-027216 was found to be the best inhibitor (Ki of 3.6 μM) 
albeit in concentrations much higher than those determined for the herbicides 
against HemY from plants (34). 
We have therefore proved that S. aureus HemY is sensitive to a 
number of acifluorfen analogues, which have the potential to be developed 
further. Moreover, as there is no homolog of HemQ in humans (28) and that 
S. aureus HemH acts upon coproporphyrin III rather than protoporphyrin IX, 
these two proteins make plausible targets for novel antimicrobial agents, 
which are essential due to the alarming increase in drug resistance amongst 
pathogens. Furthermore, as this transitional pathway is restricted to many 
Gram-positive bacteria it raises the possibility that the pathway can not only 
be explored for its potential as an antimicrobial drug target but also that it can 
be used for selective therapy to differentiate between Gram-positive and 
Gram-negative pathogens. 
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4.8.  Supplementary data 
Table S4.1. Oligonucleotides used in this work 
Name Oligonucleotide sequence (5´- 3´) 
Cloning 
SaHemE_F 
CGAGCTAGCCACCACCACCACCACCACATGGTGCATAATA
AAAAC 
SaHemE_R CTCAAGCTTAAAACTAGTTTATCTTTGTGTATATGTGTGTAC 
SaHemH_F 
CATGCTAGCCACCACCACCACCACCACATGACTAAAAAAA
TGGG 
SaHemH_R CTCAAGCTTCTTACTAGTTTAAAATATAGACTTGATTTCATC 
BsHemH_F GTGGCTAGCATGAGTAGAAAGAAAATGG 
BsHemH_R CTCTCGAGACGTCCTAATTTTTTTAATACGAC 
SaHemY_F GCGTGAAACCATATGACTAAATC 
SaHemY_R CAAAAAAAGCTTAACCTTTGTCTC 
SaHemQ_F 
GATGCTAGCCACCACCACCACCACCACATGAGTCAAGCAG
CCG 
SaHemQ_R 
CATAAGCTTACCACTAGTTTAAGAAATCGCAAAGAATTGAT
C 
Construction of S. aureus hemH and hemQ mutants 
HemHMutA CCATTAGAGCTCATTGGTGTCG 
HemHMutB CCTTCCTTTAAATGAATTATCTTTC 
HemHMutC 
TAATTCATTTAAAGGAAGGGCGTGAAACGTTGTGACTAAAT
C 
HemHMutD GTTGCAACAGTCGACCTATCCATC 
HemHOutF CGGAGTTGTGCGCTTATGTAAC 
HemHOutR CCATCATGGGTATTTTCAATGTC 
SaHemHMutF CACCACATTATTCTTCATTTTCAG 
SaHemHMutR GCCGAAACAACTAATACCGTG 
HemQMutA CACCTGGAGCTCTTTTCTCAGC 
HemQMutB TCATAAAGCAAAGGGGTAACG 
HemQMutC TTACCCCTTTGCTTTATGAGGTTTAAGCTTGGAATTTTTCGT 
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Table S4.1. continued  
Name Oligonucleotide sequence (5´- 3´) 
Construction of S. aureus hemH and hemQ mutants 
HemHMutD GTTGCAACAGTCGACCTATCCATC 
HemHOutF CGGAGTTGTGCGCTTATGTAAC 
HemHOutR CCATCATGGGTATTTTCAATGTC 
SaHemHMutF CACCACATTATTCTTCATTTTCAG 
SaHemHMutR GCCGAAACAACTAATACCGTG 
HemQMutA CACCTGGAGCTCTTTTCTCAGC 
HemQMutB TCATAAAGCAAAGGGGTAACG 
HemQMutC TTACCCCTTTGCTTTATGAGGTTTAAGCTTGGAATTTTTCGT 
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Table S4.2. IC50 data for selected screening hits 
 
Compound 
Name 
Chemical Structure 
Mean Log 
IC50 (M)  
(error as 95 
% 
confidence 
interval of 
mean) 
95 % 
Confidenc
e interval 
of fit to 
graph 
 
Ki 
(µM) 
Mean Hill 
Coefficie
nt 
Maximum 
inhibition 
(%) 
CP-027216 
 
-5.36±0.04 
-5.6 
to 
-5.1 
3.6 1.2 100 
MCP-77212 
(Oxyfluorfen) 
 
-5.31±0.02 
-5.5 
to 
-5.2 
4.1 1.1 100 
CP-143375 
 
-5.30±0.42 
-5.7 
to 
-4.8 
4.2 0.8 100 
CP-143382 
 
-5.02±0.16 
-5.2 
to 
-4.9 
8 0.9 100 
CP-227449 
 
-5.02±0.21 
-5.1 
to 
-4.9 
8 1 100 
MCP-173310 
 
-4.68±0.10 
-5.1 
to 
-4.3 
17.3 0.9 100 
0604988 
 
 
-4.46±0.14 
-4.8 
to 
-4.2 
29.2 0.8 100 
Acifluorfen 
 
-4.03±0.07 
-4.5 
to 
-3.5 
77.1 0.7 100 
CP-021292 
 
-3.91±0.02 
-4 
to 
-3.8 
101.
8 
 
5.54 
100 
UK-140415 
 
 
-4.08±0.13 
-4.5 
to 
-3.7 
68.6 0.60 100 
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Table S4.3. Comparison of S. aureus HemY kinetics with HemY from other organisms 
 
Enzyme KM (μM) Vmax (min-1) Substrate Reference 
S. aureus HemY 0.3  1.3  copro'gen III This work 
P. acnes HemY 19  3  proto'gen IX (1) 
P. acnes HemY+HemQ 10.1  19.8  proto'gen IX (1) 
B. subtilis HemY 0.56 0.358  copro'gen III (2) 
B. subtilis HemY 0.95  0.0435  proto'gen IX (2) 
 
 
Table S4.4. Ki data for acifluorfen of bacterial HemY and Human PPOX  
 
 Ki Acifluorfen (µM) Reference  
S. aureus HemY 77.1  This work 
Human PPOX  0.53  (3) 
B. subtilis HemY  32.9 - 193.6   (4–8) 
 
Homology modeling of S. aureus HemY 
Docking of acifluorfen into the homology model shows that all the 
interactions previously reported for the B. subtilis enzyme are conserved (7). 
These are the aromatic-aromatic interaction between the nitrophenyl ring of 
acifluorfen and the isoalloxazine ring of FAD, the hydrophobic interaction with 
Ile149 (S. aureus numbering), the hydrogen bond between the carboxy group 
and the main chain oxygen on Ile149, and the dipole-charge interaction 
between chorine and Lys63. The nitro group on acifluorfen projects towards 
the active site entrance and does not interact with the protein. Removal of 
this nitro group (UK 140415) caused no significant alteration on the inhibition 
effect. 
The herbicide oxyfluorfen (MCP-77212) substitutes the carboxy 
group of acifluorfen for an oxyethyl group and has a Ki approximately 19 
times lower than acifluorfen. As the modelled position for acifluorfen does not 
provide room to accommodate the extra bulk, oxyfluorfen must bind 
elsewhere in the active site. 
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Compared to acifluorfen, CP-143375 substitutes the meta chlorine for 
a methyl group and the para trifluorocarbon for a single chlorine. This results 
in an 18-fold decrease in Ki. As there are no residues close enough to form 
interactions with these groups the molecule probably binds in a different 
position to acifluorfen. CP-143382 substitutes the nitro group of CP-143375 
for an amino group with no significant change in the activity. 
CP-027216 caused the strongest inhibition. The substituents differ 
significantly from acifluorfen and therefore the compound probably binds in 
a different position. Removal of the meta chlorine from the trichlorophenyl 
ring leads to a 28-fold increase in Ki (CP-021292) showing the importance of 
this substituent for binding. Conversely the para chlorine does not seem to 
be important as moving it from the para to ortho position (CP-227449) had 
no significant effect on the activity. 
 
 
Figure S4.1. UV-visible spectrum of the purified S. aureus hemin-loaded HemQ. 
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Figure S4.2. Conversion of Fe-coproporphyrin III (Fe-Cp III) into protoheme IX by S. aureus 
HemQ and hemin-loaded HemQ. HPLC chromatograms, recorded at 400 nm, of HemQ and 
hemin-HemQ reaction products (A and B) and of the hemin-loaded HemQ (C), after treatment 
with HCl. A.  Incubation of HemQ (0.5 mg) with Fe-Cp III (15 μM). B.  Incubation of hemin-
loaded HemQ (0.5 mg) with Fe-Cp III (15 μM). C. Hemin-loaded HemQ (0.5 mg).  
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Figure S4.3. S. aureus ΔhemH forms small colony variants that revert to the wild type 
phenotype upon addition of exogenous hemin.  
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Figure S4.4. Structure based sequence alignment of B.subtilis HemY and S.aureus HemY. 
S. aureus HemY homology model was aligned with the B. subtilis HemY crystal structure 
(3I6D) in PyMol and the alignment exported to ESPript 
(http://espript.ibCp.fr/ESPript/ESPript/). The pink stars show the residues which were 
suggested to be involved in substrate binding in the B. subtilis enzyme and that are conserved 
in S. aureus HemY. The bottom line depicts the relative accessibility (Acc) of each residue. 
White identifies buried residues (Acc <0.1), cyan is intermediate (0.1 ≤ Acc ≤0.4), blue is 
accessible (0.1 ≤ Acc ≤1.0) and blue with red border is Acc >1.0. 
 
 123 
C
h
ap
te
r 
4
 Figure S4.5. Sensitivity of S. aureus wild type and ΔhemQ, to H2O2 assessed by disk diffusion 
assays. Cell suspensions prepared in phosphate saline buffer were spread on TSA plates. 
Discs of 10-mm containing 10 or 20 mM H2O2 were placed on top of the cell layer and the 
plates were incubated over night at 37 ˚C.  
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5.1. Summary 
Heme is an essential cofactor in central metabolic pathways in the 
vast majority of living systems. Most prokaryotes encode a heme 
biosynthesis pathway often coexists with a heme uptake system. However, 
how prokaryotes balance the heme requirements with toxicity associated 
with free heme remains unclear. Here, using the model pathogen 
Staphylococcus aureus, we show that IsdG, one of two heme oxygenase 
enzymes in the heme uptake system, inhibits the formation of heme by the 
heme biosynthesis pathway. More specifically, we show that IsdG decreases 
the activity of ferrochelatase, a key enzyme of the heme biosynthesis 
pathway, and that the two proteins interact both in vitro and in vivo. Further, 
a bioinformatics analysis reveals that a significant number of heme 
biosynthesis pathway containing organisms possess an IsdG-homologue 
and that those with both heme biosynthesis pathway and uptake systems 
have at least two heme oxygenases. We conclude that IsdG-like proteins 
control intracellular heme levels by coupling heme uptake with heme 
synthesis. IsdG thus, represents a novel target for the treatment of S. aureus 
infections.  
 
5.2. Introduction 
In all forms of life, the ability to perform redox reactions is crucial, 
often requiring compounds with metal centers and cofactors that are 
evolutionarily ancient. Heme is an iron-based redox center that is widely 
distributed in living organisms and which permits an extensive range of 
proteins and enzymes to function in essential cellular processes such as 
aerobic and anaerobic respiration, detoxification, microRNA processing and 
regulation of gene expression (1). Heme is obtained by either de novo 
synthesis (via heme biosynthesis pathways) or by uptake from the 
environment. Several pathogens uptake heme from their host’s hemoglobin, 
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which upon degradation serves as a source of iron to satisfy the nutritional 
needs of the pathogen (1, 2). Furthermore, a large number of 
microorganisms combine pathways for the endogenous production of heme 
with complex heme uptake systems.  
Prokaryotes utilize one of three distinct heme biosynthesis pathways, 
all of which have common early steps that lead to the intermediate 
uroporphyrinogen III (Fig. 5.1). Thereafter, the three distinct routes are 
referred to as the protoporphyrin, siroheme and coproporphyrin branches, 
reflecting intermediates that are unique to each pathway, and the genes 
involved were recently renamed (3). The protoporphyrin dependent branch 
(PPD), previously known as classic pathway, operates in many Gram-
negative bacteria. This pathway involves the decarboxylation of 
uroporphyrinogen III to coproporphyrinogen III by HemE (now UroD), 
followed by decarboxylation to protoporphyrinogen IX by HemN/HemF (now 
CgdH/CgdC) and then oxidation to protoporphyrin IX by HemY/HemG (now 
PgoX/PgdH1) prior to metal insertion by ferrochelatase HemH (now PpfC) to 
give protoheme (3, 4). The siroheme dependent branch, originally named the 
alternative heme biosynthesis pathway Ahb, is active in sulphate-reducing 
proteobacteria and archaea, transforms uroporphyrinogen III to protoheme 
via siroheme in an oxygen-independent process requiring four-enzymatic 
steps involving the enzymes AhbA-D (5, 6). The most recently discovered 
branch, namely the coproporphyrin dependent pathway (CPD), is active in 
several Gram-positive organisms including S. aureus (7). This pathway 
involves the conversion of uroporphyrinogen III to coproporphyrinogen III by 
HemE (now UroD) and subsequent oxidation to coproporphyrin III by HemY 
(now CgoX). Insertion of iron into coproporphyrin III to make coproheme is 
mediated by HemH (now CpfC), and the final step involves the 
decarboxylation of coproheme to protoheme by HemQ (now ChdC) (7, 8).  
The mechanisms of heme biosynthesis in prokaryotes vary widely (3) and 
control over the pathway has been reported to be regulated by iron, oxygen, 
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reactive oxygen species and by its final product heme (1, 3). In the case of 
the latter, the binding of heme to HemA (now GtrR), the first enzyme of the 
pathway, is thought to control the system via a feedback inhibition 
mechanism (1, 9, 10).  
Figure 5.1. Three different heme biosynthesis pathways that diverge from uroporphyrin III. 
The enzymes in the three pathways are conserved between aminolaevulinic acid (δ-Ala) and 
uroporphyrinogen III. The protoporphyrin dependent (or classical) pathway is boxed in grey 
and converts uroporphyrinogen III into heme using protoporphyrin as an intermediate. The 
coproporphyrin dependent pathway is represented in red and the siroheme dependent 
pathway (alternative heme biosynthesis pathway) highlighted in blue. 
 
The most common heme acquisition system in Gram-positive 
pathogens is the iron-regulated surface determinant (Isd). S. aureus also 
contains an additional  heme transport system (Hts) that, like the Isd proteins, 
was first described in this bacterium (11, 12). The Isd system includes the 
cell wall-anchored proteins IsdA, IsdB, IsdC and IsdH, as well as the heme-
binding protein and permease components IsdD, IsdE, and IsdF, and the 
transmembrane ABC transporter HtsABC (11, 12). Once heme is transported 
into the cytoplasm, it is either degraded by the heme oxygenases IsdG and 
IsdI to release iron (13), or becomes bound to membrane-associated 
proteins to act as a cofactor in, for example, electron transport (14). S. aureus 
also possesses the heme regulated transporter (HrtAB), an efflux pump that 
protects cells from heme toxicity (15).  
S. aureus is clinically significant as it is responsible for a large number 
of human infections including respiratory, urogenital, skin burn-associated 
and systemic infections (16). It is also a widely studied Gram-positive 
pathogen and the paradigm for the CPD pathway operating alongside a 
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heme acquisition system. Genes encoding enzymes of the CPD pathway are 
organized into two operons in S. aureus, hemAXCDB  and hemEHY, 
whereas hemQ is isolated elsewhere in the genome (7). The S. aureus heme 
acquisition system is formed by isdA, isdB, isdH, isdI and the transcriptional 
unit isdCDEF-srtB-isdG (11, 17). Like many other organisms, S. aureus 
encodes two heme oxygenases, IsdG and IsdI, which share approximately 
70% amino acid identity and which bind and degrade heme to produce iron 
and staphylobilin (13, 18).   
 In this work, we investigated how S. aureus controls intracellular 
heme levels. We show that the heme oxygenase, IsdG, provides a link 
between the heme biosynthesis and uptake pathways in S. aureus and that 
this protein prevents excessive formation of toxic heme inside bacterial cells. 
 
5.3. Materials and Methods 
Strains and growth conditions 
The strains used in this work are listed in Table 1 and were grown 
under aerobic conditions, at 37 °C and 150 rpm. S. aureus was cultured in 
tryptic soy broth (TSB), with the exception of the cells that were used for RNA 
extraction that were cultured in Roswell Park Memorial Institute (RPMI) 
medium supplemented with 1% casamino acids. E. coli strains were grown 
in Luria-Bertani (LB), except E. coli expressing the pWhiteWalker plasmid 
that was grown in Brain Heart Infusion (BHI) medium. Selection was 
achieved by addition of the indicated antibiotics, namely kanamycin (50 μg 
ml−1), erythromycin (20 μg ml−1 or 400 μg ml−1 for FRET experiments) and 
ampicillin (100 μg ml−1).  
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Table 1. Strains used in this work 
Strains Description Reference 
E. coli    
XL1-Blue Host strain used for genetic manipulation Laboratory stock 
BL21(DE3)Gold Recombinant protein expression strain Novagen 
BL21STARDE3pL
ysS 
Recombinant protein expression strain 
Novagen 
ΔvisA E. coli K12 hemH mutant strain Mark O’Brian Lab 
S. aureus    
RN4220 Restriction-deficient derivative of NCTC8325 Laboratory stock 
Newman Clinical isolate used as wild type strain Mariana Pinho Lab 
ΔhemH hemH mutant constructed in the Newman strain (7) 
ΔhemQ hemQ mutant constructed in the Newman strain (7) 
 
RNA isolation and quantitative real-time RT-PCR assays 
Overnight cultures of S. aureus were diluted to an optical density at 
600 nm (OD600) of 0.1 on RPMI containing 1% casamino acids or RPMI 
containing 1% casamino acids supplemented with hemin (2 μM). Cells at an 
OD600 = 1 were treated with an ice-cold ethanol/phenol RNA protective 
solution (5%), centrifuged at 2000 x g for 5 min, and the pellets flash frozen 
in liquid nitrogen. For RNA isolation, pellets were thawed on ice, 
resuspended in 10 mM Tris pH 8 and lysed with 2 mg ml-1 lysozyme and 30 
μg ml-1 lysostaphin at 37 °C, for 30 min. The lysates were transferred to 
Aurum RNA Binding Mini Columns and total RNA was extracted using 
Aurum™ Total RNA Mini Kit (Bio-Rad), following the manufacturer´s 
instructions. Contaminating DNA was removed using Ambion® TURBO 
DNA-free™DNase kit (Life Technologies), and RNA concentration and purity 
were evaluated in a Nanodrop ND-1000 UV–visible spectrophotometer 
(Thermo Fisher Scientific). 
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For the cDNA synthesis, 800 ng of RNA was reverse transcribed with 
the Transcriptor High Fidelity cDNA Synthesis Kit (Roche) using the 
Anchored-oligo (dT)18 and Random Hexamer primers. Quantitative real-time 
RT-PCR assays were done in a LightCycler® 480 (Roche) using the 
oligonucleotides listed in Table 2 and the LightCycler® 480 SYBR Green I 
Master kit (Roche). Relative quantification of each gene is shown in relation 
to the 16S rRNA reference gene, whose expression does not vary under the 
tested conditions, and using the comparative CT method. Assays were done 
for two independent biological samples analyzed in triplicate. 
 
Table 2. List of oligonucleotides used in this work 
Primer Oligonucleotide sequence (5´- 3´) Restriction sites 
Cloning    
SaisdG_F GGGCTAGCATGAAATTTATGGCAGAAAATAG NheI 
SaisdG_R CACTCGAGTTATTTCATGTAACTATAGCC XhoI 
SaisdI_F GAGCTAGCATGTTTATGGCAGAAAATAGATTAC NheI 
SaisdI_R CACTCGAGTTATTTTTGATAGTGGTAGCCAATATC XhoI 
SaisdGLaL_R CAACTCGAGTAAACTAGTTTATTTCATTAACTATAGCCTATATC Spe/XhoI 
SaisdILaL_R CTAGCTCGAGTTAACTAGTTTATTTTTGATAGTGGTAGCC Spe/XhoI 
SaisdGpWW_F GAATTCACAGGAGGGAGGATAATTATGAAATTTATG EcoRI 
SaisdGpWW_R GGTACCCAACCTCTTTAAATTCAAATATTTCATG KpnI 
pWWblock_F CGCGGATAACAATTAAGC EcoRI 
pWWblock_R GTCAAAGTAGTGACAAGTGTTG NcoI 
EchemH_F CGATAAGAGGCGCATATGCGTCAGACTAAAAC NdeI 
EchemH_R CTCACTCGAGGCGATACGCGGCAACAAG XhoI 
hemHpbcb1_F GGAAGGCATGCTCAATGACTAA SphI 
hemHpbcb1_R AATAGCCACTGAACTAGTCACAACG SpeI 
hemQpbcb1_F GCATGCAACATGAGTCAAGCAGCCG SphI 
hemQpbcb1_R ACTAGTAACGTACCAATGTATTAAGAAATCG SpeI 
hemQpbcb7_F GATTTTTGAAAAGGTACCATAAACATGAGTC KpnI 
hemQpbcb7_R CGTACCAATGCTAGCAGAAATCGCAAAG NheI 
isdGpbcb7_F AATAATTAAGGTAAGGTACCCAGAAAAG KpnI 
isdGpbcb7_R TCTTTAAATTGCTAGCTTTCATGTA NheI 
isdIpbcb7_F CATAAAATAGGGTACCGATTGCCCAT KpnI 
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Table 2. continued. 
Primer Oligonucleotide sequence (5´- 3´) Restriction sites 
isdIpbcb7_R GTTTTTAATAGCTAGCTTTTTGATAG NheI 
hemHpbcb7_F GAAGGTGGTACCAATGACTAAAAAAATGGG KpnI 
hemHpbcb7_R CACAAGCTAGCACGCTTCTTTCGTAATGAAAATATAG NheI 
qReal-time RT-
PCR   
hemART_F GGTGCAGGGGAAATGAGTG  
hemART_R CTCGAGGAACTGCAATATCAATC  
hemERT_F GGGGCACCATTTACATTAGCGTC  
hemERT_R CCTCGACATTTAATGCACCTACCC  
hemQRT_F CGCATTGCTGACTTCCTAATC  
hemQRT_R GGTCATACATTAATTTTTGGCG  
isdGRT_F ATTTTACACGAGACATGGGATTG  
isdGRT_R GGGCTACTTTCATCTTCATTTTTAC  
isdIRT_F CAGTGCGGAAGAAACGATTGAAC  
isdIRT_R GACTTTGCTGTCCATCGTCATCAC  
isdART_F GGATGACTATATGCAACACCCTGG  
isdART_R CATTGTTTGGTTTTGCTGCGTC  
isdBRT_F CATAGCGCACCAACTCTCGTC  
isdBRT_R CCGTTTGATACAGAGAAGCGAATG  
isdERT_F CTTAACCAGCTGTCAATCTTCCAGTTCTCA  
isdERT_R AACATTCGGCTCCATTGGTTGACC  
isdCRT_F GTAAAAACACTGCCAAAGATGAACGC  
isdCRT_R GCACCTGCTACATCAGTTGGTCCAT  
hrtBRT_F GCGCATAGTTCCATTGTGCTATTGAA  
hrtBRT_R GCTTGCTCTGCTTGATAACTCGCA  
htsART_F GCTAAAGCTTTAAATAAAGAAAAAGAAGGCG  
htsART_R GTTCGTTTAAAAATTGTCCAACATATGAATAG   
 
Gene cloning 
The genes encoding S. aureus Newman IsdG and IsdI were 
amplified, by standard PCR reactions, from genomic DNA using the Phusion 
High-Fidelity DNA Polymerase (Thermo Fischer) and the oligonucleotides 
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described in Table 2. DNA fragments were cloned into either pET-23b or 
pET-28a vectors (Novagen) to produce wild type proteins and N-terminal His-
Tag fused proteins, respectively. All plasmids were confirmed for gene 
integrity by DNA sequencing.  
For the complementation experiments, plasmid pET-23b containing 
combinations of hemH, hemQ, hemY, isdG, isdI of S. aureus (Sa), namely 
pET-23b-SahemYHQisdG, pET-23b-SahemYHQisdI, were generated by the 
link and lock methodology (19). 
For the Förster Resonance Energy Transfer (FRET) studies, the 
isdG, isdI, hemH and hemQ genes amplified from S. aureus genomic DNA, 
as described above, were cloned into pBCB plasmids, which were kindly 
provided by Mariana Pinho (ITQB-NOVA, Portugal).  
HemH and HemQ proteins fused at the N-terminal to GFP were 
generated by cloning the respective genes into SphI/SpeI-pBCB1-gfp vector 
whereas IsdG, IsdI, HemH and HemQ were fused at the C-terminal to 
mCherry (mCh) by cloning into the KpnI/NheI-pBCB7-mCh vector. After 
confirmation of the correct sequence of the fusion genes, BL21(DE3)Gold 
cells were used as recipient for the generated plasmids and analyzed by 
FRET.  
For the flow cytometry experiments, the S. aureus isdG gene was 
cloned into the EcoRI/KpnI restriction sites of pWhiteWalker3 (kind gift of 
Simon Foster, University of Sheffield, UK) to generate the in-frame fusion 
isdG-gfp (pWW-isdG-gfp). Plasmid pWhiteWalker3 that expresses only GFP 
(pWW-gfp) was also constructed to be used as control. For this purpose, a 
gBlock gene fragment of 244 bp that includes a ribosomal binding site and 
the N-terminal sequence of GFP (Integrated DNA Technologies) was cloned 
into EcoRI/NcoI-pWW-isdG-gfp. The correct sequence of the two 
recombinant plasmids was confirmed, and after electroporation into S. 
aureus the fluorescence level of GFP was analyzed by flow cytometry. 
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Complementation experiments 
Plasmid pET-23b harboring combinations of genes of S. aureus 
hemY, hemH, hemQ, isdG, isdI, and E. coli hemH were transformed into 
competent cells of E. coli ferrochelatase mutant ΔvisA (kind gift from Mark 
O’Brian State, University of New York at Buffalo, New York, USA) (20). 
Overnight cultures were grown in LB supplemented with ampicillin and 5 μM 
hemin and 1 ml aliquots of cells were centrifuged at 1700 x g for 5 min and 
washed three times with LB. These pellets were used to inoculate LB-
ampicillin, and growth was monitored for 8 h by measuring the optical density 
at 600 nm (OD600) in a spectrophotometer (Multiskan™ GO, ThermoFisher 
Scientific). Assays were done for two independent biological samples. 
 
Infection assays  
Murine macrophages J774A.1 (5 x 105 cells/ml) (LGC Promochem) 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% of fetal bovine serum, 100 μM of non-essential 
amino acids (Gibco), 50 U ml-1 of penicillin (Gibco), and 50 μg ml-1 of 
streptomycin (Gibco) in 24-well plates, at 37°C in a 5% CO2-air atmosphere. 
Prior to infection, macrophages were activated with 5 μg ml-1 LPS (Sigma) 
and 1 μg ml-1 IFN-Υ (Sigma), for 5 h. S. aureus wild type and ΔhemH mutant 
were inoculated, separately, in TSB medium and grown overnight. The 
cultures were re-inoculated in TSB, and 4 ml of cells grown to an OD600= 0.4 
were centrifuged at 4300 x g for 5 min and washed three times with PBS. 
Cells were then resuspended in DMEM, diluted to OD=0.05 (~107 CFU.ml-1) 
and used to infect the murine macrophages. After 30 min of infection, at 37 
°C, cells were washed twice with PBS and incubated with 50 μg ml-1 of 
gentamycin, at 37 °C, for 10 min, to prevent extracellular bacterial growth.  
Immediately after the addition of DMEM (time zero) and 2 and 4 h later, 
macrophages were collected, lysed with 2% of saponin and the number of 
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intracellular bacteria was determined by CFU counting on TSB agar plates, 
which also contained 4 μM hemin to allow for the growth of the ferrochelatase 
mutant strain. Experiments were done for three independent biological 
samples assayed in duplicate. 
 
Production of recombinant proteins  
For the purification of S. aureus ferrochelatase HemH, pET-23b-
SahemH was transformed into BL21STAR(DE3) pLysS (Novagen) 
competent cells that were grown in LB medium at 37 °C and 150 rpm. Cells 
at an OD600 of 0.6 were induced by addition of 400 µM of isopropyl β-D-1-
thiogalactopyranoside (IPTG) in the presence of 8 mg ml−1 of FeSO4 and 
grown for an additional 16-20 h, at 20 °C. For the production of S. aureus 
IsdG and IsdI, plasmids pET-23b-SaisdG and pET-23b-SaisdI were 
transformed, separately, in competent cells of E. coli BL21(DE3)Gold. Cells 
were grown in LB medium until reaching an OD600=0.7, and the protein 
expression was induced by addition of 1 mM of IPTG to the medium, and 
cells grown at 30°C for 3 h. Cells were harvested by centrifugation (10000 x 
g, 15 min, 4 °C), and the pellets were resuspended in 50 mM Tris-HCl pH 7.5 
(Buffer A). Cells were disrupted in a French press operating at 1000 Psi, and 
centrifuged at 27216 x g, at 4°C, for 15 min. The supernatant was applied 
onto a Ni2+ Sepharose fast flow column (GE Healthcare), previously 
equilibrated with buffer A supplemented with 10 mM of imidazole, and the 
proteins were eluted at 400 mM of imidazole and dialysed against buffer A. 
Proteins with level of purity >95%, as judged by SDS-PAGE, were 
concentrated in an Amicon Stirred Ultrafiltration Cell using a 10 kDa 
membrane (Millipore) and frozen until use.  
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Enzymatic activities  
Catalase activity  
Overnight cultures of S. aureus wild type, ΔhemH mutant were grown 
in TSB only or supplemented with 4 μM hemin to an OD600 of 1. Cells were 
pelleted by centrifugation (10000 x g, 10 min), resuspended in buffer A and 
incubated with 7 μg of lysostaphin for 45 min, at 37 °C. The protein 
concentration of the cell lysates was determined using the Pierce 
Bicinchoninic acid Protein Assay (Thermo Scientific) and Sigma protein 
standards. For the catalase activity assays, approximately 26 μg of cells 
lysate proteins were added to buffer A containing 10 mM H2O2. The catalase 
activity was measured by following the decrease in absorbance at 240 nm 
for the formation of H2O2 (ε240nm = 43.6 M-1cm-1) in a Shimadzu UV-1700 
spectrophotometer. Assays were done in triplicate. 
 
Ferrochelatase activity  
The assays were performed under anaerobic conditions in a Coy 
model A-2463 and Belle Technology chamber equipped with a Shimadzu 
UV-1800 spectrophotometer. For the preparation of coproporphyrin III (copro 
III) solution, 1–2 drops of 25% NH4OH was added to 1-3 mg of copro III 
powder followed by addition of 1 ml of water. Copro III concentration was 
determined spectrophotometrically in 0.1 M HCl (ε548 = 16.8 mM−1 cm−1).  
For the ferrochelatase assay, HemH (10 μg) was pre-incubated with IsdI 
(1:10 molar ratio) or IsdG at room temperature, for 10 min. Next, these 
proteins were added to the reaction mixture that contained copro III (10 μM) 
and (NH4)2Fe(SO4)2 (50 μM). The IsdG titration experiments, where 
performed using IsdG concentrations of 0.6, 1.2, 3 and 6 mM, which 
correspond to 1:1, 1:2, 1:5 and 1:10 stoichiometry relative to the 
concentration of HemH. The chelatase activity was measured by following 
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the decrease in absorbance of copro III, measured at 392 nm (ε392nm = 0.115 
μM-1cm-1). Assays were done in triplicate. 
 
Heme abundance assays 
 
S. aureus wild type and ΔisdG mutant cells were grown for 8h and 
then diluted in TSB in the presence of 400 μM of aminolaevulinic acid. Cells 
were harvested by centrifugation (8000 x g, 5 min, 4 ᵒC), washed and 
resuspended in buffer A, and incubated with lysostaphin, at 37 ᵒC, for 45 min. 
The supernatant was collected by centrifugation and the intracellular heme 
was quantified essentially as previously described (21, 22). Cell extracts (250 
μL) were mixed with the same volume of a solution containing 0.5 M NaOH 
and 2.5 % Triton-X-100, and the haemetine formation was determined 
measuring the absorbance at 575 nm in a spectrophotometer Shimadzu UV-
1700. Hemin from Frontier Scientific was used as standard. 
 
Mass spectrometry of tetrapyrrole products  
The plasmids pET-23b containing combinations of hemY, hemH, 
hemQ, isdG and isdI were inserted into E. coli ferrochelatase mutant ΔvisA. 
Cells were prepared as described above for the complementation 
experiments, and inoculated in LB medium to an OD600~0.05 and grown for 
7 h. Cells were harvested by centrifugation at 10000 x g for 10 min, 
resuspended in buffer A, disrupted at 900 Psi in a French press, and 
centrifuged at 17000 x g for 30 min, at 4 °C. Protein content of the cell-free 
lysates was quantified using a Nanodrop ND-2000C (Thermo Scientific). 
Lysates with the equal protein concentration were treated for heme 
extraction. Briefly, proteins were precipitated by incubation of lysates with an 
acetone:HCl (19:1 vol/vol) mixture for 20 min, at room temperature, and 
removed by centrifugation at 14000 x g for 2 min. Following addition to 
supernatants of 1 ml of cold water, few milligrams of (NH4)2SO4 (Panreac) 
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and 300 µl of pure ethyl acetate (Sigma), heme was extracted from the 
organic phase after centrifugation at 14000 x g for 2 min. Samples were 
resolved by HPLC-MS on an Ace 5 AQ column attached to an Agilent 1100 
series HPLC, equipped with a diode array detector and coupled to a 
micrOTOF-Q II (Bruker) mass spectrometer. Separation of the products was 
achieved by applying a gradient composed by 0.1% TFA and acetonitrile, at 
a flow rate of 0.2 ml min−1. The column was first equilibrated with 20% solvent 
B, and after sample injection the concentration of solvent B was increased 
up to 100% during 50 min. Heme quantification was done by measuring the 
area of absorbance peak at 400 nm for m/z 616 (heme).  
 
Flow cytometry 
Overnight cultures of S. aureus RN4220 transformed with pWW-
isdG-gfp, pWW-isdI-gfp or pWW-gfp were grown in TSB to an OD600~1.5, 
diluted to an OD600 of 0.1 in TSB supplemented with 10 μM of IPTG, and 
grown for one extra hour. At this stage, cells were divided in 10 ml aliquots 
and grown for 4 h in the absence and in the presence of 5 μM hemin or 400 
μM of aminolaevulinic acid. Cells (1 ml) were collected by centrifugation at 
11400 x g for 1 min, and the pellets were washed 3 times with PBS, diluted 
in PBS to an OD600 of 0.1 and analyzed in a Cell Sorter S3e™ (Biorad). For 
each sample, at least, 300,000 cells were collected and analyzed with the 
FlowJo software (Tree Star), and three biological samples were measured 
for each condition. 
 
Fluorescent labelling of HemH 
S. aureus HemH was covalently labelled with 5-
dimethylaminonaphthalene-1-sulfonyl chloride (dansyl chloride) according to 
the manufacturer´s instructions (Invitrogen). Briefly, recombinantly produced 
and purified S. aureus HemH (7.5 mg.ml-1), solubilized in 0.1 M sodium 
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bicarbonate pH 8.6, was incubated in a 1:1 ratio with dansyl chloride (10 mg 
ml-1 in dimethylformamide) for 1 h at 4°C, in the dark and under continuous 
stirring. The reaction was quenched by the addition of hydroxylamine (1.5 M, 
pH 8.5), and the mixture was then loaded onto a PD-10 column (GE 
Healthcare) equilibrated with buffer A in order to remove the excess of free 
dye by gel filtration. The HemH:dansyl labelling ratio was determined by 
spectrophotometric quantification of the dye (ε331nm = 4,000 M-1 cm-1) (23)  
and of HemH (ε280nm = 47,700 M-1 cm-1) (24), and estimated to be 0.97. 
 
Steady-state fluorescence anisotropy measurements 
Dansyl-labeled HemH (0.67 µM) was incubated with variable 
concentrations of IsdG or IsdI in buffer A. 
The steady-state fluorescence anisotropy of each sample, <r>, was 
calculated according to: 
< 𝑟 >=
𝐼VV − 𝐺𝐼VH
𝐼VV + 2 𝐺𝐼VH
 
(1 
where IVV and IVH are the fluorescence intensities (blank subtracted) of the 
vertically and horizontally polarized emission, when the sample is excited 
with vertically polarized light, respectively. The G factor (G= IHV/IHH) is an 
instrument correction factor which takes into account the transmission 
efficiency of the monochromator to the polarization of the light. 
Measurements were performed at 25 oC on a Fluorolog-3-21 
spectrofluorometer (Horiba Jobin Yvon) with automated dual polarizers using 
5-mm path length quartz cuvettes. The excitation wavelength was 340 nm 
with a bandwidth of 6 nm, and the fluorescence emission was recorded at 
530 nm with 5 nm bandwidth. Kd and <r>B parameters were obtained by 
fitting the experimental data (steady-state fluorescence anisotropy, <r> 
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versus [P2]𝑡, the total concentration of the binding partner 2 (dimeric IsdG or 
IsdI) using the equation: 
 < 𝑟 >=< 𝑟 >𝑓+
([P1]𝑡+[P2]𝑡+𝐾d)−√([P1]𝑡+[P2]𝑡+𝐾d)2−4[P1]𝑡[P2]𝑡(<𝑟>𝑏−<𝑟>𝑓 )
2[P2]𝑡
   
Where [P1]t represents the total concentration of the binding partner 1. The 
concentration of HemH was fixed to 0.67uM during the non-linear regression 
and assumed that the fluorescently-labeled protein is monomeric in solution; 
[P2]t is the total concentration of the binding partner 2. Binding stoichiometry 
was considered 1:1; < 𝑟 >𝑓 represents the steady-state fluorescence 
anisotropy of the free protein. <r>F= 0.165 (fixed during the analysis); and 
< 𝑟 >𝑏 the steady-state fluorescence anisotropy of the bound protein. 
 
Förster Resonance Energy Transfer (FRET) and Fluorescence Lifetime 
Imaging Microscopy (FLIM) 
E. coli BL21(DE3)Gold were co-transformed with plasmids that 
express combinations of HemH, HemQ, IsdI and IsdG fused to GFP and 
mCherry (mCh) fluorophore proteins, namely pBCB-hemH-gfp and pBCB-
isdG-mCh; pBCB-hemH-gfp and pBCB-isdI-mCh; pBCB-hemQ-gfp and 
pBCB-isdG-mCh; and pBCB-hemQ-gfp and pBCB-isdI-mCh (Table 3). Cells 
grown overnight in LB were sub-cultured into LB medium to an OD600 of 0.15, 
supplemented with 1 mM IPTG and grown for 4 h. Cells (2 ml) were 
centrifuged at 4300 x g for 3 min, and fixed by incubation with 4% 
formaldehyde (vol/vol) in PBS, at room temperature, for 30 min and 90 rpm, 
washed with PBS and immobilized on 8 well μ-slides (Ibidi, slides, Germany) 
for FRET-FLIM experiments.  
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Table 3. List of plasmids used in this work 
 
 
 
Plasmid  Plasmid description Phenotype Reference 
pET-23b-SahemH S. aureus hemH cloned into pET-23b Ampr  (7) 
pET-23b-SahemY S. aureus hemY cloned into pET-23b Ampr  (7) 
pET-23b-SahemQ S. aureus hemQ cloned into pET-23b Ampr  (7) 
pET-23b-
SahemYHQ 
S. aureus hemH, hemY and hemQ cloned into pET-
23b  
Ampr  (7) 
pET-23b-
SahemYHQisdG 
S. aureus hemH, hemY, hemQ and isdG cloned into 
pET-23b  
Ampr  This study 
pET-23b-
SahemYHQisdI 
S. aureus hemH, hemY, hemQ and isdI cloned into 
pET-23b  
Ampr  This study 
pET-23b-SaisdG S. aureus isdG cloned into pET-23b Ampr  This study 
pET-23b-SaisdI S. aureus isdI cloned into pET-23b Ampr  This study 
pET-23b-EchemH E. coli hemH cloned into pET-23b Ampr  This study 
pET-23b-EchemH-
SaisdG 
E. coli hemH and S. aureus isdG cloned into pET-23b Ampr  This study 
pET-23b-EchemH-
SaisdI 
E. coli hemH and S. aureus isdI cloned into pET-23b Ampr  This study 
pBCB1-gfp pMutin derivative vector for N- and C-terminal GFP 
fusions 
Ampr Eryr (25) 
pBCB7-mCH pMutin derivative vector for N- and C-terminal mCherry 
fusions 
Ampr Eryr (25) 
pBCB-hemHgfp S. aureus hemH cloned into pBCB1-GE Ampr Eryr This study 
pBCB-hemQgfp S. aureus hemQ cloned into pBCB1-GE Ampr Eryr This study 
pBCB-isdGmCH S. aureus isdG cloned into pBCB7-ChK Ampr Kanr This study 
pBCB-isdImCH S. aureus isdI cloned into pBCB7-ChK Ampr Kanr This study 
pBCB-hemHmCH S. aureus hemH cloned into pBCB7-ChK Ampr Kanr This study 
pBCB-hemQmCH S. aureus hemQ cloned into pBCB7-ChK Ampr Kanr This study 
pWhiteWalker pCQ11 derivative for C-terminal GFP and mCherry 
fusions 
Ampr Eryr (26) 
pWW-gfp pWhiteWalker containing the gfp gene Ampr Eryr This study 
pWW-isdGgfp S. aureus isdG fused to gfp and cloned into 
pWhiteWalker 
Ampr Eryr This study 
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All measurements were acquired in a Leica TCS SP5 (Leica 
Microsystems CMS GmbH, Mannheim, Germany) inverted confocal 
microscope (DMI6000). A 63x apochromatic water immersion objective with 
a NA of 1.2 (Zeiss, Jena Germany) was used for all experiments. GFP and 
mCherry were excited respectively with the 476 nm and 514 nm lines from 
an Argon laser, and fluorescence emission was collected in the 485-540 nm 
range for GFP, and 580-700 nm for mCherry. In these conditions, spectral 
bleed-through was negligible. 
Fluorescence lifetime imaging microscopy (FLIM) measurements 
were performed by time correlated single photon counting (TCSPC) using 
the confocal microscope coupled to a multiphoton Titanium: Sapphire laser 
(Spectra-Physics Mai Tai BB, Darmstadt, Germany) as the excitation source. 
FLIM data was acquired during 90-180 seconds to achieve reasonable 
photon statistics. The excitation wavelength was set to 840 nm and emission 
light was selected with a dichroic beam splitter with an excitation SP700 
short-pass filter and an emission 525±25 nm band-pass filter inserted in front 
of the photomultiplier. Images were acquired using a Becker and Hickl SPC 
830 module. Fluorescence decays for each cell were calculated by 
integrating the FLIM data for all pixels of each individual cell. Fluorescence 
lifetimes were obtained by analysing the fluorescence decays through a least 
square iterative re-convolution of decay functions with the instrument 
response function (IRF) using the software SPCImage (Becker and Hickl, 
Berlin, Germany). Intensity-weighted mean fluorescence lifetime (〈𝜏〉) of 
multiexponential decays were calculated as 〈𝜏〉 = ∑ 𝛼𝑖𝑖 𝜏𝑖, were 𝛼𝑖 are the 
pre-exponential factors and 𝜏𝑖 are the individual lifetime values. Average 
FRET efficiencies in each cell can be determined from <E> = 1-  〈𝜏〉DA/〈𝜏〉D, 
where 〈𝜏〉DA and <>D are the donor intensity-weighted mean fluorescence 
lifetime in the presence of acceptor and in the absence of acceptor, 
respectively. Assays were done for two independent biological samples and 
FRET efficiencies were determined for several cells. 
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Genomic analysis 
A dataset composed of 5060 complete prokaryotic genomes was 
downloaded from RefSeq (June 2016) (27). These correspond to all 
complete genomes available at the time in RefSeq. Taxonomic information 
was retrieved from NCBI and genomes were grouped by phylum or class. 
Homologous proteins involved in the several steps of heme biosynthesis and 
uptake (Urogen III synthesis: HemALBCD; PPD heme biosynthesis 
HemE(F/N)(Y/G/J)H; alternative heme biosynthesis: AhbABCD; S. aureus 
heme biosynthesis variant: HemEYHQ; Staphylococcus heme uptake and 
degradation: HstABC, IsdABCDEFGHI-SrtB, B. subtilis heme uptake: 
IsdCEDFGX1X2-Hal; heme oxygenases IsdG-type: MhuD, HmuQ/D; other 
heme oxygenases: HemO, HmuO, HmuS, HugZ, ChuS; heme transporters: 
HmuTUV, IsdEFD, HtsABC, Rv2002c-Rv2003-Rv2006c) were identified by 
BLAST (28) (E-value smaller than 10-10 and local amino acid identity of at 
least 25%). To distinguish between heme transporters systems from 
siderophores and/or cobalamin importers, sequences from biochemically-
characterized transporters were used as queries as well. All query proteins 
are listed in Supplementary Data 1. When relevant, PFAM-A domain 
annotations were obtained by using the HMM approach as available at PFAM 
(29). Query coverage, gene fusions and genomic organization were also 
used for the identification of true positive hits. Due to their small length, to 
distinguish between the different IsdG homologous, an all versus all blast of 
putative IsdGs and query sequences and an alignment were performed. Hits 
were classified according to their best hit based on sequence identity, 
conservation of the catalytic triad (for HmoA) and sequence length. Selected 
IsdG-type homologous identified by Blast were aligned with ClustalO (30) 
and a maximum likelihood tree reconstructed with IQTree (Best-model 
selection WAG+G4)(31).  
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To distinguish between “bona fide” HemN from highly similar non-
functional HemNs, all genomes were also queried for the presence of non-
functional HemN in a similar way as in Dailey et al 2015 (8).  To distinguish 
between HemQ and chlorite dismutases, sequences were aligned with 
ClustalO and a phylogenetic tree performed.  Sequences corresponding to 
chlorite dismutases were discarded based on the conservation of the 
catalytic residues and position within a phylogenetic tree. A heme 
biosynthesis pathway was only considered to be present in a genome if: 1) 
80% of its genes were identified and 2) if the characteristic proteins were 
present, HemN and/or HemF for classical heme pathway and HemQ for S. 
aureus variant. Cases in which a variant of the canonical pathways above 
described were present and/or missing one gene were assigned as hybrid or 
incomplete. Due to the high sequence similarity between genes involved in 
heme d1 biosynthesis with genes from the heme alternative pathway (5), in 
organisms containing cd1 nitrite reductase, the heme alternative pathway 
identified genes were considered to be involved in heme d1 synthesis 
instead.  
 
Statistical analysis  
In all figures, error bars represent the standard deviation of at least 
two biological samples. Statistical differences were calculated by the two-
tailed Student's t-test using GraphPad Prism (GraphPad Software). 
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5.4. Results 
The heme oxygenase IsdG interferes with heme formed via the heme 
biosynthesis pathway  
To analyze the role of the two heme oxygenases of S. aureus, the S. 
aureus CPD pathway was reconstituted in a hemin auxotrophic strain of the 
Gram-negative bacteria E. coli that is deficient in protoporphyrin 
ferrochelatase (ΔvisA). As E. coli does not take up exogenous heme through 
an Isd system, this host represents a good model to study the role of IsdG/I 
enzymes without the interference of an endogenous heme acquisition 
system, thus avoiding the use of S. aureus strains containing multiple 
mutations. The genes encoding the last three enzymes of the S. aureus CPD 
pathway, hemYHQ, were cloned by the Link and Lock method (19), 
expressed in the presence of either IsdG or IsdI in E. coli ΔvisA, and growth 
of the complemented strain was monitored. The results showed that 
expression of HemYHQ alone abolished the heme auxotrophy of the strain. 
However, in the presence of either IsdG or IsdI, the growth of the strain was 
impaired (Fig. 5.2A).    
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In order to understand the growth behavior of the complemented 
strains, the tetrapyrrole products formed during the expression of S. aureus 
hemYHQ genes in the presence of IsdI or IsdG were analyzed by HPLC-MS. 
As expected, cells expressing S. aureus HemYHQ exhibited a peak with a 
mass-to-charge ratio (m/z) of 616, confirming their ability to produce heme. 
However, this peak significantly decreased when IsdG or IsdI were also 
expressed (Fig. 5.2B), with cells expressing S. aureus HemYHQ-IsdI 
containing approximately 3 times less heme, and cells expressing HemYHQ 
together with IsdG showing no detectable peak corresponding to heme. 
Figure 5.2. S. aureus IsdG and IsdI impair heme formation. (A) Growth of E. coli ΔvisA cells 
complemented with S. aureus HemYHQ alone, or HemYHQ and S. aureus IsdG (HemYHQ 
IsdG) or HemYHQ and S. aureus IsdI (HemYHQ IsdI). (B) HPLC-MS profile of cells depicted 
in (A), with peaks corresponding to heme (m/z = 616; peak 1), iron-coproporphyrin III (m/z = 
708; peak 2), and protoporphyrin IX (m/z = 553; peak 3). (C) Growth of E. coli ΔvisA cells 
complemented with E. coli HemH alone or HemH and S. aureus IsdG (HemH IsdG) or HemH 
and S. aureus IsdI (HemH IsdI). Experiments were performed for two independent biological 
samples.  
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These results suggest that the heme oxygenases interfere with the heme 
formation in vivo. 
To investigate whether the lack of heme formation promoted by S. 
aureus IsdG/IsdI was due to degradation of the heme formed or by inhibition 
of the CPD pathway, we repeated the experiments in an E. coli strain that 
synthesizes heme via the PPD pathway. To this end, the growth of an E. coli 
ferrochelatase mutant ΔvisA, complemented with its own ferrochelatase was 
analyzed after expression of the S. aureus IsdG or IsdI.  
Expression in trans of E. coli ppfC alone and in the presence of IsdG 
fully restored the heme auxotrophy of the ΔvisA mutant strain. In contrast, 
growth impairment was observed when IsdI was present (Fig. 5.2C). These 
results show that only IsdI is able to degrade the heme formed through the 
PPD pathway.  
Collectively, from these results we can infer that IsdI promotes the 
degradation of heme, whether it is biosynthesized by either the PPD or CPD 
branches, or acquired exogenously, as recovery of heme auxotrophy is not 
observed when IsdI is present. In marked contrast, IsdG was only observed 
to prevent recovery of heme auxotrophy when it was expressed together with 
the enzymes of the CPD pathway.  
 
IsdG decreases the ferrochelatase activity of HemH 
To understand how the S. aureus IsdG and IsdI constrain the CPD 
pathway, we tested whether they interfere with the activity of the S. aureus 
HemQ enzyme that catalyzes the last step of the CPD branch promoting the 
conversion of iron-coproporphyrin III into heme in the presence of its electron 
acceptor (7). Thus, S. aureus HemQ was incubated with iron-coproporphyrin 
III in the presence of either IsdG or IsdI and hydrogen peroxide. However, 
control experiments performed in the absence of HemQ showed that 
hydrogen peroxide activates the inherent peroxidase activity in IsdG and IsdI, 
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leading to degradation of the iron-coproporphyrin III substrate (Fig. S5.1). We 
therefore shifted our attention to the penultimate enzyme of the CPD branch, 
the ferrochelatase HemH, which plays an important role in the survival of S. 
aureus (Fig. 5.3), as also shown for the HemA and HemB enzymes involved 
in the first steps of the CPD pathway (32, 33) 
 
In S. aureus and other Gram-positive operating via the CPD pathway, 
the ferrochelatase incorporates iron into coproporphyrin III to form iron-
coproporphyrin III, which is then sequentially decarboxylated by HemQ to 
yield protoheme. We observed that the cell lysate of S. aureus hemH mutant 
contained very low levels of cellular catalase activity, which was restored to 
wild type level upon addition of external hemin (Fig. 5.4). It was previously 
reported that the total cellular catalase activity was lower in S. aureus hemB 
and hemQ defective strains (34).  
Figure 5.3. Importance of ferrochelatase for S. aureus survival. Activated murine 
macrophage J774 A.1 cells were incubated with S. aureus wild type (dark grey) and 
ferrochelatase ΔhemH mutant (blue) and bacterial survival was evaluated 2 h and 4 h post-
infection. While immediately after infection similar survival rates were observed for the wild 
type and ΔhemH mutant strains, the viability of the ΔhemH mutant significantly decreased 
after 2 h and 4 h. Data represent the mean and standard deviation of three independent 
experiments, using the two-tailed unpaired Student’s t-test (*** p < 0.001). 
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Figure 5.4 – Inactivation of ferrochelatase lowers cellular catalase activity. Catalase activity 
of cell extracts from S. aureus wild type (wt) and ΔhemH mutant cells. Cells were grown in 
TSB and, where indicated, supplemented with 4 µM hemin. 
 
We next tested whether the heme oxygenases impaired 
ferrochelatase activity. S. aureus HemH, IsdG and IsdI were recombinantly 
produced and purified, yielding stable proteins that had the expected 
molecular masses of approximately 35 and 12.5 kDa, respectively. S. aureus 
ferrochelatase activity was determined by following the formation of iron-
coproporphyrin III, which yielded a specific activity of 61.6 ± 4.1 
nmol.min−1mg−1. While addition of IsdI to the reaction mixture caused no 
significant alteration (Fig. 5.5A), the presence of IsdG led to a ~50% 
decrease in ferrochelatase activity. Furthermore, the activity of the enzyme 
decreased with increasing concentration of IsdG (Fig 5.5B). 
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Figure 5.5. Influence of S. aureus IsdG on the CPD pathway. (A)  IsdG decreases the 
ferrochelatase activity of S. aureus HemH while IsdI does not impair the activity. (B) Inhibition 
of S. aureus HemH ferrochelatase activity increases with IsdG concentration. (C) Intracellular 
heme quantification of S. aureus wild type and ΔisdG mutant for cells grown in the presence 
of 400 μM of aminolaevulinic acid (Ala). 
In (A) and (B), activities were measured in reaction mixtures containing HemH alone, or with 
the addition of IsdG or IsdI, using coproporphyrin III (10 μM) and (NH4)2Fe(SO4)2 (50 μM) as 
substrates. In (B), IsdG was used in the following concentrations: 0.6, 1.2, 3.0 and 6.0 mM. 
Data depict the mean and standard deviation of three samples using a two-tailed unpaired 
Student’s t-test (** p < 0.01). 
 
These results show that IsdG, but not IsdI, attenuates the activity of 
the S. aureus HemH. Therefore, we next determined the heme cellular 
content in cells forming heme by the CPD pathway in the presence and 
absence of IsdG. For this purpose, S. aureus wild type and ΔisdG mutant 
cells were grown in the presence of aminolaevulinic acid, the first stable 
precursor of the heme biosynthesis pathway. Figure 5.5C shows that the 
IsdG inactivated strain has significantly higher heme content.  Therefore, we 
conclude that IsdG impairs HemH lowering the amount of heme formed by 
the CPD pathway. 
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Protein-protein interaction studies between IsdG and HemH 
We reasoned that the inhibition of the S. aureus HemH activity by 
IsdG is most likely to result from a direct interaction between the two proteins. 
To study this interaction in vivo fluorescence lifetime imaging based Förster 
resonance energy transfer (FLIM-FRET) was used. Additionally, interactions 
among the various CPD pathway protein components and S. aureus heme 
oxygenases were also evaluated. In order to do this, we constructed S. 
aureus HemH and hemQ proteins fused to a GFP donor molecule and IsdG, 
IsdI, HemQ and HemH fused to a mCherry acceptor molecule (Table 3).   
The interaction between IsdG and HemH was analyzed in bacterial 
cells expressing S. aureus HemH-GFP and IsdG-mCherry. HemH-GFP 
exhibited a mono-exponential fluorescence decay with a lifetime HemH-EGFP = 
2.2 ± 0.1 ns (Fig S5.2). In the presence of IsdG-mCherry, the fluorescence 
decay of HemH-GFP was no longer accurately described by a single 
exponential and a shorter component had to be included in the fit, indicating 
the presence of FRET and thus an interaction between the two proteins (Fig. 
5.6 and Fig S5.2). The FRET efficiencies (E) were dependent on the 
concentration of IsdG, according to the plots of E against mCherry/GFP 
fluorescence intensity ratios (Fig. 5.6), obtained from the confocal 
fluorescence measurements of each construct (see Methods).  
Although some degree of interaction between HemH-GFP and IsdI-
mCherry was also detected (Fig. 5.6A and 5.6C), the FRET efficiencies 
determined for this protein pair were much lower than those measured for 
IsdG and HemH (Fig. 5.6B), suggesting a much less efficient interaction. 
Furthermore, an interaction between HemQ and IsdG, but not HemQ and 
IsdI, was also observed (Fig. 5.6D and 5.6E).  
Together, these data reveal that IsdG interacts with the last two 
enzymes of the CPD pathway, namely HemH and HemQ.  
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Figure 5.6. S. aureus HemH and IsdG interact in vivo. (A) Representative FLIM-FRET data 
of E. coli cells co-expressing HemH-GFP or HemQ-GFP with IsdG-mCherry or IsdI-mCherry, 
shown as false color lifetime images. Average fluorescence lifetime (<>) was rendered as 
color according to the color index indicated on the right. Scale bar represents 10 m. For each 
cell in (A), the calculated average FRET efficiency (E) is plotted against the ratio of 
fluorescence (as measured by confocal microscopy) from the acceptor (mCherry) construct 
over donor (GFP), for HemH-GFP/IsdG-mCherry (B), HemH-GFP/IsdI-mCherry (C), HemQ-
GFP/IsdG-mCherry (D), and HemQ-GFP/IsdI-mCherry (E). Lines are drawn as a guide to the 
eye. Data are from one representative sample. (F) Steady-state and (G) time-resolved 
fluorescence polarization binding assay between dansylated HemH and IsdG or IsdI. (F) The 
steady-state fluorescence anisotropy, <r>, and (G) long correlation fluorescence lifetime, 2, 
of dansylated HemH are plotted as a function of IsdG (red circles) and IsdI (blue triangles) 
concentrations expressed as monomers.  Conditions consisted of 0.7 M dansyl-labeled 
HemH in 50 mM Tris-HCl buffer pH 8.0, at 25 °C. Dansyl fluorescence was monitored at 530 
nm with excitation at 340 nm. The cuvette path length was 5 mm. Data represent the mean 
values of three independent measurements and error bars represent the standard deviation.  
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The FLIM-FRET protein-protein interaction studies were 
complemented with an in vitro homogeneous fluorescence polarization 
binding assay to monitor macromolecular complex formation between the 
two recombinant S. aureus proteins, HemH and IsdG. For this purpose, S. 
aureus HemH was covalently conjugated to dansyl chloride, a long-lived 
fluorescent probe, in order to evaluate its binding to IsdG using both steady-
state and time-resolved fluorescence anisotropy measurements (35). The 
dansyl-labeled HemH gave a high steady-state fluorescence anisotropy in 
solution (<r> = 0.164  0.002; Fig. 5.6F and Fig. S5.3). Upon increasing the 
concentration of dimeric IsdG in solution, the steady-state fluorescence 
anisotropy of dansyl-HemH steadily augmented (Fig. S5.4) reaching a 
plateau level of <r> ~ 0.20 (Fig. 5.4F). In contrast, there was negligible 
binding observed between IsdI and HemH. Upon binding of dimeric IsdG to 
dansyl-labeled HmeH, the hydrodynamic volume of the protein complex 
increased, slowing down the overall rotational tumbling of dansyl-labeled 
HemH in solution during its excited-state fluorescence lifetime and ultimately 
producing an increase in its steady-state fluorescence anisotropy (20, 21). 
These data were further corroborated by time-resolved polarized 
fluorescence measurements of dansyl-labeled HemH during its titration with 
IsdG. The fluorescence anisotropy decay of dansyl-labeled HemH was 
greatly affected by addition of IsdG to the solution (Fig. S5.4). In particular, 
the longer rotational correlation time, 2, assigned to the overall rotational 
motion of dansyl-labeled HemH in solution, increased significantly from 2 ~ 
67 ns for dansyl-labeled HemH free in solution to 2 ~ 180 ns for dansy-
labeled HemH in the presence of 107 M IsdG (Fig. 5.6G and Table S5.1). 
A binding Kd of 14.3 ± 2.6 µM and a <r>B of 0.207 ± 0.003 was determined. 
These results clearly demonstrate that IsdG has the ability to bind to HemH 
in solution at physiological pH.  
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Hemin increases IsdG expression  
In order to assess the impact of heme uptake by the host to its 
endogenous heme biosynthesis, we determined the expression of the heme 
biosynthesis genes in S. aureus cells grown in medium supplemented with 
hemin (2.5 µM). Addition of external hemin slightly modified the transcription 
of hemA, hemE and hemQ (Fig. 5.7A). A similar change was observed with 
the genes encoding the iron-regulated surface determinants isdA, isdB and 
isdI, while hrtB and htsA were strongly upregulated (Fig. 5.7A). Treatment 
with exogenous hemin also caused a significant induction of the isdCDEG 
operon, (Fig. 5.7A).  
Figure 5.7. The cellular content of IsdG in S. aureus increases upon incubation with hemin. (A) Fold 
change in abundance of genes coding for enzymes involved in the heme biosynthesis and uptake 
pathways upon exposure to hemin. (B) Difference of the median GFP fluorescence intensity (MFI) 
between hemin-treated (5 μM) and untreated cells. (C) Difference of the median GFP fluorescence 
intensity between aminolaevulinic acid-treated (400 μM) and untreated cells. Fluorescence was 
measured in a flow cytometer and over 300,000 cells were counted. Data represent the mean and 
standard deviation of four measurements, using the two-tailed unpaired Student’s t-test (*** p < 0.001, 
**p=0.005 *p=0.04). 
 
The pronounced change in isdG gene expression led us to analyze 
the amount of IsdG protein in cells containing excess heme, which was either 
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added exogenously to the medium or produced endogenously through 
supplementation with aminolaevulinic acid. For this purpose, an IsdG-GFP 
fusion protein was constructed and the amount of IsdG was determined by 
the direct measurement of the fluorescence derived from the construct by 
flow cytometry. For comparative purposes, an IsdI-GFP fusion protein was 
also constructed. S. aureus expressing GFP, IsdG-GFP or IsdI-GFP were 
grown in either TSB supplemented with hemin or TSB containing an excess 
of aminolaevulinic acid. Addition of hemin increased the levels of IsdG, which 
was evidenced by the higher fluorescence of S. aureus cells expressing 
IsdG-GFP compared to cells expressing GFP alone (Fig. 5.7B). Cells 
expressing IsdI-GFP showed slightly higher fluorescence than cells 
expressing GFP alone, however at a much lower extent than cells containing 
IsdG-GFP (Fig. 5.7B). Interestingly, addition of aminolaevulinic acid caused 
an increase in fluorescence, revealing that internally produced heme also 
augments the cellular content of IsdG (Fig. 5.7C). In contrast, 
supplementation with aminolaevulinic acid produced a strong decrease of 
fluorescence in cells expressing IsdI-GFP. Therefore, the increase in the 
intracellular content of IsdG promoted by heme may trigger the interaction of 
IsdG with HemH with a consequential impairment of the CPD pathway.   
 
Distribution of IsdG-like proteins across genomes 
IsdG and IsdI are both IsdG-type heme degrading oxygenases, a 
family of proteins characterized by the presence of an antibiotic biosynthesis 
oxygenase (ABM) domain followed by a loop region. The loop region is 
proposed to be a target for degradation in S. aureus IsdG (37). To date, 
several members of this family have been studied, including S. aureus IsdI 
and IsdG (13), S. lugdunensis IsdG (38), B. antracis IsdG (39), 
Mycobacterium tuberculosis MhuD (40), Bradyrhizobium japonicum HmuQ 
and HmuD (41) and Brucella melitensis (41). Our analysis of the distribution 
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of IsdG-type homologues shows that such proteins are present in 1137 
(22%) of the 5060 complete and annotated genomes surveyed 
(Supplementary Data 1). Organisms containing IsdG-type enzymes belong 
to several Bacilli genera, including Actinobacteria, Deinococcus-Thermus, 
Chloroflexi, Nitrospiraea, and Proteobacteria (mainly Alphaproteobacteria) 
taxa. IsdI enzymes are only present in genomes belonging to the S. aureus 
group that contain the IsdABCDEFH system. In contrast, canonical IsdG 
enzymes are present in several Bacillus and Listeria taxa while HmuD/Q are 
mainly Proteobacterial specific and MhuD Actinobacterial specific (Fig. 5.8A, 
Supplementary Data 1).   
In a second study conducted with the genomes containing IsdGs 
homologues, an organism was considered to have a de novo heme 
biosynthesis ability if the full pathway was encoded in its genome (see 
Methods). Within this dataset, heme biosynthesis pathways were found in 
the genomes of many pathogenic bacteria from the Bacillus, Staphylococcus 
and Actinobacteria groups as well as Chloroflexi, Nitrospira and Deinoccus-
Thermus bacteria and several Proteobacteria. No siroheme heme synthesis 
occurring through the alternative pathway was found in organisms containing 
IsdG, indicating an association of IsdG only with the protoporphyrin and 
coproporphyrin biosynthesis pathways (Fig. 5.8A, Supplementary Data 1). 
Interestingly, this search revealed the presence of a potential HemQ-CPD 
pathway in several halophilic archaea, where HemQ is fused with an ABM 
domain characteristic of IsdG-type enzymes. This fusion may represent in-
built control system. 
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Figure 5.8. Distribution of heme metabolism and related genes across Gram-positive 
organisms containing IsdG-type enzymes. (A) Heat map representing the presence (blue 
ticks) or absence (white) of genes (columns) involved in heme biosynthesis, Isd systems, 
heme uptake and degradation in the 898 genomes (rows) containing IsdG-type enzymes. The 
full list is given in Supplementary Data 1. (B) Co-occurrence of IsdG-like enzymes (green) with 
heme biosynthesis pathway HBP (red), heme uptake system (yellow) and HemQ/H (brown). 
(C) Co-occurrence of additional heme oxygenases in the 747 Gram-positive organisms able 
to uptake and de novo synthesise heme and that contain one or more than one IsdG-type 
enzymes.   
 
We used the IsdG-type dataset to classify organisms according to 
their ability to take up environmentally available heme. Similarity searches 
were performed for the most common ABC-type of heme transport modules 
present in Gram-positive organisms, such as the IsdEFG-like, HtsABC and 
HmuTUV systems (Fig. 5.8A, Supplementary Data 1). In addition, the 
mycobacterial heme acquisition system was included in this search (42). An 
organism was considered to be able to perform heme uptake if its genome 
encoded a complete transport system with at least one heme binding protein 
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(HmuT, IsdE or RV2003). In total, 806 (70%) genomes were found to encode 
ABC-type heme uptake systems. Heme uptake systems were found in 
Deinococcus-Thermus, Chloroflexi, Rhizobiales and several marine 
Alphaproteobacteria, indicating that the ability to acquire heme from external 
sources is more widespread than initially thought, as exemplified by the 
experimental characterization of the heme uptake system in phytoplankton-
associated Roseobacter bacteria (43).  
The IsdG-type dataset, which contains information from 1137 
genomes, is composed of 898 (79%) Gram-positive (monoderms or 
transitional taxa) and 239 (21%) Gram-negative organisms. Within Gram-
positives, 747 organisms (83%) encode complete (or almost complete) heme 
biosynthesis and uptake systems, 126 (14%) genomes encode genes for 
only a heme biosynthesis pathway, and 10 genomes encode genes for only 
a heme uptake system (Fig. 5.8B). In the remaining 15 genomes, no 
complete heme biosynthesis or uptake systems were found. However, in 14 
of these, HemQ and/or HemH are encoded in addition to IsdG homologues. 
Several reasons might explain this observation: i) these 15 putative IsdGs 
may have a different biological role; ii) the detection of HemQ and/or HemH 
might indicate an as yet unidentified heme biosynthesis pathway; or iii) a 
different heme uptake system not surveyed in this study is present in the 
genomes of those 15 organisms (e.g., Ton-dependent heme uptake) with 
HemQ/HemH assisting IsdG in heme-degradation. Fourteen of these 15 
organisms belong to Lactobacillus plantarum or Lactobacillus reitti, species 
that are unable to perform heme biosynthesis, but when grown with heme 
(and menaquinone), couple their heme-independent fermentative 
metabolism with aerobic respiration (44).  
Within the 747 Gram-positive organisms able to access heme by 
both biosynthesis and uptake, 422 (~56%) contained two or more genes 
coding for IsdG-type heme degrading oxygenases. Apart from the S. aureus 
and B. anthracis strains that contain the Isd-like systems, Actinobacteria are 
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also represented. In the remaining genomes, although only one IsdG-type 
enzyme is present, genes coding for additional heme oxygenases belonging 
to the HemO, HmuO, ChuS/HmuS or HugZ families of heme oxygenases are 
also present in 135 cases (Fig. 5.8C). In Gram-negative bacteria, IsdG-type 
enzymes are present in 108 species that are able to access heme by both 
biosynthesis and uptake, whilst 131 organisms have just heme biosynthesis 
pathways but not uptake mechanisms.  The presence of two heme 
oxygenases in organisms with both biosynthesis and uptake systems that 
contain IsdG-type enzymes is also observed in Gram-negative bacteria, 
where within the 108 organisms with IsdG-type enzymes, 88 (81%) have one 
additional heme oxygenase.  
 The wider distribution of IsdG-like enzymes is in contrast to IsdIs 
that are mainly present in S. aureus species that contain Isd-type uptake 
systems, and the occurrence of IsdG-like proteins in organisms that only 
obtain heme by protoporphyrin and coproporphyrin heme biosynthesis 
pathway strengthen the hypothesis that interactions between IsdG-type 
enzymes and HemH and/or HemQ may control and regulate endogenously 
produced heme. This is an example of how nature has adapted the same 
structural domain to perform similar functions, although IsdG-type enzyme 
regulation appears to be different between Gram-positives and Gram-
negatives.  
 
5.5. Discussion 
We have investigated the way in which prokaryotes that obtain heme 
through heme biosynthesis and uptake pathways balance their high heme 
needs with the toxicity associated with free heme. We have shown that IsdG, 
one of the heme oxygenases in the S. aureus heme uptake pathway, controls 
intracellular heme content through a protein-protein interaction with 
ferrochelatase that results in inhibition of iron-coproporphyrin chelatase 
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activity. A comprehensive bioinformatics analysis showed that IsdG-like 
proteins are present in a significant number of prokaryotes that contain only 
the heme biosynthesis pathway. Altogether, the data allows us to propose 
that the IsdG protein family is not only the missing link between the two 
pathways, but also acts as the brake that avoids production of undesirably 
high intracellular heme levels.  
In several microorganisms, IsdG-type heme oxygenases, including 
the S. aureus IsdG and IsdI, have been assigned a hemin-degradation role 
in vitro (13), and are required for growth when hemin is the only available 
iron source (45).  We observed that IsdI impairs growth when heme is formed 
through PPD or CPD pathways, which is consistent with the heme degrading 
activity of IsdI. In contrast, IsdG inhibited growth only when heme was 
generated by the CPD pathway, which suggests that IsdG may interfere with 
the heme synthesis pathway. It is interesting to note that previous studies 
reported that S. aureus IsdG has a much lower heme degradation activity 
than IsdI  (46).  
Experimentally, we have demonstrated that strains containing IsdG 
have lower amounts of intracellular heme formed via the heme biosynthesis 
route and IsdG has the ability to decrease the iron-coproporphyrin chelatase 
activity of S. aureus HemH. Furthermore, we showed by in vivo FLIM-FRET 
and fluorescence polarization binding assays that the two proteins interact 
and have generated a model for this interaction.  
Under our conditions, addition of heme did not repress expression of 
the S. aureus CPD pathway linked genes, as has been reported previously 
for several organisms. The only exception to this observation is with the 
Corynebacterium diphtheriae gtrR, which is repressed under heme replete 
conditions (47). Thus, in general, heme does not serve as a feedback factor 
to repress its own synthesis at the transcriptional level. Heme toxicity in S. 
aureus has previously been associated with induction of the heme regulator 
transporter HrtAB (48). In agreement with this, when we treated cells with 
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hemin, they exhibited induction of the first gene of the hrtBA operon. More 
significantly, we observed that expression of isdG was highly upregulated, 
indicating that IsdG may play a role in heme regulation. Furthermore, this 
upregulation translated into an increase of the IsdG protein abundance, as 
shown by FACS. Consistent with our results, IsdG, but not IsdI, has been 
reported to be regulated at the post-transcriptional level such that it is 
stabilized in the presence of heme and undergoes proteolytic degradation in 
the absence of heme (31, 22). We observed a higher abundance of IsdG in 
S. aureus when it was grown in iron-replete medium, while other authors 
have reported that IsdG is expressed more upon addition of exogenous 
hemin to iron-starved cultures of S. aureus (45). These differences are most 
probably due to the experimental conditions used in the two assays.  
The bioinformatics analysis reported in this work estimates that 
among bacteria that only synthesize heme endogenously approximately one 
third contain IsdG-like proteins. Even in organisms with a less well-defined 
heme biosynthesis pathway, IsdG-type enzymes coexist with HemQ and/or 
HemH enzymes (Fig. 5.8B). This is in agreement with previous studies that 
have shown that the presence of IsdG is not restricted to organisms that have 
both the heme biosynthesis and acquisition machineries (49).  However, in 
many cases the genes encoding for IsdG-like enzymes are co-localised with 
genes for protoporphyrin PPD and coproporphyrin CPD pathways. Hence, 
IsdG may regulate both these routes for endogenous biosynthesis of heme. 
Our data support the proposal that in S. aureus this control occurs through 
the interaction of IsdG with HemH, as the presence of IsdG strongly 
decreases ferrochelatase activity and the intracellular heme abundance. 
Although at this stage the interaction at the molecular level between IsdG 
and HemH cannot be fully described due to the lack of detailed structural 
information, we hypothesize that this interaction may block the access of the 
substrate to the porphyrin binding cleft of HemH.  
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Until now there has been a great deal of focus on the mechanisms of 
heme uptake as a source of iron, whilst ignoring the question of how 
microbes prevent unwanted heme toxicity by fine tuning exogenously 
acquired heme with heme synthesized endogenously. The scheme depicted 
in Fig. 5.9 summarises our current proposal for bacteria to maintain their 
intracellular free heme pool below hazardous levels. Organisms with both 
heme biosynthesis and uptake systems use external heme in two different 
ways. External heme is transported into the cytoplasm through dedicated 
systems, including those of the Isd-type, where it is either directly 
incorporated into apo-hemeproteins or degraded by IsdI, HemO, HmuO, 
ChuS/HmuS or HugZ- like proteins to release iron. On the other hand, heme 
also increases the abundance of IsdG to levels that are sufficient to interact 
with HemH blocking its function, i.e, impairing the heme biosynthesis 
pathway. Hence, one of the heme oxygenase enzymes would likely be 
dedicated to heme degradation to provide a source for iron whilst the other 
would act to restrain internal heme biosynthesis. Moreover, in systems that 
only synthesize heme via an internal heme biosynthesis pathway and contain 
IsdG-like proteins, IsdG may play an important role in preventing excessive 
production of heme. 
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Figure 5.9. Proposed scheme for the role of IsdG-like proteins in the control of heme 
production through crosstalk between heme biosynthesis and uptake systems. S. aureus CPD 
is represented proceeding from uroporphyrinogen III to heme via the HemE, HemY, HemH 
and HemQ enzymes. S. aureus heme uptake is represented by the Isd system. In this scheme, 
IsdH and IsdB scavenge hemeoglobin heme which enters into the cell through IsdA, IsdC and 
IsdEFD. In the cytoplasm, heme is mainly degraded by IsdI to staphylobilin, iron and 
formaldehyde. Increase of heme content augments the IsdG abundance to levels that allow 
its interaction with HemH, resulting in the inhibition of CPD pathway. 
 
Collectively, our results show that the heme uptake and biosynthesis 
are not independent processes, and that IsdG-like proteins have a role in the 
crosstalk between these two systems which allow bacteria to adapt to a 
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range of environments while avoiding heme toxicity. Therefore, we predict 
that the design of inhibitory drugs targeting the IsdG family of proteins will 
have a significant therapeutic benefit for the treatment of pathogenic 
infections.  
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5.8. Supplementary data 
 
Supplementary Table 1. Analysis of the fluorescence anisotropy decays obtained for dansyl-
labelled HemH in the absence and in the presence of the IsdG/IsdI. Conditions consisted of 
0.67 M dansyl-labelled HemH in 50 mM Tris-HCl buffer pH 8.0, at 25 ⁰C. 𝑖 and 𝑖 are the 
amplitude and the rotational correlation time of the 𝑖th decay component. The 95% confidence 
intervals of the fitted rotational correlation times are indicated within square brackets (λex= 340 
nm; λem= 530 nm). 
 
Binding 
protein 
[Protein] 
(M) 
1 1 
(ns) 
2 2 
(ns) 
2 
 0 0.06 2.2 
[1.8; 2.6] 
0.18 67 
[64; 70] 
1.25 
 9 0.06 2.6 
[2.2; 3.1] 
0.18 80 
[77; 84] 
1.10 
IsdG 13.4 0.06 2.8 
[2.3; 3.2] 
0.18 94 
[89; 100] 
1.12 
 26.8 0.05 3.7 
[3.0; 4.4] 
0.18 128 
[118; 140] 
1.07 
 107.2 0.04 2.2 
[2.0; 3.7] 
0.19 181 
[162; 207] 
1.16 
       
IsdI 107.2 0.04 2.4 
[1.8; 3.1] 
0.18 67 
[64; 73] 
1.18 
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Supplementary Figure 5.1. S. aureus IsdG peroxidase activity in the presence of H2O2. UV-
visible spectra of iron-copro III (FeCpIII) incubated with IsdG in the absence (blue) and in the 
presence of H2O2 (red), and recorded after 7 h of incubation.  
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Supplementary Figure 5.2. Interaction between S. aureus ferrochelatase HemH and IsdG 
proteins (A) Overlay of confocal fluorescence microscopy images of HemH-GFP (green) and 
IsdG-mCherry (red) fluorescence. Scale bar of 10 m. (B) Histogram of average fluorescence 
lifetimes of HemH-GFP from individual cells in the absence (green) and in the presence of 
IsdG-mCherry (red). (C) Comparison of normalized TCSPC decays obtained for: cells 
expressing only HemH-GFP (fitted with a mono-exponential decay of  = 2.20 ns – shown in 
green), cells co-expressing HemH-GFP and IsdG-mCherry (fitted with a bi-exponential decay 
of <>= 1.93 ns – depicted in purple). A bi-exponential decay was also fitted to the isolated 
fluorescence decay of a single cell co-expressing HemH-GFP and higher levels of IsdG-
mCherry (<>= 1.79 ns – depicted in red). 
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Supplementary Figure 5.3. Representative fluorescence intensity decay of dansyl-labelled 
S. aureus ferrochelatase HemH. (A) The depicted curves correspond to the instrument 
response function (IRF, black), experimental fluorescence intensity decay (light red), and fitted 
intensity decay (dark red). The corresponding weighted residuals of the fit are presented in 
panel (B). Conditions consisted of 0.67 M dansyl-labelled HemH in 50 mM Tris-HCl buffer 
pH 8.0, at 25 ºC. The excitation and emission wavelengths used were 340 and 530 nm, 
respectively. The fitted parameters were: 1= 0.15, 1= 0.17 [0.13; 0.21] ns, 2= 0.14, 2= 1.87 
[1.73; 1.98] ns, 3= 0.32; 3= 8.7 [8.7; 8.8] ns, 4= 0.39; 4= 19.4 [19.2; 19.8] ns and the 
intensity-weighted mean fluorescence lifetime was <>= 16 ns (2= 1.1.0). The 95% 
confidence intervals of the fitted fluorescence lifetimes are indicated within square brackets. 
 
 
 
 
 
 176 
 
 
Supplementary Figure 5.4. Influence of S. aureus IsdG on the fluorescence anisotropy decay 
of dansyl-labelled S. aureus HemH. In A, the light and dark curves shown correspond to the 
experimental and fitted anisotropy decays for 0.67 M dansyl-labelled HemH in the absence 
(red curves) and in the presence of 107 M IsdG (blue curves). The corresponding weighted 
residuals of the fits are presented in panel B. The reactions were done in 50 mM Tris-HCl 
buffer pH 8.0, at 25 ºC. The excitation and emission wavelengths used were 340 and 530 nm, 
respectively.  
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6.1. Summary 
Siroheme is a modified tetrapyrrole and the prosthetic group in 
enzymes involved in life dependent processes such as nitrogen and sulfur 
assimilation. Analysis of the Staphylococcus aureus genome revealed the 
presence of two genes annotated as cysG which are putatively involved in 
siroheme biosynthesis. These genes were cloned, overproduced and the 
purified proteins were used in in vitro assays to analyze their function in 
siroheme synthesis. The two genes were shown to encode two distinct 
enzymes: one involved in the transformation of uroporphyrinogen III to 
precorrin-2 (uroporphyrinogen III methyltransferase, SirA), and another that 
performs the conversion of precorrin-2 to sirohydrochlorin (precorrin-2 
dehydrogenase, SirC). Further analysis of the S. aureus genome revealed 
the presence of a third gene encoding a protein that shares 25% sequence 
identity with Bacillus megaterium SirB. However, this gene was annotated as 
nirR and predicted to encode a nitrite reductase transcriptional regulator. 
Nevertheless, the gene was cloned and its function was investigated by in 
vivo complementation. The recombinant protein was expressed and 
biochemically characterized. The complementation assays, performed in an 
E. coli strain unable to produce siroheme showed that when NirR was 
expressed together with SirA and SirC, the cells produced siroheme. These 
results proved that the nirR gene encodes a sirohydrochlorin ferrochelatase. 
Therefore, the gene annotation was corrected as the gene was sirB. 
Altogether, the pathway and the enzymes that transform uroporphyrinogen 
III into siroheme were identified in this work. 
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6.2. Introduction 
Staphylococcus aureus is one of the leading causes of nosocomial 
infections and a major health concern due to the increase in the number of 
antibiotic resistant strains. S. aureus is a facultative anaerobe that is usually 
grown in the laboratory in the presence of oxygen. However, upon host 
invasion, S. aureus faces environments with low oxygen concentrations (e.g. 
abscesses) (1). To grow under near anaerobic conditions, S. aureus uses 
fermentation or performs respiration on the account of electron acceptors 
such as nitrate or nitrite (1–4). As mentioned in chapter 1, S. aureus reduces 
nitrate to nitrite by means of nitrate reductase (NarGHI), and the accumulated 
nitrite is reduced to ammonia by nitrite reductase (NirBD) (5, 6). NirBD 
contains a siroheme cofactor that transfers six electrons from nicotinamide 
adenine dinucleotide (NADH) to nitrite, which is reduced to ammonia.  
In general, bacteria synthesize siroheme from uroporphyrinogen III in 
a three step pathway that includes methylation of uroporphyrinogen III, 
oxidation of precorrin-2, and insertion of iron into sirohydrochlorin (7, 8) 
(Figure 6.1).  
In Escherichia coli and Salmonella enterica, the three reaction steps 
are accomplished by a single multifunctional enzyme called siroheme 
synthase CysG (7). The protein (of 457 amino acid residues) is composed by 
a N-terminal region with dehydrogenase and ferrochelatase activities 
(CysGB), and a C-terminal region with S-adenosyl-l-methionine (SAM)-
dependent uroporphyrinogen III (uro´gen III) methyltransferase (SUMT) 
activity (CysGA), that converts uro´gen III to precorrin-2 (8).  
In Saccharomyces cerevisiae, two enzymes are required for the 
synthesis of  siroheme, encoded by MET1 and MET8 genes (9). The product 
of MET1 (Met1p) is a protein that shares amino acid sequence similarity to 
the C-terminal region of the E. coli CysG, and like CysG, it has SUMT activity 
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(10). Met8p protein  encoded by the MET8 is a bifunctional enzyme that as 
the N-terminal region of E. coli CysG has NAD+-dependent precorrin-2 
dehydrogenase and sirohydrochlorin chelatase activities (10). In the Gram-
positive Bacillus megaterium, the synthesis of siroheme occurs via three 
proteins, namely SirA, SirB and SirC that are genetically organized in the 
gene cluster sirABC. These proteins exhibit SUMT activity (SirA), precorrin-
2 dehydrogenase activity (SirC) and sirohydrochlorin ferrochelatase activity 
(SirB) (11, 12).  
 
Figure 6.1. Outline of the three reactions necessary for the synthesis of siroheme.  
 
In this work, we have investigated the siroheme biosynthetic pathway 
of S. aureus and shown that three gene products are required for the 
conversion of uro´gen III to siroheme, which were named SirA, SirB and SirC. 
It is also reported that the gene annotated as nirR in the genome of S. aureus, 
putatively encoding a nitrite reductase transcriptional regulator, is in fact the 
gene that encodes the enzyme that inserts iron into sirohydrochlorin, acting 
in last step of siroheme biosynthesis, and therefore it was renamed sirB. 
 
 
6.3. Materials and Methods 
Bacterial strains and growth conditions  
Strains and plasmids used in this work are described in Table 1. E. 
coli XL1-Blue was used as host strain for genetic manipulation, E. coli 
BL21(DE3)Gold and E. coli BL21STAR DE3 pLysS were used for protein 
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expression, and E. coli 302Δa (cysteine auxothrophic cysG mutant strain) 
was used for the complementation experiments. All strains were grown 
aerobically in Luria-Bertani (LB) at 37 °C and 150 rpm. Exception was made 
for the E. coli 302Δa strain, which for the complementation experiments was 
grown on minimal medium composed of M9Salts (12.8 g/L Na2HPO4, 3 g/L 
KH2PO4, 0.5 g/L NaCl, 1 g/L NH4Cl) plus 20 mM glucose, 2 mM MgSO₄, 0.1 
mM CaCl₂ and 1.5% agar. Antibiotic resistance was selected using, 
chloramphenicol (35 μg.ml−1) and ampicillin (100 μg.ml−1). Competent cells 
were prepared essentially as described previously (13). E. coli XL1-Blue, E. 
coli BL21(DE3)Gold, E. coli BL21STAR DE3 pLysS and E. coli 302Δa were 
grown overnight in LB, at 37 °C and 150 rpm. The cells were diluted in LB at 
an OD600=0.1 and grown to an OD600=0.6. At this point, the flask was left on 
ice for 10 min and the culture was centrifugated (1087 x g, 10 min, 4°C). The 
pellet was resuspended in ice-cold TB buffer (10 mM Pipes; 55 mM MnCI2; 
15 mM CaCl2 and 250 mM KCI), incubated on ice for 10 min and centrifuged 
again as described above. Cells were resuspended in TB buffer with 7% 
DMSO and frozen in liquid nitrogen. 
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Table 6.1. Strains and plasmids used in this work 
Strain Genotype Description Resistance Reference 
E. coli 
BL21(DE3)Gold 
F– ompT hsdSB(rB
 – mB 
– ) 
gal dcm 
Recombinant protein 
expression  
 Novagen 
E. coli BL21STAR 
DE3 pLysS 
F– ompT hsdSB(rB
 – mB 
– ) 
gal dcm 
Recombinant protein 
expression  
CmR Novagen 
E. coli 302Δa NirS, Lac+,Cys-; cysG- 
cysG- strain used in 
complementation 
experiments 
 Cole 1987 
E. coli XL1-Blue 
recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac 
[F´ proAB lacIq Z∆M15 
Tn10 (TetR) 
Host strain used for 
genetic manipulation 
TetR 
Laboratory 
strain 
Plasmid Inserted genes Description Resistance Reference 
pETcoco-2ABCD 
M. barkeri cobA, M. 
thermautotrophicus 
hemB,  
B. megaterium hemC and 
hemD 
Plasmid used for the 
production of precorrin-2 
AmpR 
M.J 
Warren´s 
lab 
pETcoco-2ABCDC 
Same as pETcoco-
2ABCD plus M. 
thermautotrophicus sirC 
Plasmid used for the 
production of 
sirohydrochlorin 
AmpR (14) 
pET-23b-SacysG1 S. aureus cysG1 
S. aureus cysG1 cloned 
in pET-23b 
AmpR This study 
pET-23b-SanirR S. aureus nirR 
S. aureus nirR cloned in 
pET-23b 
AmpR This study 
pET-23b-SacysG2 S. aureus cysG2 
S. aureus cysG2 cloned 
in pET-23b 
AmpR This study 
pET-14b-DvhemC D. vulgaris hemC 
D. vulgaris hemC cloned 
in pET-14b 
AmpR (15) 
pET-14b-DvhemDd D. vulgaris hemDd 
D. vulgaris hemDd 
cloned in pET-14b 
AmpR (15) 
pET-14b-DvsirC D. vulgaris sirC 
D. vulgaris sirC cloned 
in pET-14b 
AmpR (15) 
pKK223.2-cysG E. coli cysG 
Used as positive control 
in complementation 
experiments 
AmpR (16) 
pCIQ-sirCcobA 
M. thermoautotrophicus 
sirC and P. denitrificans 
cobA 
M. thermoautotrophicus 
sirC and P. denitrificans 
cobA cloned in pACYC 
CmR (16) 
pACYC-
SacysG1SacysG2 
S. aureus cysG1 and 
cysG2 
S. aureus cysG1 and 
cysG2 cloned in pACYC 
CmR This study 
 
 
 
 
 
 
 184 
 
Cloning procedures  
S. aureus genes cysG1, cysG2 and nirR were PCR amplified using 
genomic DNA of S. aureus Newman strain and the primers described in 
Table 2. The DNA fragments were digested with the restriction enzymes 
indicated in Table 2 and ligated to pET-23b (Novagen), which was previously 
digested with enzymes so that non-tag, N-terminal or C-terminal His-tag 
fused proteins could be produced. For all genes, integrity was confirmed by 
DNA sequencing. For the complementation assays, S. aureus cysG1 and 
cysG2 were cloned into pACYCDuet plasmid previously digested with Bgl 
II/XhoI and NcoI/HindIII, respectively, to generate plasmid pACYC-
SacysG1SacysG2. 
 
 
 
 
  
1
8
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Table 6.2. Oligonucleotides used in this work 
 
 
 
 
  
 
 
 
Gene Putative enzyme Oligonucleotides 
5´-> 3´ 
Restriction 
Sites 
cysG1 Uroporphyrin III 
methyltransferase 
GAGCTAGCCACCACCACCACCACCACATGTCTGTAGAGGAATATG NheI 
CAAAGCTTTTTACTAGTTTAGTGACATAACACTGTATTAG HindIII 
nirR 
Sirohydrochlorin 
ferrochelatase 
CACAAAGCTAGCATGATTTGGTATACAATAC NheI 
CGTTAGTGCTCGAGTATTTTCATTGGAATC XhoI 
cysG2 
Precorrin-2 
dehydrogenase 
AAGGAGCTAGCTCAACATGAATATGCCATTAATG NheI 
CGCTACTCGAGTCTTACATCCAACCACGCTA XhoI 
Complementation 
experiments 
 
cysG1 
Uroporphyrin III 
methyltransferase 
GAACGTAGATCTATGTCTGTAGAGGAATATG Bgl II 
TTATTCTCGAGAAATTAGTGACATAACACTG XhoI 
cysG2 
Precorrin-2 
dehydrogenase 
AAGGACCATGGTCAACATGAATATGCCATTAATG NcoI 
CAAAGCTTCCGACTAGTTTATCTTACATCCAACCACGC HindIII 
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Protein expression and purification 
CysG1 (N-terminal-His-tag), NirR (C-terminal-His-tag) and CysG2 (C-
terminal-His-tag) proteins from S. aureus and HemC, HemDd (HemD domain 
that contains uro´gen III synthase activity) and SirC His-tagged proteins from 
Desulfovibrio vulgaris were purified as described previously (17) (Tables 1 
and 2). Plasmids pET-23b-SacysG1, pET-23b-SanirR, pET-23b-SacysG2, 
pET-14b-DvhemC, pET-14b-DvsirC and pET-14b-DvhemDd were 
transformed, separately, in E. coli BL21STAR(DE3) pLysS competent cells 
and grown in LB medium to an OD600=0.6. At this stage, cells were induced 
with 400 µM of isopropyl β-D-1-thiogalactopyranoside (IPTG) and grown for 
16-20 h, at 20 °C. Cells were harvested by centrifugation (11000 x g, 10 min, 
4°C), resuspended in 20 mM Tris-HCl buffer pH 8 and lysed in a French 
press at 1000 psi. Cells were centrifuged twice (48300 x g, 10 min, 4°C), and 
the soluble fraction was applied onto a Ni2+ Sepharose fast flow column (GE 
Healthcare), previously equilibrated with 20 mM Tris-HCl buffer pH 8, 500 
mM NaCl and 10 mM imidazole. S. aureus CysG1, NirR, CysG2 proteins 
were eluted in 50 mM Tris-HCl buffer pH 8, 500 mM NaCl and containing 500 
mM imidazole. The D. vulgaris HemC, HemDd and SirC proteins were eluted 
in the same buffer that contained 400 mM imidazole. Protein fractions were 
concentrated in an Amicon Stirred Ultrafiltration Cell using a 10 kDa 
membrane (Millipore) and buffer exchanged against 50 mM Tris-HCl buffer 
pH 8 in PD-10 columns (GE Healthcare). This last step was done under 
anaerobic conditions (Coy model A-2463 and Belle Technology) to avoid the 
inactivation of the enzymes. Proteins were judged pure by SDS-PAGE, and 
protein concentration was determined spectrophotometrically, at 280 nm, 
using the following theoretical extinction coefficient (ExPASy software) (18), 
ε280nm=22920 M-1 cm-1 SaCysG2, ε280nm=31665 M-1 cm-1 SaCysG1 and 
ε280nm=8480 M-1 cm-1 DvSirC. 
 
 187 
C
h
ap
te
r 
6
 
Enzymatic assays 
The enzymatic assays were performed under anaerobic conditions in 
a Shimadzu UV-1800 spectrophotometer in the anaerobic chamber 
mentioned above. All reactions were done in 50 mM Tris-HCl buffer pH 8 and 
at room temperature. Kinetic parameters were obtained by fitting the activity 
and substrate concentration values to a Michaelis-Menten equation and 
using GraphPad Prism (GraphPad Software, La Jolla, CA, USA). 
 
Uroporphyrinogen III methyltransferase activity 
Due to its commercial unavailability, the uro´gen III substrate was 
produced anaerobically by incubation of 5 mg of the D. vulgaris His-tagged 
enzymes HemC and HemDd with 1 mg of porphobilinogen (PBG) (Frontier 
Scientific) in a reaction volume of 2 ml. Uro´gen III was separated from the 
His-tagged D. vulgaris enzymes using a Ni2+ Sepharose fast flow column. 
Uro´gen III was diluted in 1 M HCl and its concentration was determined 
spectrophotometrically at 405 nm (ε405=5.4×105 M−1 cm−1).  
So far, precorrin-2 has not been characterized regarding its extinction 
coefficient, and the quantification of the generated precorrin-2 is evaluated 
indirectly through the conversion to sirohydrochlorin (19). Therefore, the 
uro´gen III methyltransferase activity of CysG1 was coupled to precorrin-2 
dehydrogenase activity of D. vulgaris SirC as described previously (15). The 
reaction mixture consisted of 31 µg of S. aureus CysG1, 8 µg D. vulgaris 
SirC, 125 µM S-adenosyl-L-methionine (SAM), 100 µM NAD+ and uro´gen III 
(0.4-7 µM) in a final reaction volume of 1 ml and the formation of 
sirohydrochlorin was observed by following an increase of absorbance at 376 
nm (ε376=2.4×105 M−1 cm−1). 
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Precorrin-2 dehydrogenase activity 
Since the precorrin-2 substrate is also not commercially available, the 
porphyrin was produced using the recombinant plasmid pETcoco-2ABCD 
(Table 2), which expresses a His-tagged form of the following enzymes 
required for the formation of precorrin-2 from δ-aminolevulinic acid (δ-Ala): 
Methanosarcina barkeri uro´gen III methyltransferase (CobA), 
Methanothermobacter thermautotrophicus porphobilinogen synthase 
(HemB), Bacillus megaterium porphobilinogen deaminase (HemC) and 
uro´gen III synthase (HemD). To this end, plasmid pETcoco-2ABCD was 
transformed into E. coli BL21(DE3)Gold competent cells that were grown ,in 
LB medium supplemented with 0.2% (w/v) glucose and ampicillin, to an 
OD600 of 0.5. At this stage, the medium was further supplemented with L- 
arabinose (0.02% w/v), grown for two extra hours, and after addition of 400 
µM IPTG the cells were cultured overnight, at 20°C. Following expression, 
cells were harvested by centrifugation (11000 x g, 10 min, 4°C), the cell pellet 
was resuspended in 50 mM Tris-HCl buffer pH 8, 100 mM NaCl and 
disrupted in a French Cell, at 1000 psi. The soluble fraction was buffer 
exchanged under anaerobic conditions against 50 mM Tris-HCl buffer pH 8 
using a PD-10 column (GE Healthcare). Precorrin-2 was produced by an 
overnight incubation of a reaction mixture that contained 3 ml of the cell 
lysate, 2 mg SAM and 2 mg δ-Ala followed by passage through a Ni2+ 
Sepharose fast flow column, to separate the His-tagged proteins from 
precorrin-2. 
Precorrin-2 dehydrogenase activity was measured by incubation of 
precorrin-2 (2.5 µM) (quantified as described above) with several 
concentrations of NAD+ (0.05-2 mM) and S. aureus CysG2 (4 µg), in a final 
reaction volume of 1 ml. The activity was measured by following the 
appearance of sirohydrochlorin,  
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Sirohydrochlorin ferrochelatase activity 
The sirohydrochlorin substrate was also prepared enzymatically by 
transforming the recombinant pETcoco-2ABCDC, which contains the same 
genes as in pETcoco-2ABCD plus the M. thermautotrophicus sirC (Table2) 
(14), into E. coli BL21(DE3)Gold competent cells. Cell growth, protein 
expression and preparation of cell fraction was done essentially as described 
in the previous section where pETcoco-ABCD was used. Sirohydrochlorin 
was produced by mixing 3 ml of the soluble fraction resultant from pETcoco-
2ABCDC expression, 3 mg NAD+, 2 mg δ-Ala and 3 mg SAM in an overnight 
incubation done under anaerobic conditions, and the sirohydrochlorin formed 
was determined spectrophotometrically. Siroheme was produced by 
anaerobic incubation of sirohydrochlorin (4 µM), (NH4)2Fe(SO4)2 (100 µM) 
and S. aureus NirR (15 µg), in a 1 ml reaction mixture, and its formation was 
followed by the UV–Visible spectroscopy. 
 
Complementation experiments 
Plasmid pACYC-SacysG1SacysG2 was introduced into a strain 
lacking cysG, namely E. coli 302Δa, that is unable to synthesize siroheme. 
Siroheme is the cofactor of sulfite reductase and therefore the strain is also 
unable to reduce sulfite to sulfide requiring a source of sulfide or cysteine to 
grow, as sulfide is a precursor of cysteine synthesis (20). Plasmid pKK223.2-
cysG (16), that was used as a positive control for the synthesis of siroheme, 
and pCIQ-sirCcobA, harboring Methanothermobacter thermoautotrophicus 
sirC and Pseudomonas denitrificans cobA genes (16), were also transformed 
into E. coli 302Δa competent cells and used in the complementation 
experiments. pET-23b-SasirB was transformed into E. coli 302Δa harboring 
pCIQ-sirCcobA or pACYC-SacysG1SacysG2 and used to test in vivo the 
ferrochelatase activity. E. coli 302Δa colonies expressing the desired 
plasmids were diluted in PBS to an OD600 of 0.1 and grown in plates that 
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contained minimal medium supplemented with or without cysteine (0.05 mg 
ml-1) and appropriated antibiotics. The plates were incubated, at 37°C, for 20 
h to 48 h. 
 
6.4. Results 
The amino acid sequences of the enzymes known to perform the 
synthesis of siroheme were used to search homolog proteins in S. aureus 
genome by means of BLAST (21). Two genes were identified as cysG, which 
encode a hypothetical uro´gen III methyltransferase and a precorrin-2 
dehydrogenase/sirohydrochlorin ferrochelatase (Figure 6.2). In order to 
establish how siroheme is biosynthesized in S. aureus, these genes that 
were named cysG1 and cysG2 were cloned, and the proteins were 
recombinantly produced and biochemically characterized.  
  
 
 
 
 
 
Figure 6.2. Genomic organization of genes encoding putative enzymes involved in siroheme 
synthesis in S. aureus Newman. Putative uro´gen III methyltransferase is located 
downstream of the genes encoding nitrite reductase large subunit (NirB) and nitrite reductase 
small subunit (NirD). The putative precorrin-2 dehydrogenase/sirohydrochlorin 
ferrochelatase is located downstream of a gene encoding a putative sulfite reductase 
flavoprotein CysJ.  
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The uroporphyrinogen III methyltransferase of S. aureus  
The CysG1 protein contains 325 amino acids and a molecular mass 
of approximately 40 kDa. This protein shows the highest amino acid 
sequence identity and similarity with the B. megaterium SirA (Table 3), 
although the latter contains several extra residues at the C-terminal (Figure 
6.3).  
 
Table 6.3. Amino acid sequence identity and similarity of homologs of S. aureus CysG1, NirR 
and CysG2 enzymes. Accession numbers: SirA/CobA proteins: S. aureus CysG1 
(WP_000109968.1), B. megaterium SirA (AAA22317.1), Pseudomonas (P.) denitrificans 
CobA (AAA25773.1), E. coli CysG C-terminal 216-457 (WP_000349855.1), Paracoccus (Pa.) 
denitrificans CobA (WP_011748768.1). SirB/CbiX proteins: S. aureus NirR (YP_001333335), 
B. megaterium SirB (CAD48922), Synechocystis sp. CbiX (BAA10794.1), Archaeoglobus (A.) 
fulgidus CbiX (WP_010878224.1), Paracoccus (Pa.) pantotrophus CbiX (A0A023GPI5). SirC 
proteins: S. aureus CysG2 (YP_001333335), B. megaterium SirC (CAD48923) E. coli CysG 
N-terminal 1-223 (WP_000349855.1), Desulfovibrio (D.) vulgaris SirC (YP_010682), 
Saccharomyces (Sac) cerevisae Met8p (NP_009772.1). 
 
 Identity (%) Similarity (%) Query cover (%) 
SirA (uro´gen III 
methyltransferase)    
B. megaterium 44 62 76 
P. denitrificans 37 54 72 
E. coli 38 55 95 
Pa. denitrificans 37 52 73 
SirB (sirohydrochlorin 
ferrochelatase)    
B. megaterium 25 43 81 
Synechocystis sp. 23 40 76 
A. fulgidus 29 53 19 
Pa. pantotrophus 25 42 72 
SirC (precorrin-2 
dehydrogenase)    
B. megaterium 35 61 97 
E. coli 27 50 95 
D. vulgaris 23 42 91 
Sac. cerevisae 22 37 68 
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Figure 6.3. Sequence alignment of S. aureus CysG1 with selected bacterial SUMT proteins. 
The colors represent the conservation of residues from black (high) to light grey (low). 
Accession numbers: S. aureus CysG1 (WP_000109968.1); B. megaterium SirA 
(AAA22317.1); P. denitrificans CobA (AAA25773.1.); E. coli CysG C-terminal 216-457 
(WP_000349855.1); Pa. denitrificans CobA (WP_011748768.1). Proteins were aligned using 
MUSCLE (22). 
 
To investigate whether S. aureus cysG1 encodes a protein able to 
function as uro´gen III methyltransferase, the purified protein was incubated 
with uro´gen III and SAM in vitro. The reaction generated a yellow product 
with a UV-Visible spectrum typical of precorrin-2 (Figure 6.4A) (19). The 
kinetic parameters were obtained by coupling the CysG1 activity with the D. 
vulgaris SirC activity, as described in the methods section. S. aureus CysG1 
converts uro´gen III to precorrin-2 with a specific activity of 7.0 ± 0.6 nmol.mg-
1min-1 and a KM for uro´gen III of 0.3 ± 0.15 µM (Figure 6.4B). As CysG1 
functions as a uro´gen III methyltransferase enzyme we decided to rename 
it as SirA. 
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Figure 6.4. S. aureus CysG1 uroporphyrinogen III methyltransferase activity. (A) UV-Visible 
spectrum of precorrin-2 generated after incubation of uro´gen III with SAM and S. aureus 
CysG1. (B) S. aureus CysG1 activity was observed by coupling its reaction with the reaction 
for precorrin-2 dehydrogenase activity, using D. vulgaris SirC, NAD+, SAM and uro´gen III. 
 
S. aureus CysG2 is a precorrin-2 is dehydrogenase  
 The putative S. aureus precorrin-2 dehydrogenase CysG2 was 
overproduced and purified as described in the materials and methods. It is a 
201 amino acid protein with a molecular mass of approximately 25 kDa. The 
protein exhibits low sequence identity with other known precorrin-2 
dehydrogenases, namely those of E. coli, D. vulgaris, S. cerevisiae and the 
highest identity with the B. megaterium SirC (Table 3). S. aureus CysG2 
contains a sequence that in other proteins constitutes the NAD+ binding site; 
nevertheless, in the S. aureus enzyme the last glycine of this motif is 
substituted by a valine (GlyxGlyxxAlaxxxAlax6Val) (Figure 6.5).  
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Figure 6.5. Amino acid sequence alignment of S. aureus CysG2 with selected bacterial 
precorrin-2 dehydrogenases. The NAD+ binding motif is marked with asterisks. The colors 
represent the conservation of residues from black (high) to light grey (low). Accession 
numbers: S. aureus CysG2 (YP_001333335); B. megaterium SirC (CAD48923); E. coli CysG 
N-terminal 1-223 (WP_000349855.1; D. vulgaris SirC (YP_010682); and Sac. cerevisae 
Met8p (NP_009772.1). Proteins were aligned using MUSCLE (22). 
 
The activity of the S. aureus CysG2 was tested by incubation of the 
purified protein with precorrin-2, which was previously prepared in a reaction 
containing S. aureus SirA and NAD+. Formation of sirohydrochlorin was 
deduced by the change in color of the reaction mixture from yellow to purple, 
and further confirmed by the presence of a maximum peak at 376 nm in the 
UV-Visible spectrum (Figure 6.6A), which is a characteristic of this compound 
(19). The catalytic parameters of the NAD+-dependent precorrin-2 
dehydrogenase activity of S. aureus CysG2 were determined. The 
measurements were done using as substrates, precorrin-2, generated by the 
enzymes expressed from pET-coco2-ABCD, and NAD+, and following the 
appearance of sirohydrochlorin peak at 376 nm. The S. aureus CysG2 has 
a specific activity of 62 ± 2 nmol.mg-1min-1 and a KM for NAD+ of 340 ± 44 µM 
(Figure 6.6B). Therefore, CysG2 was renamed SirC as their homologues in 
B. megaterium and D. vulgaris. 
 
 195 
C
h
ap
te
r 
6
 
 
Figure 6.6. S. aureus CysG2 precorrin-2 dehydrogenase activity (A) UV-Visible spectrum of 
sirohydrochlorin generated after the incubation of precorrin-2 with NAD+ and S. aureus 
CysG2. (B) Activity of the S. aureus CysG2 activity evaluated in the reaction containing 
precorrin-2 and several concentrations of NAD+ (0.05-2 mM) as substrates. 
 
The sirohydrochlorin ferrochelatase of S. aureus 
BLAST search of the S. aureus Newman genome did not retrieve a 
gene encoding a sirohydrochlorin ferrochelatase (SirB). Since S. aureus SirA 
and SirC showed the highest amino acid sequence identity and similarity to 
B. megaterium (Table 3), a more extensive BLAST search was done using 
B. megaterium sirohydrochlorin ferrochelatase SirB. The new search 
retrieved nirR gene annotated as nitrite reductase regulator (NirR). This gene 
is located upstream of nirBD that encodes the nitrite reductase large subunit 
(NirB) and the nitrite reductase small subunit (NirD) (Figure 6.7). S. aureus 
NirR shares 25% sequence identity and 43% similarity to the B. megaterium 
SirB (Table 3).  The nirR gene has 732 bp and its initiation codon is annotated 
as GTG, which encodes a valine amino acid instead of a methionine. 
Therefore, we searched in the upstream region of this erroneously annotated 
initiation codon for nucleotides encoding a methionine amino acid, which was 
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found 39 bp apart creating a gene with 771 bp. After cloning this gene into 
pET-23b, the protein was expressed and purified for further analysis. 
 
 
 
 
 
The expression of NirR generated a poorly soluble protein of 255 
amino acid with a molecular mass of approximately 29 kDa. To test if S. 
aureus NirR works as a sirohydrochlorin ferrochelatase, an in vitro reaction 
was performed in the presence of Fe2+ and sirohydrochlorin, which was 
generated by the proteins expressed from pETcoco-2ABCDC. Incubation of 
S. aureus NirR with sirohydrochlorin and ferrous iron produced a significant 
change in the sirohydrochorin UV-Visible spectrum towards the formation of 
a spectrum characteristic of siroheme (Figure 6.8) (23). We therefore 
concluded that NirR has sirohydrochlorin ferrochelatase activity, and the 
protein was renamed SirB as it homolog protein in B. megaterium. 
 
 
 
 
Figure 6.7. Genomic organization of nirR gene upstream genes encoding nitrite reductase 
large subunit (NirB) and nitrite reductase small subunit (NirD) in S. aureus Newman. 
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Figure 6.8. UV–Visible spectra of siroheme (dashed line) after the incubation of 
sirohydrochlorin (solid line) with (NH4)2Fe(SO4)2 and S. aureus NirR/SirB. 
 
Despite the low sequence identity (around 25%) to other known 
SirB/CbiX proteins (Table 3), the amino acid sequence alignment of S. 
aureus SirB with orthologues reveals conservation of the histidine residues 
essential for sirohydrochlorin ferrochelatase activity. His22 (S. aureus 
numbering) present in all aligned sequences, His86 (S. aureus numbering), 
are conserved in B. megaterium and Archeoglobus fulgidus, and His145 (S. 
aureus numbering) is found in the amino acid sequences of D. vulgaris and 
P. pantotrophus (Figure 6.9). The conservation of these histidine residues 
corroborates the role of S. aureus SirB as a sirohydrochlorin ferrochelatase 
enzyme. 
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Figure 6.9. Amino acid sequence alignment of S. aureus SirB with selected bacterial 
SirB/CbiX enzymes. The colors represent the conservation of residues from black (high) to 
light grey (low). Asterisks represent histidine amino acids required for sirohydrochlorin 
ferrochelatase acitivity in selected SirB/CbiX homologs. Accession numbers: S. aureus SirB 
(YP_001333335); B. megaterium SirB (CAD48922); P. pantotrophus cbiX (A0A023GPI5); D. 
vulgaris CbiKP (WP_010937953.1); and A. fulgidus cbiX (WP_010878224.1). Proteins were 
aligned using MUSCLE (22). 
 
In vivo role of S. aureus SirA, SirB and SirC enzymes 
The E. coli cysG deletion mutant Δ302a is unable to synthesize 
siroheme and can only grow in minimal medium when supplemented with 
cysteine, sulfide or when transformed with plasmids carrying genes that 
encode proteins that perform the biosynthesis of siroheme (20).  
To investigate whether S. aureus SirA, SirB and SirC proteins 
produce siroheme in vivo, we have done complementation experiments 
using the strain described above. First, the S. aureus SirB was tested for its 
sirohydrochlorin ferrochelatase activity in vivo. The S. aureus sirB gene was 
 199 
C
h
ap
te
r 
6
 
transformed into E. coli Δ302a together with M. thermoautotrophicus sirC and 
P. denitrificans cobA and grown in minimal medium without cysteine. We 
observed that the presence of the three genes in E. coli Δ302a allowed the 
growth of the strain in the absence of cysteine supplementation (Figure 
6.10A), thus confirming the role of S. aureus SirB as a sirohydrochlorin 
ferrochelatase.  
The three proteins of S. aureus, SirA, SirC and SirB were also tested 
together in E. coli Δ302a to infer their role in siroheme biosynthesis in vivo. 
After the transformation of the three genes, the growth of this strain was 
assessed in a minimal medium that did not contain cysteine. We observed 
that E. coli Δ302a carrying S. aureus sirA, sirB and sirC genes relieved the 
cysteine auxotrophy phenotype (Figure 6.10B). Therefore, we conclude that 
in S. aureus three consecutive steps are required for siroheme synthesis 
which are performed by the newly renamed SirA, SirB and SirC. 
Figure 6.10. S. aureus produces siroheme using SirA, SirB and SirC. CysG represents the 
growth of E. coli 302Δa strain carrying pKK223.2-cysG, used as positive control, and control 
represents the growth of E. coli 302Δa strain carrying an empty pET-23b, used as negative 
control. All strains were grown in the absence of cysteine. (A) E. coli 302Δa strain expressing 
M. thermoautotrophicus SirC and P. denitrificans CobA (pCIQ-sirCcobA) plus S. aureus SirB 
(pET-23b-SanirR). (B) E. coli 302Δa strain expressing S. aureus SirA and SirC (pACYC-
SacysG1SacysG2) plus S. aureus SirB (pET-23b-SanirR). 
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6.5. Discussion 
In this work, we have identified and characterized for the first time the 
proteins that are required to perform the biosynthesis of siroheme in S. 
aureus. These genes were named sirA, sirB and sirC, as their B. megaterium 
counterparts, and encode a uroporphyrinogen III methyl-transferase, a 
sirohydrochlorin ferrochelatase and a precorrin-2 dehydrogenase, 
respectively. Contrary to B. megaterium, these genes are not organized in a 
single operon (11), but instead are widespread in the genome of S. aureus, 
with sirA and sirB being relatively closely located: sirA is part of the nirBD 
operon which is located downstream of nirD, while sirB is located upstream 
of the nirBD operon (Figure 6.2 and 6.7). The sirC gene is found in a different 
region of the genome (Figure 6.2). 
Although S. aureus sirA and sirC were annotated as cysG, which in 
E. coli encodes a single siroheme synthase that is capable of performing all 
the steps involved in siroheme synthesis, we have demonstrated that these 
two gene products are required to perform the uroporphyrinogen III methyl-
transferase and precorrin-2 dehydrogenase, respectively. The kinetic 
parameters obtained for uroporphyrinogen III methyl-transferase activity of 
S. aureus SirA (7.0 nmol.mg-1min-1 and a KM of 0.3 µM for uro´gen III) are 
similar to those reported for D. vulgaris CobA (3 nmol.mg−1min−1 and a KM of 
0.4 µM for uro´gen III) (15).  
Despite the high amino acid sequence identity between the S. aureus 
and B. megaterium SirA (Table 3), the first has 87 extra amino acids residues 
in the C-terminal. Although the role of these residues are not known, it is 
possible that they are required for the correct folding of the protein.  
Unlike the CysGB of E. coli, the S. aureus SirC does not have 
ferrochelatase activity and only acts as a precorrin-2 dehydrogenase. This 
protein has a specific activity of 62 ± 2 nmol.mg-1min-1 which in the same 
order of magnitude of activity reported for B. megaterium SirC (60 
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nmol.mg−1min−1) (11). On the other hand, S. aureus SirC has a much lower 
activity and also lower affinity for NAD+ (340 ± 44 µM) when compared to D. 
vulgaris SirC (700 nmol.mg−1min−1 and KM for NAD+ of 70 µM) (15). 
The genome of S. aureus does not describe a homolog protein of 
SirB, which is probably due to low sequence identity of the protein with the 
other bacterial homolog proteins. This first led us hypothesize that S. aureus 
SirC would have a dehydrogenase/chelatase activity similar to what was 
observed for CysGB of E. coli and Met8p of Sac. cerevisiae (8, 10). However, 
S. aureus SirC shows no ferrochelatase activity. A suitable candidate was 
found in the gene annotated as nirR, which was shown to encode a functional 
sirohydrochlorin ferrochelatase as attested by the generation of siroheme 
when the enzyme is incubated with sirohydrochlorin and ferrous iron (Figure 
6.8). 
Overall, this work revealed that S. aureus has a functional pathway 
to produce siroheme that involves three independent enzymes, which has 
enlarged our knowledge on the metabolism of tetrapyrrole biosynthesis in 
this important pathogen. 
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7.1. The coproporphyrin-dependent pathway of Staphylococcus 
aureus  
For several years, bacteria were known to synthesize heme through 
the protoporphyrin-dependent (PPD) pathway, but this notion was 
challenged upon the discover of the siroheme-dependent (SHD) pathway (1), 
that is currently considered to be the more ancient route for the synthesis of 
heme. The work presented here also uncovered a third route used by S. 
aureus to synthesize heme, namely the coproporphyrin-dependent (CPD) 
pathway. This route involves the decarboxylation of uro´gen III to copro´gen 
III, oxidation of the latter to coproporphyrin III, insertion of iron into 
coproporphyrin III yielding iron-coproporphyrin III or coproheme and, in the 
last step, the decarboxylation of iron-coproporphyrin III to heme. Dailey and 
co-workers have proposed that this pathway is active in Gram-positive 
bacteria, mostly in Firmicutes and Actinobacteria (2). Hence, it is now known 
that heme may be synthetized through three pathways that share the 
common intermediate uro´gen III but differ at the stage at which the ferrous 
iron is inserted into the porphyrin, and in the type of the intermediates that 
are formed along the route. 
The CPD and the PPD pathways have a common first enzymatic 
reaction in which uro´gen III is converted to coproporphyrinogen III, and that 
is catalyzed by the uro´gen III decarboxylase enzyme (HemE). In the next 
step of the CPD pathway, copro´gen III is oxidized to copro III by the 
coproporphyrin synthase or copro´gen oxidase HemY (Chapter 4). Similarly, 
the penultimate step of the PPD pathway is carried out by proto´gen oxidase 
HemY that promotes the oxidation of protoporphyrinogen IX to 
protoporphyrin IX (proto IX). The overall structure of the HemY´s that operate 
in the CPD and PPD pathways is similar and the major differences between 
the two structures occur at the active site. The CPD HemYs present a 
substrate pocket that is larger and more positively charged than that of  the 
PPD HemYs, and this difference is most likely due to the need to 
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accommodate the two extra propionate side chains of copro´gen III (3). 
Nevertheless, the similarity of the overall structures suggests that the two 
families of enzymes use a similar reaction, which consists in a six-electron 
oxidation where oxygen acts as electron acceptor and that generates H2O2. 
Interestingly, while in B. subtilis, that uses the CPD route, the HemY enzyme 
is also capable of oxidizing proto´gen IX (4), the S. aureus HemY cannot 
perform this reaction (Chapter 4). 
In the CPD pathway, the insertion of iron into the copro III substrate 
occurs in the penultimate step, whereas in the PPD pathway the insertion of 
iron into proto IX occurs in the last step. In the SHD pathway, iron is inserted 
into sirohydrochlorin to yield siroheme that is then converted to heme in three 
additional and consecutive steps catalyzed by the enzymes AhbA and AhbB, 
AhbC and AhbD. In spite of these differences, the copro III and proto IX 
ferrochelatases have resembling structures differing mainly by the presence 
of an extra loop in the active site of the protoporphyrin ferrochelatases. The 
absence of this loop in the active site of coproporphyrin ferrochelatases is 
proposed to allow the housing of the bulkier coproporphyrin substrate (2).  
The last reaction of the CPD pathway is the decarboxylation of the 
two propionate side chains of coproheme to yield heme catalyzed by HemQ. 
In the SHD pathway a similar reaction also occurs that is promoted by AhbD 
(1). Although both proteins decarboxylate coproheme by two consecutive 
steps, the proteins are structurally and mechanistically different. While 
HemQ is a homopentamer in a donut-shape structure that does not require 
any cofactor but uses an electron acceptor for the reaction, AhbD is a 
monomeric protein arranged in a Triosephosphate Isomerase (TIM) barrel-
like motif that harbors two iron-sulfur clusters and promotes the cleavage of 
S-adenosyl methionine to perform the decarboxylation reaction (5). In S. 
aureus, HemQ firstly decarboxylates the ring A of coproheme forming 
monovinyl, in a reaction that requires one molar equivalent of H2O2, and then 
promotes the decarboxylation of ring B generating heme. This last reaction 
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is slower and requires, at least, five molar equivalents of H2O2 (Figure 
4.6/Chapter 4). In contrast, HemQ of Listeria requires 2 molar equivalents of 
H2O2 for the complete decarboxylation of both propionates (6). Although, in 
vitro HemQ enzymes use FMN and H2O2 as acceptors (7), the in vivo 
electron acceptor of this decarboxylation reaction is not yet know. 
Some of the genomes of bacteria predicted to synthesize heme via 
the CPD pathway encode two coproheme descarboxylases, HemQ and 
AhbD (2). We speculate that HemQ will be active under aerobic conditions, 
while AhbD would function under anaerobic conditions. Similarly, some 
Gram-negative bacteria with the PPD pathway contain two coprogen 
oxidases, namely HemF and HemN, which are active under aerobically and 
anaerobic conditions, respectively. 
In prokaryotes, the PPD pathway is the most used route and occurs 
frequently in Proteobacteria and Cyanoacteria (8). The CPD branch is largely 
present in Firmicutes and Actinobacteria, but also exists in monoderm to 
diderm transition organisms such as Deinococcus (7). A significant number 
of Firmicutes and few representatives of Actinobacteria also encode a SHD 
pathway, which is mainly present in the Archaea and the denitrifying and 
sulfate-reducing bacteria (8). It is interesting to note that although the SHD 
pathway is considered to be the more ancient route, it seems to be the less 
represented of the heme biosynthetic pathways among bacteria (8).  
 
7.2. Staphylococcus aureus regulates the heme biosynthesis pathway 
by crosstalk with the heme uptake system 
The de novo heme biosynthesis pathway and the heme uptake 
system are two ways which S. aureus uses to obtain heme. However, the 
simultaneous utilization of the two pathways for the same purpose could be 
energetically costly. Therefore, we hypothesized the existence of a crosstalk 
mechanism between the two pathways that could regulate the intracellular 
 212 
heme levels. Furthermore, and as mentioned in Chapter 2, high heme levels 
are extremely toxic for the bacterium and mechanisms are expected to exist 
to tightly regulate the intracellular content of this essential molecule. 
The heme translocated into the cell by the S. aureus Isd system has 
two fates: i) direct incorporation of heme into apo-hemeproteins; and/or ii) 
heme degradation by IsdI and IsdG proposed to yield nutritional iron. 
However, in this work we observed that elevated heme concentrations 
increased the abundance of the IsdG protein (Figure 5.7/Chapter 5), that 
interacts with the coproporphyrin ferrochelatase (Figure 5.6/Chapter 5). 
Moreover, we showed that the interaction of IsdG with HemH decreases the 
coproporphyrin ferrochelatase activity, in a concentration dependent mode 
(Figure 5.5/Chapter 5).  
Although we have shown by FLIM-FRET that IsdG also interacts with 
HemQ (Figure 5.6/Chapter 5), more experiments are required to further 
understand the implication of this interaction on the heme biosynthesis 
pathway. Interestingly, the HemQ protein of Haloferax volcanii was 
previously reported to be fused to a monooxygenase protein (9) which 
suggests that these proteins may function together. Also, in 
Propionobacterium acnes, HemH is fused to HemQ (10). Taking to account 
these observations, and the fact that HemQ catalyzes the enzymatic step 
that follows the reaction promoted by HemH, is tempting to speculate that 
the three proteins HemH/IsdG/HemQ may form an active complex for a 
tighter regulation or better operation of the heme synthesis process. This 
would explain the co-occurrence of IsdG with HemH/HemQ proteins even in 
the absence of an operational heme biosynthesis pathway, as accessed by 
the bioinformatic analysis (Figure 5.8/Chapter 5). Additionally, a complex 
between these proteins would also explain the presence of copro III rather 
than coproheme in the hemQ mutant strain (11), as copro III is the substrate 
for HemH and not for HemQ. 
 213 
C
h
ap
te
r 
7
 
IsdG-type proteins are widely distributed across prokaryotic genomes 
and present in both monoderm and diderm bacteria. IsdG-type proteins are 
also found in organisms that only contain heme uptake systems, thus 
suggesting that they may act as heme oxygenases. Nevertheless, 
differences may exist among IsdG-type proteins of Gram-positive and Gram-
negative bacteria as S. aureus IsdG impairs CPD heme biosynthesis 
pathway but not the PPD pathway (Figure 5.2/Chapter 5), which is the more 
common pathway occurring in Gram-negative bacteria.  
Altogether, we show that in S. aureus there is a crosstalk between 
the two heme supply systems that is promoted by IsdG.  
Other examples of heme regulation involving ferrochelatases have 
been reported. Previous studies have shown that in Bradyrhizobium 
japonicum and in Alphaproteobacteria mainly of the Rhizobiales order, the 
iron response regulator (Irr) modulates heme biosynthesis through the 
interaction with ferrochelatase (12). Irr senses iron indirectly by interaction 
with ferrochelatase upon insertion of iron into proto IX, which occurs in the 
last step of the PPD pathway (12, 13). In iron-replete cells, ferrochelatase is 
active due to the presence of the substrates, protoporphyrin IX and iron, and 
promotes the formation of heme. Irr responds to the iron status of heme 
biosynthesis and forms a complex with ferrochelatase that leads to its 
inactivation. Irr is subsequently degraded upon binding of the heme formed 
through the ferrochelatase activity. Under iron-limiting conditions, the lack of 
iron bound to ferrochelatase activates Irr, which represses the heme 
biosynthesis gene hemB and prevents the accumulation of toxic porphyrins 
(13, 14).  
The control of heme synthesis by Irr differs from what we observed in 
S. aureus. In B. japonicum Irr inhibits heme biosynthesis through the 
repression of heme biosynthetic genes when ferrochelatase is not producing 
heme. In S. aureus, the increase of the IsdG levels triggered by heme 
promote the interaction of IsdG with hemH and the consequent inhibition of 
 214 
the ferrochelatase activity. Although both mechanisms to control heme 
biosynthesis involve ferrochelatase, they are opposed since the regulation 
by Irr requires the disassembling of the ferrochelatase-Irr complex while in 
S. aureus it requires the formation of the ferrochelatase-IsdG complex. 
In humans, frataxin delivers iron to ferrochelatase. It was reported 
that lower concentrations of human frataxin promoted the activity of the 
human ferrochelatase while high concentrations frataxin impairs the 
ferrochelatase activity (15).  
 More recently, a new mechanism of regulation via protein interaction with 
ferrochelatase was described for the purple photosynthetic Rhodobacter 
sphaeroides (16). PufQ regulates the switch between the formation of heme 
and the formation of bacteriochlorophylls, as both products are synthetized 
from protoporphyrin IX in the tetrapyrrole synthesis pathway. Under oxygen-
limited conditions, the PufQ protein interacts with ferrochelatase to impair 
heme synthesis and favors the insertion of magnesium into protoporphyrin 
IX by magnesium chelatase, towards the formation of bacteriochlorophyll 
(16). In this case, PufQ sequesters ferrochelatase thus restricting the 
availability of the protoporphyrin IX substrate. 
Although only three mechanisms to control heme synthesis via 
protein interaction are described so far, it is curious to note that all have in 
common the involvement of ferrochelatase. 
 
7.3. Staphylococcus aureus synthesizes siroheme 
It was previously suggested that S. aureus harbors genes encoding 
proteins putatively involved in siroheme synthesis (17, 18), but the 
organization and characterization of this pathway was never addressed.  
We have shown that S. aureus owns a fully operational siroheme 
biosynthesis pathway, that converts uro´gen III into siroheme in three 
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consecutive reaction steps, carried out by three proteins, namely SirA, SirB 
and SirC. 
S. aureus SirA has uro´gen III methyltransferase activity and 
catalyzes the bis-methylation of uro´gen III into precorrin-2. (Figure 
6.4/Chapter 6). This activity was previously reported to be associated with 
the CysGA domain of the multifunctional CysG enzyme of E. coli (19) and the 
Met1p protein of Sac. cerevisae (20). The amino acid sequence similarity 
observed between S. aureus SirA, the CysGA domain of E. coli and CobA of 
P. denitrificans (Table 3/Chapter 6) suggests for SirA a kidney-like shape 
overall structure, formed by a homodimer with two sequential α/β domains 
(21, 22).  
S. aureus SirC is involved in the second step of the siroheme 
synthesis catalyzing the oxidation of precorrin-2 to sirohydrochlorin (Figure 
6.4/Chapter 6). This NAD+-dehydrogenase activity was previously reported 
for the CysGB and Met8p proteins of E. coli and Sac. cerevisae, respectively 
(19, 20). The crystal structure of these proteins comprises three domains: i) 
an N-terminal Rossmann fold that binds NAD+; ii) a central dimerization 
domain; and iii) a C-terminal helical domain (21, 23, 24).  The high amino 
acid sequence similarity between S. aureus SirC and CysGB and Met8p and 
the presence of NAD+ binding motif at the N-terminal region suggests that S. 
aureus SirC may adopt a similar structure. However, CysGB and Met8p have 
dual activity and perform the insertion of iron into sirohydrochlorin, the last 
step of the pathway, a feature that was not observed for S. aureus SirC. 
In S. aureus, the final step of the pathway is achieved by the 
sirohydrochlorin ferrochelatase SirB that generates siroheme in vitro and in 
vivo (Figure 6.8 and 6.10/Chapter 6). Although CysGB of E. coli and Met8p 
of Sac. cerevisae also have sirohydrochlorin ferrochelatase activity, the 
biochemical properties of S. aureus SirB are more similar to the type-II 
chelatases, such as the protoporphyrin IX ferrochelatase and the bacterial 
CbiK/CbiX (25) including the SirB of B. megaterium (26). 
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The comparison of the amino acid sequence of several 
sirohydrochlorin chelatases (Figure 6.9/Chapter 6) shows the conservation 
of several histidine residues that were previously reported to modulate the 
chelatase activity and/or being involved in metal binding. For example, two 
of the residues that in A. fulgidus CbiXs (His10 and His75)  are proposed to 
be involved in metal binding (27), are also present in S. aureus SirB (His22 
and His86).  
D. vulgaris contains two types of cobaltochelatases, CbiKC and CbikP, 
that are both able to insert iron into sirohydrochlorin (28). CbikP has higher 
iron chelatase activity and it was demonstrated that His182 is the most 
important residue for iron chelation into sirohydrochlorin (29). In P. 
pantotrophus CbiX, the equivalent His127 is proposed to be involved in 
substrate and metal binding (30). This histidine residue is conserved 
(His145) in S. aureus SirB. Interestingly, and in spite of the high amino acid 
sequence similarity between S. aureus and B. megaterium SirB proteins 
(Table 6.3/Chapter6), the latter does not contain this residue.  
The chelatase activity is also proposed to rely on another histidine 
residue that is present in D. vulgaris CbiKP (His244) and P. pantotrophus 
CbiX (His187) (29, 30). In S. aureus SirB, this amino acid is replaced by the 
positively charged Lys209, suggesting that this lysine residue could be 
important for the chelatase activity.  
Therefore, the catalytic site of S. aureus SirB is predicted to 
accommodate residues His22, His86, His145 and possibly Lys209 that are 
expected to be involved in metal/substrate binding and/or chelatase activity. 
Type II chelatases are monomers or homodimers with a mixed α/β 
architecture. Larger type II chelatases, such as SirB, CbiXL, CbiK and HemH, 
are proposed to have evolved from CbiXS by a gene duplication and fusion 
event (25, 27) and the residues forming the active site are either located in 
the N-terminal or C-terminal regions (25). In B. megaterium SirB and CbiXL, 
the residues that form the active site are present in the N-terminal region 
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(25), while in D. vulgaris CbikP, Salmonella enterica CbiK and P. 
pantotrophus, these residues are located in the C-terminal region (27, 30). 
This pattern is not observed in S. aureus SirB, as the enzyme contains 
conserved histidine residues, which are proposed to form the catalytic site, 
in the N and the C-terminal regions. Although the importance of His145 in 
the catalytic activity of S. aureus SirB remains to be established, these 
observations may suggest that this protein represents an evolutionary later-
branch point. 
 
7.4. Final remarks 
At the beginning of this work, little information was available on the 
metabolism of porphyrins in S. aureus. The data obtained in this dissertation 
have shown how S. aureus builds up the tetrapyrrole molecules and controls 
the heme biosynthesis pathway. In Figure 7.1 it is schematized the 
tetrapyrrole related pathways of S. aureus which are important for the 
adaptation of the bacteria to different host environments. 
During infection, S. aureus has to survive in the iron-restricted 
environment of the host and faces fluctuating concentrations of O2. S. aureus 
uses the Fur protein to sense iron and under iron starvation conditions Fur 
no longer represses isd genes (31), which triggers the uptake of exogenous 
heme from the host hemeproteins into the cytoplasm. Internalized heme is 
either degraded by S. aureus heme oxygenases, which we proposed to 
mainly occur via IsdI, or is directly incorporated into hemeproteins. 
Nevertheless, under iron-replete conditions, the import of heme still occurs 
and heme is directly incorporated into membrane cytochromes (32, 33).  
In parallel to heme uptake, S. aureus synthesizes heme de novo 
through the heme biosynthesis pathway via coproporphyrin III, using HemE, 
HemY, HemH and HemQ to catalyze the final steps of the route (Chapter 4).  
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The increase of intracellular heme content, resultant from the two 
pathways, elevates the amount of IsdG in the cell (Chapter 5), which 
promotes the interaction with the HemH protein of the CPD pathway. This 
interaction causes the inhibition of HemH ferrochelatase activity and 
therefore impairs the formation of heme through this pathway as shown in 
Chapter 5.  
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  Figure 7.1 Overview of the metabolic heme pathways of S. aureus studied in this dissertation. 
The scheme shows the relationship of S. aureus heme pathways, the heme uptake system 
(proteins in blue), the heme biosynthesis (proteins involved in early steps in grey and the CPD 
pathway in red) and the siroheme pathway (proteins in green). Under low iron conditions, the 
heme uptake system imports heme, which is degraded in the cytoplasm mainly by IsdI. Heme 
biosynthesis provides heme to hemeproteins, KatA (Catalase) and Cyt (cytochrome 
oxidases). On the other hand, HemH and HemQ of the heme biosynthesis are inhibited by the 
IsdG protein of the heme uptake system. Under low oxygen environments, siroheme is 
synthesized and is incorporated into NirBD (nitrite reductase). L-lactate (Lqo), succinate (Sdh) 
and malate (Mqo) dehydrogenases; suc, succinate; fum, fumarate; L-lac, L-lactate; pyr, 
pyruvate; mal, malate; oxac, oxaloacetate. H+, proton. Ala, aminolevulinic acid. PBG, 
porphobilinogen. HMB, hydroxymethylbilane. Uro´gen III, uroporphyrinogen III. Copro´gen III, 
coproporphyrinogen III. Copro III, coproporphyrin III. Hp, haptoglobin. Hb, hemoglobin. 
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In vivo, S. aureus faces different oxygen tensions which are critical 
for its growth (34). The energy requirements in these different environments 
are in part accomplished by heme, which is synthesized aerobically and 
anaerobically to replenish cytochromes operative in aerobic and anaerobic 
respiration. When colonizing O2-restricted environments, which can be found 
in the abscesses, bone and bone marrow, intestinal lumen and during S. 
aureus biofilm formation (35), S. aureus uses nitrate or nitrite as electron 
acceptors, and in the absence of these electron acceptors the bacteria shifts 
to fermentative metabolism (36). When nitrate is available during  anaerobic 
growth, the NreABC regulator induces the expression of nitrate and nitrite 
reductase genes, as well as the sirB gene, now shown to be involved in 
siroheme synthesis (Chapter 6) (18). As mentioned in Chapter 1, the 
respiratory nitrate reductase (NarGHI) reduces nitrate to nitrite, which is 
further reduced to ammonia by nitrite reductase (NirBD). The latter contains 
a siroheme cofactor that was demonstrated here to be synthesized from 
uroporphyrinogen III via S. aureus SirA (Uro´gen III methyltransferase), SirC 
(Precorrin-2 dehydrogenase) and SirB (Sirohydrochlorin ferrochelatase) 
(Chapter 6). In vivo, the nitrite reductase operon, that includes the sirA gene 
was shown to be upregulated in early adaptation to the mouse lung (37). This 
observation could reflect the accumulation of nitrite in sites infections due to 
the oxidation of nitric oxide produced by phagocytic cells (38). 
S. aureus pathogenesis is commonly associated with small colony 
variants (SCV), which have been frequently isolated from infected patients 
(39). These metabolically inactive persister cells have deficient respiration 
and are known to be more resistant to antibiotics (39). Several heme 
biosynthesis mutants have a SCV phenotype (11, 40, 41), as is the case of 
S. aureus HemH mutant (Figure S4.3/Chapter 4). As shown for other genes 
involved in heme synthesis (40–42), the hemH gene is important for S. 
aureus survival (Figure 5.3/Chapter 5).  
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As persister cells are generally found in biofilms (43), which are quasi-
anaerobic environments, NarGHI, NirBD and proteins for siroheme synthesis 
are expected to play an important role in the dormant phase of the bacteria. 
In agreement, nitrate and nitrite reductase genes are upregulated in S. 
aureus biofilms (44) and the nirA of Mycobacterium tuberculosis, which 
encodes a siroheme containing sulfite reductase, was found to be 
upregulated in cells at the dormant state (45).  
Humans synthesize heme via a PPD pathway (46); moreover, the 
enzymes participating in heme biosynthesis pathway of S. aureus are 
apparently different or absent from the human genome, such as HemQ. We 
also showed that S. aureus HemY resists acifluorfen inhibition contrarily to 
the human HemY homolog (Chapter 4). Therefore, this protein is a possible 
candidate for drug targeting and can contribute to the urgent requirement of 
novel antibiotics to fight S. aureus infections, which has a significant negative 
socioeconomic impact.  
 
To conclude, this thesis provides novel insights into S. aureus 
physiology and metabolism. It elucidates on how these bacteria synthesize 
heme and siroheme, a knowledge that can be extended to other pathogens. 
Additionally, a crosstalk between two heme providing pathways in S. aureus 
was uncovered, a mechanism that is important to maintain non-toxic 
intracellular heme levels. Future studies are required to comprehend all 
biological aspects of this entanglement. Hopefully, the outcomes of this work 
will aid to deal with the urgent problem associated with the infections caused 
by this “superbug”. 
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